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PREFACE 
Behaviour - considered as the dynamic process by which a living 
organism attempts to control its input signals by output actions (Cools, 
1981; Powers, 1973) - is mediated via a vast number of neuronal pro-
cesses within the brain. Most of these processes are neurochemically 
regulated, which accounts for the ability of drugs to affect behaviour. 
Such drugs are used clinically for therapeutic treatment of patients 
suffering from nervous and mental disorders and for producing such 
valuable effects as analgesia, sedation or anaesthesia. In order to 
improve the effective use of drugs for these purposes, it is necessary 
to get more insight into the functional and pharmacological properties 
of central processes that are involved in the regulation of behaviour. 
Many disciplines are involved in this field, including biochemistry, 
neurochemistry, neuropharmacology, neurophysiology, neuroanatomy, 
physiological psychology, and psychiatry. Each of these uses its own 
characteristic methods with their own specific advantages and dis-
advantages. 
This thesis deals with the effects of intracerebrally injected drugs 
on morphine-induced behaviour of cats. The aim of this work is to in-
vestigate whether the morphine-induced behaviour of cats, in combina-
tion with intracerebral injection of drugs, may be a new and suitable 
method for the study of the pharmacological and functional properties 
of neurotransmission (NT-)processes in the brain. This method may have 
substantial advantages compared to other methods: 
Within the context of this thesis, the term neurotransmission is 
used in the broadest sense of the word, i.e. neuronal communication 
involving neurochemicals. 
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1. The intracerebral injection technique enables us to change pharmaco­
logically the activity of specific NT-processes in anatomically cir­
cumscribed regions of the brain. 
2. The highly structured organized behaviour of morphine-treated cats, 
together with their characteristic behaviour patterns, enables us 
to detect subtle changes in their behaviour following the intra­
cerebral injection of drugs (Cools et al., 1974; Chapter 2). 
3. The use of behaviour as an experimental variable enables us to per­
form experiments гп vivo in unanaesthetized animals. 
4. The drug-induced behaviour provides a test-situation in which the 
animals move freely, not constrained - as in avoidance or operant 
behaviour - by a learned task. 
5. Results are obtained in acute experiments; training is not required. 
6. An advantage of cats as experimental animals is that the larger di­
mensions of their brains compared with those of such other laboratory 
animals, so as mice or rats, allow more definite conclusions about 
any specific location of the intracerebrally evoked effects. 
7. The morphine pretreatment enables us to study the action of morphine 
on central NT-processes. The cat is a suitable experimental animal 
for this purpose as most of the morphine-induced effects are similar 
in both man and cats (see sections 1.3 and 1.4) 
Several aspects of NT-processes are selected in order to investigate 
whether the present method is, indeed, suitable for the study of central 
NT-processes: 
1. The_functional_activitY_of_NT-2rocesses_at_the_behaviour_level 
The existence of NT-processes within a particular brain region can 
be established on the basis of histochemical and biochemical studies. 
Their functional activity, however, can be only established by assess­
ing their ability to produce biological responses. These biological 
responses can be measured at different levels, e.g. at the electro­
physiological, biochemical, physiological, or behaviour level. 
Especially, their functional activity at the behaviour level is of 
interest as it indicates which NT-processes may play a critical role 
in the ability of drugs to prevent or cure disturbed behaviour. 
Little is known about the functional activity, at the behaviour 
level, of NT-processes within the septal nuclei although this brain 
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structure has been implicated in a wide variety of behaviours, e.g. 
avoidance behaviour, operant responding, and food and water intake. 
In the present study, it is investigated a) whether the morphine-
induced behaviour of cats may serve as a suitable tool for the dis-
closure of septal evoked effects, and b) whether the present method 
may enable us to establish the functional activity of septal NT-
processes at the behaviour level. Septal, cholinergic processes are 
selected for the first purpose as these processes have already 
previously been implicated in behaviour (section A.2). Septal, 
dopaminergic and endorphinergic processes are selected for the 
second purpose as these processes were previously unknown to be 
involved in behaviour. 
ïtie_Eiî§IÏÏ!2£2Î2Si£êi £!2aE§£ÏÊE_°£_EÊ£SEÏ2E_2iï£5 
It is known that multiple receptor sites exist for one and the same 
neurotransmitter. These receptor subtypes can be differentiated in 
several ways, e.g. biochemically, anatomically, histochemically and 
pharmacologically. Especially, the pharmacological character of re-
ceptor sites are of interest, e.g. for researchers, neurologists 
and psychiatrists, as it indicates how the activity of specific 
neuronal systems can be changed pharmacologically, e.g. in order to 
prevent or cure disturbed behaviour. It is investigated as to whether 
the present method may enable us to establish the presence and phar-
macological character of particular subtypes of receptors within the 
septal nuclei. Dopamine receptors (section 4.3) and opiate receptors 
(section A.4) are selected for this purpose as it is known that sub-
types of receptors exist for both dopamine and opiates. 
!!ίΕ_£1§ΐϊίΐΐίί£Σ_2ί_Ϊ!Τ I2E°£Ë5S e s 
The flexibility of NT-processes, i.e. their ability to adjust their 
properties to changes in NT-activity, is a mechanism which enables 
NT-processes to maintain homeostasis. It is quite possible that this 
flexibility of NT-processes may play a critical role in the develop-
ment of tolerance to and dependence on the effects of drug treatments. 
Flexibility has been reported especially for noradrenergic processes. 
Noradrenergic processes in the raphe nuclei have been implicated in 
the behaviour effects of morphine. Hence, it is investigated whether 
the present method may enable us to get more insight into the flex-
ibility of noradrenergic processes within the raphe nuclei and to 
I I 
investigate whether this flexibility may play a role in the develop-
ment of tolerance to morphine (section 3.1). 
Brain functioning is dependent on interactions between NT-processes. 
Disturbance of normally occurring interactions between NT-processes 
is a major cause of nervous and mental disorders in man, e.g. an im-
balance between central dopaminergic and cholinergic interactions, 
particularly within the caudate nucleus, is generally thought to be 
one of the etiological factors in Parkinson's disease. The functional 
relationship between NT-processes is of interest, e.g. for neurol-
ogists, as it enables them to treat the consequences of dysfunction-
ing NT-processes not only by manipulation of the disturbed pro-
cesses, but also by manipulation of functionally related processes, 
e.g. both dopamino-mimetics and anticholinergics are beneficial in 
the treatment of Parkinson's disease. As there is some evidence that 
not only NT-processes in the caudate nucleus but also NT-processes 
in the septal nuclei may play an important role in the central 
dopamine-acetylcholine interactions and, consequently, in the etio-
logy of Parkinson's disease, it is investigated whether the present 
method may enable us to achieve more insight into the functional 
relationship between dopaminergic activity in the caudate nucleus 
and a dopamine-acetylcholine balance in the septal nuclei (Chapter 
5). 
5. The_action_of_mor2hine_on_NT-£rocesses 
Morphine, a drug belonging to the group of natural opium alkaloids, 
is known already over the centuries because of its therapeutic prop-
erties, which are used clinically for allaying severe pain and al-
leviating anxiety, and its euphoric properties, which account for 
its compulsive abuse by addicts (for the history of morphine see 
section 1.2). More knowledge of the mechanism of action of 
morphine is a prerequisite to achieve an improved therapeutic use 
and a decreased abuse of morphine. Much controversy exists about 
morphine's action on central NT-processes. This may be partly due 
to the fact that most studies investigate morphine's overall effect 
on complex neuronal systems, which may mask morphine's action on 
single neuronal systems, and partly due to the fact that most studies 
pay little attention to the time-pattern of the morphine-induced ef-
12 
fects. It is investigated as to whether the present method may en-
able us to distinguish morphine's action on two pharmacologically 
distinct, dopaminergic processes in the caudate nucleus, and to 
establish a distinct role of these dopaminergic processes during 
different periods after morphine administration (section 3.2). 
Morphine affects NT-activity within a particular brain structure 
either directly via opiate receptors within that structure or in-
directly via fibres afferent to that structure. It is investigated 
as to whether the present method may enable us to establish whether 
morphine's action on septal neuronal activity is mediated via an 
direct action on the septal opiate receptors or via an indirect 
action on septal afferent fibres (section 4.4). 
The present investigations show that morphine-induced behaviour of 
cats is, indeed, a suitable tool for the study of pharmacological 
and functional properties of central NT-processes. In other words, 
it provides a new method for extending our knowledge of NT-processes 
in the brain. 
References 
Cools, A.R., H.J. Janssen and C.L.E. Broekkamp, The differential role 
of the caudate nucleus and the linear raphe nucleus in the initia-
tion and the maintenance of morphine-induced behavior in cats, 
Arch. int. Pharmacodyn. 2J_0, 163 (1974). 
Cools, A.R., Aspects and prospects of the concept of neurochemical and 
cerebral organization of aggression: introduction of new research 
strategies in "brain and behaviour" studies. In: The Biology of 
Aggression, NATO-study Institute, in press (1981). 
Powers, W.T., Behavior: The Control of Perception, Aldine Publishing 
Company, Chicago (1973). 
13 
CHAPTER 1 
MORPHINE-INDUCED EFFECTS: A GENERAL INTRODUCTION 
I.1 INTRODUCTION 
Morphine - belonging to the group of the natural opium alkaloids -
is a well-known drug already over the centuries because of its thera-
peutic properties, which are used clinically for allaying severe pain 
and alleviating anxiety, and its euphoric properties, which account for 
its abuse by addicts. In this thesis, advantage is taken of another 
property of the opiate agonist, viz. its ability to evoke a particular, 
species-specific behaviour syndrome in cats. This morphine-induced be-
haviour in cats is, in combination with intracerebral injection of 
drugs, introduced as a new method for the study of the pharmacological 
and functional properties of neurotransmission processes in the brain. 
As a general introduction to this subject, a survey is given of the 
overt effects of morphine in man and the cat, with the main emphasis 
on pure behaviour effects (section 1.3). Behaviour is closely related 
to various events taking place inside the organism. Accordingly, ef-
fects of morphine on such events may, at least partly, underly the 
behaviour effects of the opiate agonist. Therefore, a summary of the 
more specific effects of morphine in man and the cat is also given 
(section 1.4). It will be indicated that most of the morphine-induced 
effects in the cat are similar to those in man. This close similarity 
between man and the cat makes it feasible to use cats as experimental 
animals for the study of morphine's mechanism of action. More insight 
into this mechanism of action is a prerequisite for achieving an im-
proved therapeutic use and a decreased abuse of morphine. The action 
of morphine on central neurotransmission processes is, therefore, one 
of the subjects investigated within the scope of this thesis. As an 
introduction to this subject, data from literature over the central 
effects of morphine in cats is reviewed (section 1.5). But, first of 
all, the fascinating history of morphine will be shortly summarized 
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(section 1.2). The experimental method, i.e. the analysis of the experi-
mentally evoked effects on the morphine-induced behaviour of cats, is 
discussed in Chapter 2. 
1.2 HISTORY OF MORPHINE 
The therapeutic and euphoric properties of opiates like morphine have 
been known already for a very long time. Gradually, but in an ever in-
creasing tempo, some aspects of the working-mechanism of these drugs 
have been disclosed. The history about the discoveries made in this 
field until now are fascinating, and, for those who are not acquainted 
with it, it is shortly summarized below (for references to the older 
literature, the reader is referred to Krueger et al. (1943)). 
The ancient Sumerians (4000 B.C.) depicted in their hieroglyphics 
a plant of joy; it might be that they were acquainted with the euphoric 
properties of the poppy plant. Papaver Somniferum, which is indigenous 
to Asia Minor. Also Theophrastus (third century B.C.) mentioned the pop-
py juice in his writings. The air-dried juice of the un-ripe fruit of 
the poppy plant was called opium (after the Greek word for juice). 
Arabic physicians were acquainted with the analgesic and stopping 
action and, probably, with the narcotic and euphoric action of opium. 
Arabic traders introduced the drug into the Orient and China, where it 
was mainly used in the treatment of dysenteries. In the 16th century, 
the most important pharmacological properties of the drug were known 
in Europe, and it was already regularly used in medical sciences at 
that time. The opium preparation laudanum, which was compounded by 
Paracelsus (1493-1541), is still in use today. In 1803 the most im-
portant component of opium was isolated by the German pharmacist 
Sertuner; it was called morphine after Morpheus, the Greek god of 
dreams. Later on, other opiate alkaloids were discovered, e.g. codeine 
(1832) and papaverine (1848). By the middle of the 19th century the 
medical world began to use pure alkaloids rather than crude opium pre-
parations. Pharmacists and chemists tried to synthesize substitutes for 
morphine. The synthesis of meperidine (pethidine), the first synthetic 
narcotic analgesic, may be considered as a great triumph. Nowadays, 
several synthetic opiates are commercially available; because of the 
difficulties involved in the synthesis, also many semi-synthetic deri-
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vatives are prepared from morphine. The development of synthetic sur-
rogates of morphine had important consequences for the clinical applica-
tion of opiates and also for the progress in opiate research. Clinically, 
some synthetic agents have distinct advantages over morphine, e.g. a 
higher potency, a higher oral effectiveness, a lower addiction liability, 
or a longer duration of action. Methadone was not only useful as a mor-
phine substitute, developed for pain relief, but it found also applica-
tion for gradual discontinuation of morphine-abuse by the narcotic 
addict. Furthermore, methadone, being a racemate, could be resolved in-
to an active levorotatory isomer and an inactive d-isomer and these two 
substances were used to establish stereospecificity of narcotic action. 
For similar purposes another enantiomorph pair was used more extensive-
ly, viz. levorphanol and dextrophan, which were synthesized shortly 
after methadone. In 1915, Pohl reported antagonism of morphine- and 
heroin-induced respiratory depression by N-allylnorcordeine. The true 
impact of this discovery was not realized at that time. In the period 
between 1941 and 1943, N-allylnormorphine was synthesized in an attempt 
to synthesize a morphine surrogate with fewer respiratory depressant 
properties and lower addiction liability than morphine (Hart and 
McCawley, 1944). It appeared that this compound could antagonize the 
action of morphine. In 1952, Eckenhoff reported a successful clinical 
usage of nalorphine as an antidote for narcotic overdosage. In 1953, 
Wikler et al. reported precipitation of withdrawal symptoms by nalor-
phine in subjects who had received morphine, methadone, or heroin. 
Since then, search for better narcotic antagonists led to the intro-
duction of several specific antagonists (e.g. naloxone and naltrexone). 
One of the best known properties of morphine and its congeners (e.g. 
heroin) is the addicting action characterized by the development of 
tolerance to and dependence on the drug's action. The Greek physicians 
were already acquainted with it, but opium smoking first became popular 
in the 18th century. The discovery of pure opium alkaloids, the inven-
tion of the hypodermic needle, the advent of opium smoking Chinese 
labourers and the extensive use in the U.S.A. of morphine among wounded 
Civil War soldiers led to an increased compulsive drug abuse. The re-
cognition of this serious drawback of morphine stimulated a research 
for potent analgesics that would not lead to compulsive drug abuse. 
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Almost all the potent narcotic analgesics have similar characteris­
tics with respect to their chemical structures. These minimal structural 
features usually associated with narcotic analgesic activity are: 
1) a quaternary carbon atom, 2) an phenylgroup linked to this carbon, 
3) a tertiary aminogroup linked to the quaternary carbon atom through 
a chain of 2 saturated carbon atoms, and A) a relatively small group 
linked to the aminogroup. 
The observations that the various opiate drugs had common structural 
properties, that enantiomerics of the narcotic drugs showed great dif­
ferences in potency, and that structurally related specific opiate 
antagonists existed, indicates the existence in the brain of specific 
opiate receptors. Using low concentrations of radioactively labelled 
opiate agonists or antagonists of high specific activity and with the 
help of repeated washprocedures, stereospecific binding of these agents 
to brain homogenates was demonstrated in 1973. This was realized in­
dependently by three different groups of workers: Simon (1973), Snyder 
et al. (1974) and Terenius (1973). It is only reasonable that evolution 
did not produce specific receptor sites in animals for the sole purpose 
of receiving an external stimulus, such as narcotic drugs. Accordingly, 
the existence was postulated of endogenous substances within the brain 
that act on the opiate receptors. The existence of such endogenous 
opiate ligands was further strenghtened by the observations that 
electrical stimulation of the periaqueductal grey of rats produced' 
analgesia (Reynolds, 1969) and that such stimulation-produced analgesia 
was antagonized by the opiate antagonist naloxone (Akil et al., 1976). 
Hughes (1974) isolated an endogenous substance with opiate activity; 
it was called "enkephalin" (after the Greek word for head) and appeared 
to be a mixture of two peptides, H-Tyr-Gly-Gly-Phe-Met-OH (Met-enke-
phalin) and H-Tyr-Gly-Gly-Phe-Leu-OH (Leu-enkephalin). Further research 
resulted in the discovery of other opiate-like peptides called "endor­
phins" (after endogenous morphine) . According to the sequence of their 
discovery, the endorphins received the prescripts α, В and γ. It appeared 
that with exception of Leu-enkephalin all opiate-like peptides (opioid 
peptides) were fragments of the polypeptide B-lipotropin (ß-LPH), viz. 
Met-enkephalin (8-LPHfi._fi[.), α-endorphin (ß-LPH,,-,), ß-endorphin 
(ß-LPH,._„.), and γ-endorphin (ß-LPH,,
 7 7 ) . Various reviews appeared 
dealing with the discovery of the opiate receptors, the endogenous opiate 
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ligands, and their distribution over the brain (e.g. Adler, 1980; Chau-
Pham, 1978; Frederickson, 1977; Goldstein, 1974; Miller and Cuatrecasas, 
1978; Simon, 1981; Snyder, 1975, 1977; Snyder and Simantov, 1977). The 
Met- and Leu-enkephalin containing neuronal system seems to be comprised 
of many cellgroups with short fibre systems distributed over the brain. 
The (3-endorphin containing system shows one cellgroup in the hypothalamus 
with major fibre paths coursing to several brain regions. The endogenous 
opioid peptides and their synthetic analogues have, in general, pharmaco-
logical properties similar to those of the exogenous opiates. It was 
found that the ranking order of potencies with which unlabelled ligands 
displaced binding of labelled ligands is dependent on the type of 
labelled ligand used. This indicated the existence of either a single 
class of opiate receptors that can exist in several conformational 
states or, alternatively, of multiple types of opiate receptors with 
distinct pharmacological properties. Indeed, the existence of more than 
one type of opiate receptor has been suggested (Lord et al., 1977; 
Martin et al., 1976; Wüster et al., 1979): the μ-receptor (for opiate 
alkaloids like morphine), the б-receptor (for the enkephalins), the 
e-receptor (for the endorphins), the σ-receptor (for SKF-10.047), and 
the K-receptor (for ketocyclazocine). 
At present, an impressive amount of work has been done in opiate 
research. Only a very small part of it is summarized above. But, as 
always in science, all this work has raised more questions than it has 
answered. In the present study, the attention is focussed on two main 
features of morphine: a) its ability to affect behaviour via changing 
the activity of central neurotransmission processes within particular 
brain regions (Chapter 3) and b) its ability to change the activity 
of central neurotransmission processes via stimulating one or more 
subtypes of opiate receptors (section 4.4). The experimental results 
obtained from this work may contribute to our knowledge of the central 
action of opiates. Eventually, this knowledge may lead to an improved 
therapeutic use and a decreased abuse of morphine by man. 
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1.3 OVERT EFFECTS OF MORPHINE IN MAN AND CATS 
This section gives a survey of the overt effects of morphine in man 
and cats with most attention to the purely behaviour effects; more 
specific effects of morphine are discussed in section 1.4. 
1.3.1 Overt effects of morphine in man 
Respiratory depression, pupillary constriction and emesis - belonging 
to the most pronounced overt effects of morphine in man - are discussed 
in detail in section 1.4. Other effects produced by the opiate agonist 
at therapeutic analgesic doses (about 10 mg) are the following: drowsi-
ness, loss of anxiety, lethargy, apathy, mental confusion, muscular 
relaxation, sleepiness and decreased sensitivity to internal and 
external stimuli. In the presence of pain, sedation and hypnosis may 
result from relief of pain and from its accompanying mental and physical 
exhaustion. Morphine produces euphoria and some feelings of improved 
mentation in post-addicts, but dysphoria and feelings of impaired menta-
tion in non-addicted subjects. Morphine-induced sedation, though gener-
ally accompanied with diminished physical activity, does not produce any 
slurring of speech or marked motor inco-ordination. As the dose is in-
creased (about 30 mg), the depression deepens to complete unconsciousness 
from which the subject can be aroused only with difficulty. Some individ-
uals, particular women, are excited by morphine; however, convulsions are 
rarely seen in the human subject. Doses in excess of 100 mg produce 
serious symptoms, and doses over 250 mg are usually fatal. Tolerance may 
built up to a remarkable degree: doses as much as 4 g are without adverse 
effect in subjects chronically treated with morphine. Withdrawal from 
morphine causes yawning, lacrimation, sneezing, stuffy nose, mydriasis, 
chills, piloerection, perspiration, muscle twitching, diarrhea, nausea, 
restlessness, and a feeling of weakness; sleep, caloric intake, and 
weight are decreased following withdrawal (for references: Goldstein et 
al., 1974; Martin and Sloan, 1977; Pradhan and Dutta, 1977; Reynolds and 
Randall, 1957). 
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1.3.2 Overt effects of morphine in cats 
Acute_effects 
Respiratory depression, pupillary dilatation, and emesis belong to the 
overt effects of morphine in cats and are discussed in detail in section 
1.4. Other overt effects accompanying the pure behaviour effects are 
salivation, defaecation and micturation (Cools et al., 1974; Dhasmana et 
al., 1972; French et al., 1979b; Kayan and Mitchell, 1968; Labrecque and 
Domino, 1974). 
Table 1.1 gives references to studies dealing with the behaviour ef-
fects of morphine in cats. These effects are clearly dose- and time-
related: small doses produce a long period of sedation followed by some 
excitation, high doses produce mainly excitation preceded by a short 
period of sedation. Doses of 0.05 mg/kg have a mild sedative effect 
(Phillis et al., 1973). Daily treatment with doses of 0.2 mg/kg for 
five days produces an increase in operant responding (Djahanguire et 
al., 1966). A dose of 0.3 mg/kg totally eliminates sleep for approxi-
mately 6 hr; the cats adopt a sphinx-like posture during this period 
(Echols and Jewett, 1972). A dose of 0.5 mg/kg produces some excitation 
but only after a lapse of 40-60 min following intraperitoneal injection 
or 10-30 min following intravenous injection (Phillis et al., 1973): 
the cats appear inattentive moving the head in apparently random fashion, 
some cats show mild muscle spasms and they are more responsive to such 
external stimuli as noise. Following a dose of 1 mg/kg, the period of 
sedation is reduced to 30-45 min (intraperitoneal injections) or 10-20 
min (intravenous injections) (Dhasmana et al., 1972; French et al., 
1979b). During this period the animals lie quietly in the cage, they 
remain in the same position if undisturbed, and they do not react to 
mild external stimuli as opening of the cage door. Later on, the animals 
become more active: sitting becomes highly dominant and head movements 
increase. Additional effects observed are: licking, staring, scratching, 
and loud mewing. Remarkably, grooming does not occur at all (French et al., 
1979b). With increasing doses the periods of sedation become shorter 
and the signs of excitation more pronounced as seen by increased loco-
motion. Cools et al. (1974) distinguish three behaviour phases, viz. 
depression, re-organization, and ritualization, which appear in suc-
cession following a dose of 5 mg/kg. Depression is a period of hypo-
activity, re-organization a period of increasing activity, and 
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TABLE 1.1 
References to studies dealing with the 
behaviour effects of morphine in cats 
dose references (route of administration) 
(mg/kg) 
0.05 Phillis et al., 1973 (i.p.; i.v.) 
0.2 Djahanguire et al., 1966 (s.с.) 
0.3 Echols and Jewett, 1972 (s.c.) 
0.5 Phillis et al., 1973 (i.p.; i.v.) 
1.0 Dhasmana et al., 1972 (i.p.); French et al., 1979Ъ (i.V.); 
Navarro and Elliott, 1971 (i.p.) 
2.0 Chernov and Woods, 1965 (s.c); French et al., 1979b (i.v.) 
3.0 Labrecque and Domino, 1974 (s.c.) 
4.0 French et al., 1979b (i.v.) 
5.0 Cools et al., 1974 (i.p.); Dhasmana et al., 1972 (i.p.); 
Gunne, 1963 (s.c); Van Dongen, 1980a (i.p.); Wikler, 1944 
(i.V.; s.c) 
10.0 Borrell and Borrell, 1975 (i.p.); Dhasmana et al., 1972 
(s.c); Guaza et al., 1979 (i.p.); Loewe, 1956 (s.c); 
Moore et al., 1965 (i.V.); Navarro and Elliott, 1971 (i.p.); 
Wikler, 1944 (i.V.; s.c.) 
15.0 Fertiziger et al., 1974 (i.p.); Mehta, 1975 (i.V.); 
Wikler, 1944 (i.V.; s.c) 
20.0 Dhasmana et al., 1972 (i.p.); Loewe, 1956 (s.c); Norton 
and De Beer, 1956 (p.o.); Sturtevant and Drill, 1957 (s.c.) 
30.0 Chernov and Woods, 1965 (s.c); Gunne, 1963 (s.c); 
Moore et al., 1965 (i.p.) 
i.p. - intraperitoneal 
i.V. - intravenous 
s.a. - subcutaneous 
p.o. - per os (oral) 
ritualization a period of hyperactivity. Moreover, a restricted number 
of behaviour patterns is continuously repeated during ritualization. 
Other animals in the cage are ignored, and the cat's motor performances 
are poorly co-ordinated following this dose of morphine (Wikler, 1944). 
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A small number (20%) of the cats tested with a dose of 5 mg/kg exhibit 
a characteristic manic response, showing vigorous motor excitement with 
periods of rage-like activity and producing harsh, loud and prolonged 
cries (Dhasmana et al., 1972). This manic response occurs in 40% of the 
animals tested with a dose of 10 mg/kg and in all cats tested with a 
dose of 20 mg/kg (Dhasmana et al., 1972). The excitatory effects follow-
ing a dose of 15 mg/kg have a duration of 6-8 hr (Guaza et al., 1979; 
Wikler, 1944). Muscle twitches are sometimes seen after a lapse of 
several hours following a dose of 15 mg/kg, but frank convulsions do 
not occur after this dose (Wikler, 1944). Following doses of 30 mg/kg, 
convulsions occur and 50% of the animals die within 4-8 hr (Chernov and 
Woods, 1965; Moore et al., 1965). Some degree of unrest is generally 
noted for more than 12 hr and is occasionally present even 24 hr after 
a dose of 30 mg/kg (Gunne, 1963) . 
As indicated above, acute injections of morphine produce both de-
pressant and excitatory behaviour effects which appear in succession. 
When doses are low, the depression phase predominates and has a long 
duration; when doses are high, the sedation phase becomes shorter and 
the excitatory phase more intense. The behaviour effects of morphine 
following a moderate dose of 5 mg/kg are discussed in more detail in 
Chapter 2; it will be indicated that this dose of morphine produces a 
highly characteristic behaviour syndrome which enables us to detect 
subtle, experimentally-evoked changes in behaviour. 
Intracerebroventricular injections of morphine produce behaviour 
effects similar to those of systemic administration of morphine (see 
below: intracerebral injections), which indicates that these effects 
are centrally mediated. Since morphine produces different effects when 
injected into different regions of the brain (see below: intracerebral 
injections), it can be stated that the behaviour effects of systemic 
administration of morphine are the overall effect of morphine's action 
at various regions of the brain. In the present study, we pay attention 
to morphine's central action (Chapter 3; section 4.4). 
Catlin et al. (1978) report the behaviour effects of intravenous in-
jections of B-endorphin (50-300 ug/kg). The cats assume a sitting or 
crouching position and, in general, they remain stationary for at least 
7-10 min. The head is usually lowered, the eyes are open, and the cats 
stare. The animals remain alert, respond rapidly to a tap on the cage, 
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and follow attentively an object moving in front of it 5 min after in-
jection. No abnormal movements are observed and no motor impairment 
occurs. Additional effects are: licking, tremors, defaecation and head 
shakes. In contrast to morphine, ß-endorphin has no effect on respira-
tory rate or pupillary diameter, and it does not produce micturation. 
Moreover, grooming - which is absent following morphine - occurs fol-
lowing 8-endorphin. Hence, it can be stated that the behaviour effects 
of systemic injections of 8-endorphin are different from those of mor-
phine. In contrast, intraventricularly administered ß-endorphin produces 
effects very similar to those of morphine (see below: intracerebral in-
jections) . This discrepancy indicates that the opioid peptide does not 
readily pass the blood-brain barrier. Moreover, the observation that 
intraventricular injections of ß-endorphin but not of Met-enkephalin 
produce effects similar to those of morphine (see below: intracerebral 
injections), suggests that the behaviour effects of the exogenous opiate 
morphine are mediated by the S-endorphin system rather than by the 
enkephalin system. 
Chronic effects 
In general, chronic administration of morphine results in the development 
of tolerance to and dependence on its effects. Much controversy, however, 
exists about the development of tolerance to and dependence on the be-
haviour effects of morphine in cats. This may be partly due to the ab-
sence of quantitative measures or detailed qualitative descriptions in 
most studies, and partly due to differences between studies in dose, 
duration and schedule of morphine treatment. 
Djahanguire et al. (1966) report tolerance to morphine's effect on 
operant responding after daily injections of doses of 0.2 mg/kg for more 
than 12 days. Kayan and Mitchell (1968) fail to observe tolerance to the 
behaviour effects of morphine following 4 weeks of weekly injections and, 
for the next 2 weeks, daily injections of morphine in a dose of 1 mg/kg; 
but, in contrast to Djahanguire et al. (1966), these authors use no 
quantitative measures and they observe only gross behaviour. French et 
al. (1979b) - using quantitative measures - indicate that cats treated 
with daily injections of morphine (1-4 mg/kg) for 7 days develop partial 
tolerance to morphine's behaviour effects: the total time spent engaging 
in lying down increases whereas scores for sitting and moving decrease. 
Moreover, the same study shows that naloxone administered to cats daily 
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treated with this dose of morphine produces a withdrawal syndrome con-
sisting of wet-dog shakes, urination, pupillary constriction, loud mew-
ing, hyperpnea and a catatonic-like posture. Eddy and Himmelsbach (1936) 
report tolerance to morphine's overt behaviour effects after daily doses 
of 2 mg/kg administered for a long period of 2 months. In the absence of 
quantitative measures or detailed qualitative descriptions, Gunne (1963) 
fails to find tolerance, following 5 daily doses of 5-30 mg/kg. A con-
siderable degree of tolerance is found, however, when cats are treated 
for a longer period of 30 days with daily doses of 10 mg/kg (Borrell and 
Borrell, 1975; Guaza et al., 1979). As described in these studies, 
nalorphine-induced withdrawal in the chronically treated animals pro-
duces excitement comparable to that observed following acute injections 
of morphine. Tolerance to the overt behaviour effects of morphine de-
velops already after 10-12 days when progressively increasing doses of 
morphine (2-20 mg/kg/day or 9-30 mg/kg/day) are administered (Labrecque 
and Domino, 1974; Mullin and Phillis, 1974). These same studies report 
naloxone-induced withdrawal phenomena consisting of agitation, frequent 
mewing, miosis and rage reactions. About half of the cats die within 
1 hr after naloxone administration preceded by clonic-tonic convulsions. 
Using the technique of implantation of morphine pellets (resulting in 
the daily delivery of 16-58 mg/kg), Huidobro and Lewin (1969) find pro-
found tolerance around the 15th day. These authors describe nalorphine-
induced withdrawal phenomena consisting of micturation, sneak walking, 
nasal and lacrimal secretion, mewing, polypnea, miosis, salivation, 
emesis and agitation; the cats neither obey nor recognize during the 
withdrawal period, they become irritable and aggressive. Hyperreflexia, 
tremors, and convulsions sometimes occur during the withdrawal period. 
Following daily doses of 40 mg/kg administered for 5 months, Tatum et 
al. (1929) find no tolerance but rather sensitization to morphine-in-
duced excitation, i.e. an increased rather than a decreased response of 
the cats to morphine administration. The doses used, however, are quite 
high, and accumulation of morphine in the body may have influenced the 
development of tolerance. Finally, it is of interest to note that cats 
do self-administer morphine, suggesting the development of psychological 
dependence to morphine in cats (Kilbey and Ellinwood, 1980). 
Summarizing, it can be stated that chronic administration of morphine 
results in the development of tolerance to and dependence on the behav-
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iour effects of morphine. The rate and degree of tolerance development 
are dependent on the dose, duration and schedule of morphine treatment. 
When doses are small and intervals between doses long, the degree of 
tolerance may be low: quantitative measures or detailed descriptions 
are required for the disclosure of such a low degree of tolerance. When 
doses are higher and intervals shorter, the degree of tolerance may be 
more pronounced and visible by inspection of gross behaviour. Very high 
doses may cause accumulation of the drug in the body and, consequently, 
produce an increased rather than a decreased response to morphine. In 
general, the rate of tolerance development may be expected to be maximal 
in the case of a high and constant concentration of the drug at the 
receptor level. In the present study, we investigate whether morphine-
induced changes in central neurotransmission processes within particular 
brain regions anyhow contribute to the development of tolerance to 
morphine's behaviour effects (section 3.1). 
Intraventricular injections of morphine (25-1000 pg) produce emesis, 
mydriasis, salivation, vocalizations and varying degrees of excitation 
(Clark and Cumby, 1978; Feldberg and Shaligram, 1972; Meglio et al., 
1977; Moore et al., 1965). Low doses (25-100 yg) cause sudden quick 
head movements, fine head tremors, fixation of the eyes into space, 
and a diminished response to external stimuli; these effects are antag-
onized by naloxone (Meglio et al., 1977). Some animals become restless 
and pace throughout the cage (Clark and Cumby, 1978). Apparently, the 
effects are identical to those elicited by systemically administered 
morphine (Feldberg and Shaligram, 1972): initially, the cats are sitting 
on their hindquarters moving their head and forepaws. The cats stare 
vacantly and do not react to objects moving in front of their eyes. 
After some minutes a gradually increasing amount of compulsive loco-
motion is observed. The cats resist handling but without trying to bite 
or attack. The animals are not cataleptic. 
Morphine ( 2 x 5 Mg), bilaterally injected into or near the nucleus 
centralis oralis or the nucleus laterodorsalis tegmenti, produces be-
haviour inactivation (Van Dongen, 1980a). Morphine (10 ug) unilaterally 
injected into or near the substantia nigra causes dyskinetic movements 
and contralateral turning of the head (Broekkamp, 1976). A 1 hr localized 
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perfusion of the sensorimotor cortex with a morphine containing solution 
(1-5%) does not affect the behaviour of cats (Mullin and Phillis, 1974). 
Intraventricular administration of ß-endorphin (12.5 \xg) produces 
within 15-20 min sudden quick head movements, head tremors, mild exci-
tation, fixation of the eyes into space, and pupillary dilatation 
(Meglio et al., 1977). The cats barely respond to external stimuli and 
appear to have "visual hallucinations". The effects have a duration of 
about 1 hr and are antagonized by naloxone. Higher doses (25-50 pg) pro-
duce more pronounced effects which have a longer duration. Infusion into 
the third ventricle (10-20 pg) produces mydriasis, vocalizations, star-
ing, and after a lapse of 30 min following the injection hyperexcitabil-
ity i-nd restlessness (Feldberg and Smyth, 1977) . During the state of 
hyperexcitability, external stimuli cause the cat to make rapid, brisk 
movements usually leading to circling in the cage. Later on, circling 
occurs spontaneously. In some animals, signs of catalepsy are observed 
1-1.5 hr after infusion. The effects are antagonized by naloxone. 
Intraventricular injection of Met-enkephalin (100-400 ug) does not 
affect the behaviour of cats (Meglio et al., 1977). Infusion into the 
third ventricle of N-methyl-Met-enkephalinamide (150-180 yg) produces 
some mydriasis and, within 15 min, deep stupor and catalepsy; these ef-
fects have a duration of 1-2 hr, are antagonized by naloxone, but not 
mimicked by those of Met-enkephalin (30-400 pg) (Feldberg and Smyth, 
1977). 
As the intracerebral injection of morphine and related opioid 
peptides appears to be an effective tool to elicit behaviour changes, 
we used this technique to elucidate the nature of opiate receptors 
within a particular brain region (section 4.4). 
Effects_of_drugs 
High doses of the catecholamine-depleting drugs reserpine (2.5 mg/kg, 
given 24 hr before morphine) and tetrabenazine (75 mg/kg, given 18 hr 
before morphine) block the excitatory responses of cats to morphine 
administration (20 mg/kg) (Dhasmana et al., 1972). Lower doses of 
reserpine (0.1-0.5 mg/kg) administered several hours after morphine 
(20 mg/kg) also antagonize the behaviour excitation; in contrast, when 
administered several hours before morphine, these lower doses enhance 
the behaviour effects of morphine (Sturtevant and Drill, 1957). When a 
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single dose of reserpine (25-100 pg/kg) is given 90-180 min before 
morphine or when daily doses of reserpine are administered for 3 days 
(total dose 150-200 yg/kg), the last injection being given 150 min be­
fore morphine, the excitatory effects of morphine are enhanced; pro­
gressively lower doses tend to cause a greater increase in morphine's 
effects (Loewe, 1956). Cats pretreated with 2 intraventricular injec­
tions of 0.5 mg reserpine, one given 18 hr and the other 4 hr before 
an intraventricular morphine injection (0.75 mg), show enhanced exci­
tation and some signs of catalepsy (Feldberg and Shaligram, 1972). 
The dopamine antagonist chlorpromazine (2-20 mg/kg) partially antag­
onizes the behaviour excitation caused by morphine (20 mg/kg) (Loewe, 
1956; Sturtevant and Drill, 1957). A similar result is obtained when 
the dopamine antagonist haloperidol is administered in a dose of 2.0 
mg/kg to cats pretreated with morphine in a dose of 5 mg/kg (Cools et 
al., 1974) or in a dose of 0.5 mg/kg to cats treated with morphine in 
a dose of 20 mg/kg (Dhasmana et al., 1972). Haloperidol (50 ug) micro-
injected into the rostromedial part of the caudate nucleus blocks the 
morphine-induced behaviour when administered 20 min after morphine, 
but it potentiates the behaviour effects when administered 30-40 min 
after morphine (Cools et al., 1974). 
The adrenergic blocker phenoxybenzamine (10-20 mg/kg) enhances the 
behaviour effects of morphine (10-20 mg/kg) given 145-210 min later 
(Loewe, 1956). When phenoxybenzamine (10 mg/kg) or propranolol (2.5 
mg/kg) is administered 60 min before morphine (20 mg/kg), such an 
enhancement is not observed (Dhasmana et al., 1972). When noradrenaline 
(250 pg) or adrenaline (250 yg) is injected into the lateral ventricles 
15 min before and 30 min after intraventricular morphine (0.75 mg), the 
morphine-induced excitation is greatly reduced (Feldberg and Shaligram, 
1972). Noradrenaline (2 χ 10 yg) bilaterally administered into the 
nucleus raphe linearis of cats pretreated with morphine (5 mg/kg) 20 
or 30-40 min earlier completely suppresses morphine's behaviour effects 
(Cools et al., 1974) . 
The cholinergic blocker atropine (5 mg/kg) given 1 hr before morphine 
(20 mg/kg) does not affect the behaviour excitation (Dhasmana et al., 
1972). The cholinergic agonist carbachol ( 2 x 2 yg) bilaterally injected 
into the nucleus raphe linearis enhances the morphine-induced excitation 
(Cools et al., 1974). 
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Pretreatment with the opiate antagonist naloxone (0.25-1.0 mg/kg) 
antagonizes the behaviour effects of morphine (1-4 mg/kg) (French et 
al., 1979b). Naloxone (2-10 \ig) bilaterally injected into the region 
of the substantia nigra causes cats pretreated with morphine (5 mg/kg) 
to become hypoactive (Van Dongen, 1980b). Naloxone (2-10 pg) injected 
into the dorsolateral pontine tegmentum partially antagonizes the be-
haviour effects of morphine (5 mg/kg): the cats remain hyperactive but 
they show more "normal" behaviour activities (Van Dongen, 1980b). 
Lysergic acid diethylamide (0.5 mg/kg) or the antihistaminic drug 
mepyramine (10 mg/kg) does not affect the excitement elicited by mor-
phine (20 mg/kg) given 1 hr later (Dhasmana et al., 1972). Intraventri-
cular 5-hydroxy-tryptamine (250 \ig) does not affect the excitation 
elicited by intraventricular morphine (250 pg) (Feldberg and Shaligram, 
1972). Systemic administration of 5-hydroxy-tryptophan (10 mg/kg) does 
not affect the behaviour effects of intraventricular ß-endorphin (Hoso-
buchi et al., 1977). Pretreatment with the anticonvulsant drug diphenyl-
hydantoin (30 mg/kg) given for a period of 4-6 days prior to morphine 
injection (15 mg/kg) antagonizes the behaviour effect of morphine 
(Fertiziger et al., 1974). Daily administration of cortisone (25 mg/kg) 
for 4 days enhances the excitatory effects of morphine (12 rag/kg) given 
on the 5th day (Winter and Flataker, 1951), whereas desoxycorticosterone 
daily given over 5-12 days in a total dose of 75-180 mg/kg diminishes 
the morphine-induced excitation (Loewe, 1956) . 
As indicated above, the morphine-induced behaviour response in cats 
is influenced by a wide variety of systemically or intracerebrally in-
jected drugs. This indicates that the behaviour effects of morphine are 
mediated via a large number of neurotransmission processes in the brain. 
In other words, the behaviour effect of morphine is related to neuro-
transmission activity in various regions of the brain. Accordingly, 
changing neurotransmission activity should, in general, affect the be-
haviour response to morphine. 
In the present study, we investigate whether pharmacological manipula-
tion of particular neurotransmission processes in morphine-treated cats 
gives insight into morphine's ability to change behaviour via changing 
the activity of central neurotransmission processes (Chapter 3; section 
4.4). 
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1.4 SPECIFIC EFFECTS OF MORPHINE IN MAN AND CATS 
In the preceding section, overt effects of morphine have been dis-
cussed. More specific effects of the opiate agonist in man and cats are 
discussed in this section. For general information about the morphine-
induced effects in other species the reader is referred to the follow-
ing publications: Jaffe and Martin, 1975; Martin and Sloan, 1977; 
Pradhan and Dutta, 1977; Reynolds and Randall, 1957. 
1.4.1 Analgesia 
With regard_to man 
Analgesia is induced in man by administration of morphine in oral doses 
of 0.1-0.3 mg/kg (Jaffe and Martin, 1975). It is principally indicated 
in the treatment of constant dull or sharp pain, post-operative pain, 
as well as pain caused by coronary, pulmonary, or peripheral vascular 
trombosis, neoplasm, fractures, burns and renal or biliary colic (Prad-
han and Dutta, 1977) . The use of peridural or spinal opiates for anal-
gesia without significant side-effects is promising (Behar et al., 1979; 
Dirksen and Nijhuis, 1980; Torda, 1979; Wang et al., 1979; Zenz, 1981). 
Analgesia is induced in cats by injections of morphine in doses of 0.25-
4.0 mg/kg (Denavit-Saubié et al., 1978; Kayan and Mitchell, 1968; Malseed 
and Goldstein, 1979; Mitchell, 1964, 1966). Chronic treatment results in 
the development of tolerance to and dependence on this effect of morphine 
(Kayan and Mitchell, 1968; Mullin and Phillis, 1974); multiple injections 
of morphine have been reported to cause an increased rather than a de-
creased responsiveness to the analgesic test (Kayan and Mitchell, 1968). 
Pretreatment with tricyclic antidepressants enhances the antinociceptive 
action of morphine (Malseed and Goldstein, 1979). Analgesia is also ob-
tained after intraventricular injections of morphine (150-200 yg) or 
g-endorphin (10-25 ug) or after intrathecal administration of morphine 
(40-80 pg) (Dey and Feldberg, 1976; Feldberg and Smyth, 1977; Meglio et 
al., 1977; Yaksh, 1978). Intraventricular injection of Met-enkephalin 
(30-400 yg) produces no or very weak analgesia; the more stable analogue 
N-methyl-Met-enkephalin, however, does produce analgesia after its intra-
ventricular injection (Feldberg and Smyth, 1977; Meglio et al., 1977). 
Tolerance develops rapidly to the analgesia induced by intraventricular 
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injection of ß-endorphin; the analgesia is restored if 5-hydroxy-trypto-
phan (10 mg/kg) is administered soon after 3-endorphin (Hosobuchi et al., 
1977). Analgesia is also obtained after intravenous injection of 8-endor-
phin (Catlin et al., 1977). Injection of morphine (10 ug/kg) into the 
nucleus reticularis gigantocellularis causes suppression of the jaw 
opening reflex (Chan, 1979). Structures in the periaqueductal grey 
and the nucleus raphe magnus may also play a critical role in opiate-
induced analgesia (Sessie et al., 1981b). 
1.4.2 Respiratory depression 
With_regard_to_man 
Respiratory depression is one of the most prominent actions of morphine, 
which, in man, reduces respiration rate, even in doses below the anal-
gesic level. Doses only slightly larger than the therapeutic doses pro-
duce death from respiratory depression (Jaffe and Martin, 1975). 
Morphine depresses all components of respiratory activity, and may in-
duce irregular breathing. Morphine depresses the response of the brain 
stem respiratory center to raised blood carbon dioxide tension. Volun-
tary control of respiration is also affected by morphine, and this is 
considered beneficial in the management of patients with pulmonary 
edema, in which the patients' effort to breath may aggrevate the under-
lying pathology (Pradhan and Dutta, 1977; Jaffe and Martin, 1975; Rey-
nolds and Randall, 1957). In addicts stabilized on morphine, respiration 
is within normal limits; withdrawal from morphine causes an increased 
respiratory rate (Martin and Sloan, 1977). 
With_regard_to cats 
Morphine in doses of 1-10 mg/kg depresses respiration in cats (Florez 
et al., 1968; Pentiah et al., 1966). Chronic treatment results in the 
development of tolerance to and dependence on this effect of morphine 
(Flórez et al., 1973). Morphine-induced respiratory depression is re-
versible by naloxone (Flórez and Mediavilla, 1977). Reserpine and para-
chlorophenylalanine, but not 6-hydroxydopamine, antagonize the respira-
tory depression; pargyline and tranylcypramine enhance it (Flórez et al., 
1973). Moreover, para-chlorophenylalanine facilitates, pargyline partial-
ly inhibits, and reserpine does not affect the development of tolerance 
(Flórez et al., 1973). Intravenous 8-endorphin (10-500 yg/kg) does not 
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affect respiratory rate (Catlin et al., 1978). Morphine-induced respira-
tory depression is thought to be mediated via ventral surface areas in 
the brain stem involved in respiratory regulation (Flórez et al., 1968; 
Flórez and Mediavilla, 1977; Hassen et al., 1976; Pentiah et al., 1966; 
Pokorski et al., 1981). Morphine (10-50 pg) injected into the bulbar 
subarachnoid space induces respiratory depression qualitatively similar 
to that obtained after intravenous injection (Flórez et al., 1968). 
Met-enkephalin (1.6 μπιοί) directly applied to the ventral surface of the 
brain stem, consistently depresses respiration (Flórez and Mediavilla, 
1977). Morphine (1-2 mg/kg, i.v.) selectively depresses the activity of 
pontile apneustic neurons and, to a lesser extent, of medullary inspira-
tory neurons in the midcollicular decerebrated cat (Hassen et al., 1976) 
In slightly sedated, freely moving cats or in bi-vagotomized paralysed 
cats, microelectrophoretically applied morphine and Met-enkephalin, and 
systemically administered morphine (0.1-0.5 mg/kg) depress the sponta-
neous and evoked firing of respiration related neurons in the region of 
the tractus solitarius, nucleus ambiguus and in the pons, nucleus para-
brachialis medialis; these effects are antagonized by naloxone (Denavit-
Saubié, 1978). Electrical stimulation of the periaqueductal grey and 
the nucleus raphe magnus suppresses neuronal functions associated with 
respiration and respiratory-related activities; as the effects were 
antagonized by naloxone, these neuronal systems may be involved in the 
opiate-induced effects on respiration (Sessie et al., 1981a). 
1.4.3 Pupil reaction 
With_regard_to_man 
In man, morphine produces constriction of the pupil (miosis). Tolerance 
to this miotic action does not develop readily, and, consequently, con-
stricted pupils (pinpoint pupils) are observed in the morphine addict 
(Pradhan and Dutta, 1977; Reynolds and Randall, 1957). In cases of 
fatal poisoning, the pupils ultimately dilate due to asphyxia (Reynolds 
and Randall, 1957). Withdrawal from morphine causes mydriasis (Martin 
and Sloan, 1977). The precise mechanism for the miotic action is not 
established, but it is believed to be mediated through stimulation of 
the cranial nerve nucleus; miotic action is blocked by atropine and 
related cholinergic blocking agents (Pradhan and Dutta, 1977). 
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With_regard to cats 
In the cat, morphine in doses of 0.3 mg/kg and more, produces an opposite 
effect, viz. dose-dependent dilatation of the pupil (mydriasis) in a 
naloxone-reversible way (Denavit-Saubié et al., 1978; Echols and Jewett, 
1972; Labrecque and Domino, 1974; Sturtevant and Drill, 1957; Wallen-
stein, 1979; Wallenstein and Wang, 1979; Wikler, 1944). Tolerance to 
this effect of morphine does not develop rapidly (Labrecque and Domino, 
1974), but has been reported to occur (Huidobro and Lewin, 1969; Mullin 
and Phillis, 1974). Withdrawal from morphine causes miosis (French et 
al., 1979b; Huidobro and Lewin, 1969; Labrecque and Domino, 1974; Mullin 
and Phillis, 1974). Pupillary dilatation is also evoked by intraventri-
cular injections of morphine (25-1250 vg), Met-enkephalin (1-2 mg), 
2 
(D-Ala )-Met-enkephalinamide (3.1-400 ug), or g-endorphin (12.5 ug) 
(Clark, 1977; Clark and Cumby, 1978; Clark and Ponder, 1980; Meglio et 
al., 1977; Moore et al., 1965). Intravenous 0-endorphin (10-500 yg/kg) 
does not produce mydriasis (Catlin, 1978). Morphine-induced mydriasis 
is accompanied by an increased firing rate of all light-sensitive, 
pupilloconstrictive neurons recorded from the pretectal region and the 
anterior oculomotor nucleus including the nucleus of the third nerve in 
sedated, immobilized cats (Wallenstein and Wang, 1979). Intravenously 
or topocally applied phenoxybenzamine antagonizes morphine-induced 
mydriasis indicating a peripheral source of sympathetic input as the 
basis for morphine-induced mydriasis (Wallenstein and Wang, 1979). In 
adrenalectomized animals, morphine (2 mg/kg) produces miosis instead 
of mydriasis but it still increases the firing rate of the light-
sensitive neurons mentioned above (Wallenstein and Wang, 1979). These 
observations suggest that, in the cat, morphine activates the oculomotor 
nerve to produce miosis, but that this effect is masked by the morphine-
induced release of catecholamines, mainly from the adrenal glands, which 
produce mydriasis (Wallenstein and Wang, 1979). Morphine-induced mydriasis 
is blocked by two intraventricular injections of reserpine (0.5 mg), one 
given 18 hr and the other given 4 hr before morphine (Feldberg and Shali-
gram, 1972). Morphine-induced mydriasis is not affected by systemic in-
jections of chlorpromazine (20 mg/kg) (Sturtevant and Drill, 1957). It 
is worth mentioning that morphine-induced mydriasis is also commonly 
observed in other species (e.g. pigs, cows, sheep, goats, lions, tigers, 
bears and horses) in which morphine produces excitation of behaviour as 
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well (Jaffe and Martin, 1975; Pradhan and Dutta, 1977). Monkeys show 
also morphine-induced mydriasis but not the morphine-induced excitation 
of behaviour (Jaffe and Martin, 1975). Anyhow, behaviour excitation is 
not the cause of the morphine-induced mydriasis since anaesthetized 
cats also show pupillary dilatation after morphine administration 
(Wallenstein, 1979). 
1.4.4 Emesis 
With_regard_to_man 
Vomiting often occurs as undesirable side-effect of morphine action in 
man; the incidence of this side action is much greater in ambulatory 
patients (Reynolds and Randall, 1957). 
With_regard_to_cats 
Morphine in doses higher than 0.3 mg/kg readily produces emesis in the 
cat (Reynolds and Randall, 1957). Vomiting is also observed after intra-
venous injections of ß-endorphin (higher than 50 μg/kg) or after intra­
ventricular injections of morphine (50-1000 yg), Met-enkephalin (1-2 mg) 
2 
or (D-Ala -)-Met-enkephalinamide (50-400 yg) (Catlin et al., 1978; Clark, 
1977; Clark and Cumby, 1978; Clark and Ponder, 1980; Costello and Bori-
son, 1977; Moore, 1965). Tolerance develops rapidly to the emetic action 
of morphine (Costello and Borison, 1977; Labrecque and Domino, 1974). 
Lesions of the area postrema suppress morphine's emetic action (Moore, 
1965). Apart from an emetic action morphine has also a late anti-emetic 
action: the emetic action is thought to be mediated via excitation of 
the medullary emetic chemoreceptor triggerzone and the anti-emetic action 
via the vomiting center within the medullary reticular formation (Cos­
tello and Borison, 1977). 
1.4.5 Temperature response 
With regard_to_inan 
In man, at therapeutic dosage morphine slightly reduces body temperature, 
but continued administration of higher doses may cause a hyperthermic 
response (Pradhan and Dutta, 1977). Withdrawal from morphine produces 
an increase in body temperature (Martin and Sloan, 1977). 
With_regard_to_cats 
In the cat, morphine, administered in doses of 1-10 mg/kg, produces 
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dose-related hyperthermia; doses of 0,25-0.50 mg/kg do not affect body 
temperature (Clark and Cumby, 1978; French et al., 1978a, b). Chronic 
treatment results in the development of tolerance to and dependence on 
this effect of morphine (French et al., 1978b). The hyperthermic re-
sponse is blocked by ergotamine (Banerjee et al., 1968), and enhanced 
by the dopamine antagonist pimozide or the serotonin uptake inhibitor 
fluoxetine (French et al., 1978a). Neither metiamide nor indomethacin 
do affect morphine-induced hyperthermia (Clark and Cumby, 1978). Intra-
ventricular administration of morphine (2.5-1250 ug), g-endorphin (5-50 
2 
Vg), Met-enkephalin (1-2 mg), or (D-Ala -)-Met-enkephalinamide (3.1-50 
2 
pg) also produces hyperthermia; higher doses of (D-Ala -)-Met-enkephalin-
amide (200-400 yg) result in a diminished hyperthermia and sometimes in 
hypothermia (Banerjee et al., 1968; Clark, 1977; Clark and Cumby, 1978; 
Clark and Ponder, 1980). Differences in the thermoregulatory effects of 
various opiate agents indicate the involvement of multiple types of 
opiate receptors (Clark and Ponder, 1980). Just as morphine-induced 
mydriasis, morphine-induced hyperthermia is commonly observed in other 
species in which morphine produces excitation of behaviour as well. 
Morphine-induced behaviour excitation is certainly not the cause of 
the hyperthermia, since the hyperthermic response to morphine is also 
observed in paralysed, sedated cats (Wallenstein, 1978). 
1.4.6 EEG effects 
With_regard_to_man 
In man, single therapeutic doses of opiates produce synchronization of 
the EEG, i.e. a shift towards increased voltage and lower frequencies, 
such as occurs in natural sleep or after a low dose of barbiturates 
(Jaffe and Martin, 1975). In post-addicts, morphine decreases REM 
(rapid-eye-movement) sleep, increases non-REM light sleep, and de-
creases non-REM deep sleep. It increases the waking state. The initial 
decrease in the REM state was followed by an increase in the third night 
in some subjects (Kay et al., 1969). 
With regard to cats 
In awake, unrestrained cats, morphine (1 mg/kg) produces cortical EEG 
activation, i.e. increased frequency and decreased amplitude; in awake, 
paralysed animals, morphine (10 mg/kg) causes convulsant EEG patterns 
in the hippocampus (Navarro and Elliott, 1971). Cats are awake for about 
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6 hr following administration of morphine (0.3 mg/kg, s . c ) ; the return 
to regular sleep patterns occurs after about 11 hr. A rebound increase 
in REM sleep is noted 11-17 hr after the morphine administration. The 
alerting action of morphine is blocked by naloxone, but not by ос­
те thy 1 tyros ine or 5-hydroxy-tryptophan (Echols and Jewett, 1972). In 
brain stem-transected cats, the effect of morphine (0.31-10.0 mg/kg) 
varies with the EEG pattern present prior to morphine administration: 
in EEG activated cats, no obvious EEG modification is observed while, 
in EEG synchronized animals, morphine causes an activation (Aiello-
Malmberg, 1979; Labrecque and Domino, 1974). With larger doses of 
morphine, EEG activation is less consistent than with lower doses 
(0.31-1 mg/kg) (Labrecque and Domino, 1974). Chronic morphine treat­
ment results in the development of tolerance to and dependence on the 
morphine-induced EEG activation (Labrecque and Domino, 1974). In cats 
trained to press for milk reward, morphine (0.1-0.4 mg/kg) causes a 
strong monophasic enhancement of post-reinforcement EEG synchroniza­
tion (PRS); higher doses (0.6-1.0 mg/kg) have a biphasic action, viz. 
initial enhancement followed by strong suppression; doses of 1.0-1.2 
mg/kg predominantly suppress PRS (Marczynski and Hackett, 1976) . 
7 Cardiovascular effects 
With_regard_to_man 
In man, therapeutic doses of morphine produce little or no effect on 
cardiovascular function. Cardiac responses to morphine in patients 
with myocardial infarction are inconsistent and often produce pro­
nounced hypotension and bradycardia. Hypovolemic patients are more 
susceptible to the vasodepressor action of morphine (Jaffe and Martin, 
1975; Pradhan and Dutta, 1977). In addicts stabilized on morphine, 
heart rate and blood pressure are within normal limits; withdrawal 
from morphine causes an increase in blood pressure (Martin and Sloan, 
1977). 
With_regard_to_cats 
In unanesthetized cats, small doses of morphine (0.5-2.0 mg/kg) produce 
a fall in blood pressure whereas higher doses (2-10 mg/kg) mainly pro­
duce an increase in blood pressure (Feldberg and Wei, 1977; Grundy, 
1971; Kayaalp and Kaymakcalan, 1966). The morphine-induced fall in 
blood pressure, which is accompanied with mild bradycardia, is also 
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observed after intracisternal administration (A00 yg) but not after 
intraventricular administration (Feldberg and Wei, 1977; Grundy, 1971). 
The morphine-induced vasodepression is still present after cutting both 
vagi and is antagonized by naloxone (Feldberg and Wei, 1977). It is 
thought that the vasodepression and bradycardia result largely from 
removal of sympathetic tone to blood vessels and heart (Feldberg and 
Wei, 1977). The hypertension observed after higher doses is blocked by 
ganglion-blocking and sympathetic α-receptor blocking agents, and absent 
in spinal cats (Kayaalp and Kaymakcalan, 1966). In anaesthetized cats, 
morphine (2-10 mg/kg) causes a fall in blood pressure, which is antag­
onized by nalorphine (Kayaalp and Kaymakcalan, 1966). In brain stem-
transected cats, morphine (0.31-10 mg/kg) causes a dose-related hypo­
tension and a decreased heart rate; tolerance develops to these effects 
of morphine (Labrecque and Domino, 1974). In sedated, paralysed cats, 
the cardiovascular effects of morphine appear to be biphasic in that 
small doses (1-2 mg/kg) lower blood pressure and heart rate while 
larger doses (8-12 mg/kg) increase blood pressure and heart rate (Wal­
lenstein, 1979). In adrenalectomized cats, small doses of morphine 
(1-2 mg/kg) decrease, but - in contrast to in unadrenalectomized cats -
larger doses (8-12 mg/kg) do not longer increase blood pressure and 
heart rate (Wallenstein, 1979) . This latter observation suggests a 
role for the adrenals in the excitatory phase. As a dose of 1 mg/kg 
of morphine affects blood pressure but not heart rate, these effects 
of morphine seem to be independent (Wallenstein, 1979) . Naloxone antag­
onizes the cardiovascular effects of low doses of morphine, but enhances 
those of larger doses of morphine (Wallenstein, 1979). Structures at the 
dorsal surface of the medulla and in the nucleus gigantocellularis reti­
cularis have been suggested as site of action for the cardiovascular 
effects of morphine (Feldberg and Wei, 1978; Hwa and Chan, 1981). 
1.4.8 Effects on endocrine glands 
With_regard_to_man 
Single or repeated administration of opioids has been shown to exert 
profound effects on hypothalamo-hypophysial target gland areas (George, 
1971; Meites et al., 1979; Sloan, 1971). In man, acute single doses of 
morphine are either without effect or produce a liminal depression of 
corticosteroid excretion. Chronic morphine administration results in 
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suppression of corticosteroid excretion to which partial tolerance 
develops. The early abstinence syndrome in man is associated with 
signs of adrenal cortical stimulation, whereas during protracted 
abstinence the urinary levels of corticosteroids are normal. The 
morphine-induced effect on corticosteroid secretion is thought to 
be mediated via an altered release of adrenocorticotrophic hormone 
(Meites et al., 1979; Sloan, 1971). Acute administration of an opiate 
to post-addicts suppresses luteinizing hormone levels; chronic treat-
ment is associated with decreased testosterone levels (Mendelson et al., 
1980). 
With regard_to cats 
In the cat, acute administration of morphine (1-10 mg/kg) increases 
adrenal corticosteroid release, while chronic morphine administration 
results in a reduced increase or even in a decrease of adrenal cortico-
steroid release (Borrell et al., 1975; French et al., 1979a; Guaza et 
al., 1979). Acute morphine (1-4 mg/kg) also causes elevated plasma 
levels of growth hormone (French et al., 1979a). The increase in growth 
hormone levels decreases as the dose of morphine is increased, which in-
dicates that the effectiveness for growth hormone release is inversely 
related to morphine doses. Tolerance does not develop to the morphine-
induced growth hormone release (French et al., 1979a). Opiate antag-
onist-induced withdrawal in tolerant cats results in an increase in 
corticosteroid secretion but it does not change growth hormone levels 
(Borrell et al., 1975; French et al., 1979a; Guaza et al., 1979). In 
the cat, single doses of morphine (10-60 mg/kg) decrease catecholamine 
levels in the adrenal medulla and increase catecholamine levels in 
blood and urine (Borrell et al., 1974; Elliott, 1912; Gunne, 1963; 
Maynert, 1967; Vogt, 1954; Way and Shen, 1971). In the anaesthetized 
cat, this effect of morphine remains absent (Borrell et al., 1974). 
When noradrenaline and adrenaline are evaluated separately, the effect 
of morphine on adrenomedullary function depends on the stage of morphine 
treatment (Guaza et al., 1979). Single doses of morphine (10 mg/kg) de-
crease the adrenal level of both catecholamines. No variations in 
adrenaline/noradrenaline ratio are observed. After 7 days of daily 
morphine (10 mg/kg) an increase in adrenal noradrenaline level is found 
together with a decrease in adrenal adrenaline level and a decrease in 
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the adrenaline/noradrenaline ratio. After 2 weeks of daily morphine 
treatment the adrenal contents of both catecholamines are again within 
the range of control animals. Nalorphine injection at this stage of 
morphine treatment results in increased levels of noradrenaline but 
decreased levels of adrenaline and a lower adrenaline/noradrenaline 
ratio. After 1 month of daily morphine, the adrenal levels of both 
catecholamines are elevated; no change in the adrenaline/noradrenaline 
ratio is observed. Borison et al. (1962) and Moore et al. (1965), 
attributed the release of catecholamines from the adrenal medulla after 
morphine treatment to the stimulation of chemoreceptors in the brain 
stem. These chemoreceptors are thought to be localized at the ventral 
surface of the brain stem most probably in the upper part of the 
medulla oblongata (Dey et al·., 1975; Feldberg and Gupta, 1974). 
1.4.9 Hyperglycaemia 
With regard to man 
Morphine produces transient hyperglycaemia (elevation of blood glucose) 
in humans, resulting from mobilization of liver glycogen through release 
of adrenaline from the adrenals (Pradhan and Dutta, 1977). 
With_regard_to_cats 
In the cat, morphine (10 mg/kg) also produces hyperglycaemia (Borrell 
et al., 1975; Moore et al., 1965). Borison et al. (1962) and Moore et 
al. (1965) described a chemoreceptor in the brain stem which when 
activated by morphine causes the release of adrenaline and noradrenaline 
from the adrenal medulla, which is responsible for the increase in blood 
sugar. Hyperglycaemia is also produced by morphine (0.75 mg) or ß-en-
dorphin (60 pg) injected into the cerebral ventricles (Dey et al., 1975; 
Feldberg and Gupta, 1974; Feldberg and Smyth, 1977). The chemoreceptors 
are thought to be localized at the ventral surface of the brain stem, 
most probably in the upper part of the medulla oblongata (Dey et al., 
1975; Feldberg and Gupta, 1974). Morphine-induced hyperglycaemia is 
reduced by intraventricular injection of 5-hydroxy-tryptamine, nor-
adrenaline and adrenaline; reserpine pretreatment accentuates morphine-
induced hyperglycaemia (Feldberg and Shaligram, 1972). 
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10 Comments 
Various effects produced by morphine in man and the cat are dis­
cussed in detail above and summarized in Table 1.2. Most of the effects 
are similar in both man and cat. Moreover, the differences that exist 
between both species in morphine-induced effects seem to be not funda­
mental, but rather the consequence of differences between both species 
in the ratio of adrenal catecholamine levels as argued by the follow­
ing. In such species as cats, which respond to morphine with excitation 
of behaviour, the ratio between the levels of adrenaline and noradrena­
line within the adrenal gland is smaller than in such species as rats 
or humans, which respond to morphine with sedation of behaviour (Guaza 
et al., 1979). As morphine affects adrenal activity, and adrenaline and 
noradrenaline have differential effects on the various biological sub­
systems within the organism that are involved in the other morphine-
induced effects, it is evident that differences between species in the 
ratio of adrenal catecholamine levels may underly differences in the 
various morphine-induced effects. This is on line with the observation 
TABLE 1.2 
Morphine-induaed effects in man and oat 
effects 
analgesia 
behaviour activity 
blood pressure 
body temperature 
corticosteroid excretion 
emesis 
heart rate 
hyperglycaemia 
physiological dependence 
psychological dependence 
pupillary diameter 
respiratory depression 
tolerance 
man 
+ 
Kocc. i ) 
осе. \ 
\~\ 
оссД 
+ 
OCC.J 
+ 
+ 
+ 
\ 
+ 
+ 
cat 
+ 
l-t 
l-t 
t 
t 
+ 
\~\ 
+ 
+ 
+ 
t 
+ 
+ 
+ = present; t - increase; \ = decrease;-^-higher doses; 
oca. - occasionally 
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that hypertension and mydriasis are not obtained by morphine administra-
tion to adrenalectomized cats (sections 1.4.3 and 1.4.7). 
The similarity of the morphine-induced effects in man and the cat 
argues for the use of cats as an experimental animal for the study of 
morphine's mechanism of action. We have selected the cat as an experi-
mental animal hoping that insight into morphine's actions in this species 
will lay a solid foundation for the understanding of morphine's actions 
in man. 
CENTRAL EFFECTS OF MORPHINE IN CATS 
The central effects of morphine in cats are discussed in this section. 
For information about the central effects of morphine in other species 
the reader is referred to the following publications: Brase, 1979; Clouet 
and Iwatsubo, 1975; Domino et al., 1976; Domino, 1979; Iwamoto and Way, 
1979; Martin and Sloan, 1977; North, 1979). 
Effects on neurotransmission processes 
Acetylcholine 
Morphine (0.5-5 mg/kg) enhances the release of acetylcholine from the 
cerebral cortex and into the cerebral ventricles of unanaesthetized 
cats; the effect is antagonized by naloxone, and chronic morphine treat-
ment results in the development of tolerance and dependence (Mullin et 
al., 1973; Mullin and Phillis, 1974; Phillis et al., 1973). The effect 
on cortical acetylcholine release appears to be mediated subcortically 
as a one hour perfusion of the sensorimotor cortex with a 1-5% solution 
of morphine is ineffective (Mullin and Phillis, 1974). In the anaesthe-
tized brain stem transected cat, morphine (0.1-5 mg/kg) depresses the 
release of acetylcholine from the cerebral cortex and into the cerebral 
ventricles; this effect is antagonized by naloxone (Beleslin and Polak, 
1965; Jhamandas et al., 1971). In the unanaesthetized brain stem 
transected cat, the effect on cortical acetylcholine release appears 
to be dose-dependent, in that doses of 0.3-5.6 mg/kg or less yield 
depression, whereas higher doses (10-15 mg/kg) produce enhancement of 
acetylcholine release; chronic morphine treatment results in the de-
velopment of tolerance to and dependence on both the increasing and 
decreasing action of morphine (Labrecque and Domino, 1974; Mehta, 1975). 
Morphine (1-5 mg/kg) produces a dose-dependent and naloxone-reversible 
depression of both the resting and evoked release of acetylcholine from 
the caudate nucleus of the unanaesthetized brain stem transected cat 
(Yaksh and Yamamura, 1975). Morphine-induced behaviour excitation in 
the cat appears to be related to increased release of brain acetyl-
choline (Domino et al., 1976). 
Noradrenaline 
Vogt (1954) reports that morphine (30-60 mg/kg) decreases noradrenaline 
levels in the brain of cats. These findings are confirmed by Gunne 
(1963), Laverty and Sharman (1965), Maynert (1967), and Reis et al. 
(1969). Reis et al. (1969) show that morphine decreases levels of nor-
adrenaline in the medial hypothalamus, the midbrain, cerebellum, and 
cervical cords but that it increases levels in the mammillary bodies 
and globus pallidus. Reduced levels of noradrenaline in the hypo-
thalamus are obtained after intravenous (10 mg/kg), intraventricular 
(1 mg), but not intracisternal (1 mg) administration of morphine (Moore 
et al., 1965). Chronic morphine treatment results in the development of 
tolerance to the effect of morphine on brain noradrenaline (Gunne, 1963). 
Doj> amine 
Intraventricular (1 mg) or systemic (10-30 mg/kg) administration of 
morphine to cats does not affect dopamine levels within the caudate 
nucleus; but, as it increases homovanillic acid levels, it may increase 
dopamine turnover (Laverty and Sharman, 1965; Moore et al., 1965). In-
deed, locally administered opiate agents stimulate the in vivo release 
of dopamine from the caudate nucleus (Chesselet et al., 1981). 
Serotonin 
Morphine (30 mg/kg) slightly increases the content of serotonin and its 
metabolite 5-hydroxy-indoleacetic acid in the thalamus of the cat 
(Laverty and Sharman, 1965). Morphine (6 mg/kg) increases the release 
of 5-hydroxy-tryptamine from the cerebral cortex and the caudate nucleus 
of brain stem transected cats (Aiello-Malmberg, 1979). 
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1 .5.2 Electrophysiological responses 
Administration of morphine (2 mg/kg) to immobilized cats has little 
effect on somatically evoked responses in the neocortex (McKenzie, 
1964). lontophoretic application of morphine or naloxone does not 
affect the spontaneous or acetylcholine-induced firing of neurons in 
the neocortex of anaesthetized or decerebrated cats (Duggan et al., 
1976). Microiontophoretic administration of morphine excites cholino-
excitable neurons in the cerebral cortex of decerebrated cats, but 
this effect is not antagonized by naloxone (Bioulac et al., 1975). 
Morphine (2 mg/kg) depresses somatically evoked responses, but it 
does not affect septally evoked responses in the hippocampal formation 
of immobilized cats (McKenzie, 1964). Nakamura and Mitchell (1972) de-
monstrate in a more detailed study that administration of morphine 
(1-4 mg/kg) to immobilized cats does not affect hippocampal or 
entorhinal excitability but that it reduces sensory input into the 
entorhinal area. Administration of morphine (0.5-2.0 mg/kg) to im-
mobilized cats augments the spontaneous firing of hippocampal neurons; 
this effect is antagonized by naloxone (Chou and Wang, 1977). Micro-
injections of Leu-enkephalin produce epilepticformic changes in the 
hippocampal EEG of spinal cats which are antagonized by naloxone; 
tolerance develops rapidly to this opioid peptide-induced effect 
(Elazar et al., 1979) . 
Forebrain 
Administration of morphine (0.5-2.0 mg/kg) to immobilized cats augments 
the spontaneous firing rate of neurons in the amygdala, lateral hypo-
thalamus, caudate nucleus and septum (Chou and Wang, 1977; Robinson 
and Wang, 1979). Electrophoretic administration of morphine to decere-
brated or anaesthetized cats excites neurons in the ventrobasal thalamus 
that have nicotinic receptors for acetylcholine; this effect is antag-
onized by naloxone (Duggan et al., 1976). In anaesthetized, immobilized 
cats, morphine (1-2 mg/kg) blocks the bradykinin-induced increase in 
thalamic unit activity (Lim et al., 1969). Electrophoretic administra-
tion of morphine to anaesthetized, immobilized cats depresses the 
glutamate-induced, the noxious stimuli-induced, and the spontaneous 
neuronal activity but not the acetylcholine-induced neuronal activity 
in the medial thalamus; naloxone does not antagonize this effect of 
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morphine but, in contrast, mimicks it (Duggan and Hall, 1977). Intra­
venous administration of morphine (0.5-1.5 mg/kg) mimicks electrophoretic 
administration of morphine in its effect on glutamate-induced neuronal 
activity in the medial thalamus, but it has inconsistent effects on the 
spontaneous and the noxious stimuli-induced firing of medial thalamic 
neurons. The effect of glutamate-induced firing is antagonized by 
naloxone (Duggan and Hall, 1977). 
Midbrain 
Administration of morphine (1-4 mg/kg) to immobilized cats depresses 
the somatically evoked responses in the ventral tegmental area, para-
lemniscal area, central grey, and mesencephalic reticular formation 
(McKenzie, 1964; Straw and Mitchell, 1964). Neurons in the periaque­
ductal grey are inhibited by iontophoretic administration of morphine, 
α-endorphin or Met-enkephalin; some of the neurons are excited, with 
or without a preceding inhibitory phase, particularly by morphine and 
α-endorphin (Gent and Wolstencroft, 1979b). 
Hindbrain 
Iontophoretic application of morphine, Met-enkephalin or α-endorphin 
inhibits neurons in the reticular formation of medulla and pons, and 
in the nucleus raphe magnus of unanaesthetized, decerebrated cats (Gent 
and Wolstencroft, 1976b). Iontophoretic administration of morphine, 
Met-enkephalin or Leu-enkephalin depresses also the firing rate of 
neurons in the nuclei reticularis gigantocellularis and pontis caudalis 
of unanaesthetized, decerebrated cats. None of these responses is blocked 
by naloxone (Gent and Wolstencroft, 1976a). Intravenous administration 
of morphine (1-4 mg/kg) excites medullary raphe neurons of decerebrated 
or anaesthetized cats. This effect is antagonized by naloxone (Anderson 
et al., 1977). Iontophoretic application of enkephalin reduces the 
spontaneous and noxious stimuli-induced firing of nociceptive neurons 
in the trigeminal nucleus caudalis of decerebrated cats. This effect 
is antagonized by naloxone (Anderson et al., 1978). Morphine (0.25-1.0 
mg/kg) inhibits the spontaneous activity of cells in the locus coeruleus 
of anaesthetized, immobilized cats in a naloxone-reversible way; more­
over, systemic administration of naloxone suppresses the inhibitory 
responses of locus coeruleus cells to stimulation of the hypothalamic 
arcuate nueleus, i.e. the origin of ß-endorphin containing neurons 
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afferent to the locus coeruleus (Strahlendorf et al., 1980). Electro-
phoretic administration of morphine or Met-enkephalin depresses the 
firing of respiration related neurons in the region of the tractus 
solitarius, the nucleus ambiguus and in the pons, the nucleus para-
brachialis medialis; these effects are mimicked by those of intravenous 
administration of morphine (0.1-0.5 mg/kg) and antagonized by naloxone 
(Denavit-Saubié, 1978). 
1.5.3 Comments 
Morphine produces a wide variety of effects, which are used and 
abused by the human being. Most of these effects are centrally mediated 
(sections 1.3 and 1.4). More knowledge about morphine's central action 
is a prerequisite to achieve an improved therapeutic use and a decreased 
abuse of morphine by man. We have chosen the cat as experimental animal 
in our studies on the central action of morphine. In section 1.4, we 
have already emphasized that morphine's actions in man and cats share 
many common features. The relatively large dimensions of the feline 
brain, together with the relatively high sensitivity of the cat to 
morphine, are considered as additional advantages of the use of cats 
in the study of morphine's central action. On the other hand, our know-
ledge about morphine's central action in cats is rather limited as dis-
cussed in the previous sections. Although there is already some evidence 
that at least cholinergic, noradrenergic, dopaminergic and serotonergic 
processes are involved in the central actions of morphine (see sections 
1.5.1, 1.4), it is not yet possible to draw definite conclusions because 
of the following reasons: 1) The great variety of doses, routes of ad-
ministration and experimental conditions preclude any comparison between 
the outcome of the available studies, 2) Morphine-induced changes within 
the brain are rarely analyzed in terms of being consequences of a direct 
or indirect action of morphine, 3) Morphine-induced changes are only 
partly analyzed in terms of being specific or not, 4) Almost no atten-
tion is paid to the time-course of the morphine-induced changes. In the 
present study, we pay particular attention to these factors. In all ex-
periments, dose, route of administration and experimental conditions 
are fully standardized according to the outcome of pilot experiments. 
If necessary, experiments are included in order to separate direct and 
indirect actions of morphine and/or to establish the specificity of the 
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effects elicited. And, finally, attention is paid to effects appearing 
at different time-intervals after the administration of morphine. 
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CHAPTER 2 
MORPHINE-INDUCED BEHAVIOUR OF CATS: A TOOL FOR 
THE STUDY OF CENTRAL NEUROTRANSMISSION PROCESSES 
2.1 INTRODUCTION 
Behaviour - considered as the dynamic process by which the living 
organism attempts to control its input signals by output actions (Cools, 
1981; Powers, 1973) - is mediated via a large number of neuronal pro-
cesses within the brain. Accordingly, changing the activity of these 
central processes will, in general, affect behaviour. This relationship 
between behaviour and central neuronal activity enables investigators 
to use behaviour as an experimental variable for the study of central 
processes. Most of these central processes are neurochemically regulated. 
Accordingly, the activity of these processes can be changed experiment-
ally by intracerebral injection of drugs that have the ability to inter-
fere specificly with these processes. The aim of the present thesis is 
to investigate, whether the morphine-induced behaviour of cats, in com-
bination with intracerebral injections of drugs, may be a suitable 
method for the study of the functional and pharmacological properties 
of neurotransmission processes in the brain. 
Intracerebral injection of drugs is chosen as a method to change the 
activity of central neurotransmission processes. In contrast to other 
techniques such as lesions or electrical stimulation, the intracerebral 
injection technique offers the possibility to affect single neuronal 
systems, rather than whole brain structures. These neuronal systems can 
be characterized both pharmacologically, taking advantage of the spe-
cificity of the intracerebrally injected drugs, and anatomically by 
histological verification of the injection sites. 
Behaviour is chosen as an experimental variable for the study of 
central neurotransmission processes. Accordingly, the experiments are 
performed -in vivo in unanaesthetized animals. As a direct consequence 
of the use of behaviour as experimental variable, only neurotransmission 
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processes can be studied that are somehow connected with behaviour. 
Knowledge of the functional and pharmacological properties, especially 
of these processes is of interest as it indicates, 1) which neuronal 
systems may play a critical role in disturbed behaviour, and 2) how 
the activity of these systems may be changed pharmacologically to pre-
vent or cure disturbed behaviour. 
Several test situations are available for the disclosure of experi-
mentally-evoked changes in behaviour. Such gross behaviour effects as 
excitation, sedation, aggression, convulsions, tremors, defaecation, 
emesis, or urination can be disclosed in the open-field test situation. 
More subtle changes in behaviour, e.g. dealing with the organization of 
complex behaviour, are less evident in the open-field, and require a 
more specific test situation. In the present study, drug-induced be-
haviour is chosen. This drug-induced behaviour has the advantage 
compared to other test situations, such as avoidance behaviour or 
operant responding, that it can be studied in acute experiments with-
out any preceding training trials. 
On the basis of its highly structured organization and characteristic 
behaviour patterns, the morphine-induced behaviour of cats may serve as 
a suitable tool for the disclosure of experimentally-evoked changes in 
behaviour as will be argued below. An advantage of cats as experimental 
animals is that the larger dimensions of their brains compared with 
those of other laboratory animals, such as mice or rats, allow more 
definite conclusions about any specific location of the intracerebrally 
evoked effects. Apart from providing a suitable test situation, the 
morphine treatment offers also the possibility to study morphine's 
action on central processes. 
Experimentally-evoked changes in the behaviour of morphine pretreated 
cats have been reported previously (Dhasmana et al., 1972; Feldberg and 
Shaligram, 1972; Fertiziger et al., 1974; French et al., 1979; Loewe, 
1956; Sturtevant and Drill, 1957; Wikler, 1944; Winter and Flataker, 
1951). In general, these authors used such terms as "frightened", 
"avoids handling", "rage", "mania", and "hyperactivity" to describe 
the morphine-induced behaviour. On the basis of the results of Cools 
et al. (1974), we have developed a more detailed description of the 
morphine-induced behaviour of cats. This detailed description, which 
uses both qualitative and quantitative measures, enables us to disclose 
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subtle changes in behaviour following the intracerebral injection of 
drugs. 
Before considering both qualitative and quantitative aspects of the 
morphine-induced behaviour of cats in section 2.3, resp. 2.4, a general 
outline of the experimental procedure is given in section 2.2. 
2.2 EXPERIMENTAL PROCEDURE 
Only general aspects of the procedure are mentioned below; details 
of the procedure relevant to the individual experiments are described 
under the headings Materials and Methods in the various experimental 
sections. 
Cats of both sexes are used. They are treated with an intraperi­
toneal injection of morphine (5 mg/kg) and observed for a period of 
60 min immediately following the injection. Drugs are intracerebrally 
injected at variable time intervals after morphine is administered. 
The intracerebral injections are performed within a 2 min period during 
which the behaviour is not analyzed. The experiments are performed be­
tween 8.00 A.M. and 4.00 P.M. 
The morphine-induced behaviour of cats greatly depends on the 
external stimulation in which it develops (Cools et al., 1974). There­
fore, it may be useful to note that the experiments on morphine-pre-
treated cats described in this thesis are performed under strict ex­
perimental conditions: 
1. Care is taken to prevent environmental changes during the course of 
the experiments. For instance, the experimental cage is placed in a 
separate room protected against disturbing influences such as changes 
in the environment, and observations are made via closed circuit 
television. 
2. The cats are habituated to the experimental cage during 2 separate 
periods of 1 hr each and during a 15 min period immediately preced­
ing each experiment. 
3. The dimensions of the experimental cage are rather small 
(75 χ 75 χ 80 cm, or 88 χ 66 χ 61 cm). 
4. The experiments are performed with a single animal in the cage in 
the absence of food, drinking water and a cat-box. 
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2.3 A DESCRIPTION OF THE BEHAVIOUR 
In this section, a general description is given of the behaviour 
effects of morphine in cats under the experimental conditions mentioned 
above. This description partly replicates and partly extends the results 
of Cools et al. (1974). 
During the first minute following morphine administration, the cat 
is slightly excited due to the injection itself: the cat is alert, 
paces throughout the cage, and may sometimes stand against the cage 
door in attempt to escape. Within 2 min after the injection, however, 
the morphine-induced behaviour changes appear, ushered in by repetitive 
movements of the mouth. These repetitive mouth movements, which appear 
in almost all animals, are particularly pronounced 2-4 min after the 
injection, but they may be present during the whole observation period 
of 60 min. In a small percentage of the animals, effects such as emesis, 
defaecation, and/or urination take place within the first 5 min follow-
ing morphine administration accompanied with the corresponding species-
specific behaviour phenomena. Gradually, the excitation diminishes, 
the cat lies down, and it adopts either the crouching or bending down 
posture. The animal becomes relatively hypoactive as measured by low 
frequencies of head movements, limb movements, and postural changes. 
This period, which is called the depression phase (Cools et al., 1974), 
continues until 10-15 min after the morphine injection. 
At 10-15 min after morphine administration, the second behaviour 
phase or re-organization phase begins (Cools et al., 1974). During 
this phase of the morphine-induced syndrome, the cat becomes more and 
more active, gradually extending its behaviour activities. Head move-
ments, limb movements and postural changes appear in succession. The 
movements, which are initially performed in a regular, fluent way, 
rapidly lose their normal character and are replaced by a great number 
of staccato-like motor elements which increase in rate and frequency 
and are of a disorderly character: in other words, it starts to re-
organize its ongoing behaviour. When the animal is lying, it stands 
up and adopts a sphinx-like posture moving its head abruptly from one 
direction to another. Meanwhile, mydriasis has developed and the cat 
stares vacantly with its pupils maximally dilated and its eyes wide 
open. The animal appears alert, and it seems to track objects visually 
which are not present. The cat frequently raises, stretches, or shakes 
56 
its forepaws. Next, sideward movements appear: the cat scarcely raising 
its hindquarters, places its forepaws first to one, then to the other 
side. Somewhat later, such sideward movements lead to circling around 
stationary hindlimbs. At first, the cat circles once, and then sits 
down again; later on, it circles several times without stopping. The 
circling goes on with increasing speed, whilst the periods of circling 
become longer and/or more frequent. Apart from or instead of circling, 
some cats develop an alternative locomotor pattern, viz. running from 
one side of the cage to the other side, sometimes jumping against the 
walls. Again, the frequency of running gradually increases. Between 
periods of locomotion, the cat nearly always resumes its original 
sphinx-like posture moving its head from one direction to another and 
frequently raising, shaking or stretching its forepaws. 
At about 30 min after morphine administration, the behaviour is 
stabilized: when time progresses, a restricted number of behaviour 
patterns is regularly repeated. This stabilized behaviour phase is 
called ritualization phase (Cools et al., 1974). During this period, 
the cat neither recognizes, nor friendly responds to the observer 
when he is approaching, nor does follow an object moving in front of 
its eyes. The morphine-induced behaviour patterns and movements dis-
played during this period are characteristic in the sense that they 
are: 
1. Ritualized, i.e. restricted to a certain number of senseless be-
haviour patterns which are repeated in random order at variable 
time intervals, and 
2. Stereotyped, i.e. the way in which single units are integrated 
into spatio-temporal patterns is completely fixed. 
This ritualization period outlasts the 60 min observation period. 
The morphine-induced syndrome is sometimes accompanied with mewing 
or salivation; profuse salivation may occur after multiple morphine 
injections. Grooming, washing, scratching or sleeping, which is fre-
quently observed in control cats, is never or almost never seen in 
morphine-treated cats. Fragments of such behaviour, which are per-
formed in an abortive way, are occasionally observed. The cats neglect 
their own vomits and faeces. 
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Summarizing, the morphine-induced behaviour of cats consists of three 
distinct behaviour phases, i.e. depression, re-organization, and ritua-
lization, which appear in succession. Depression - ushered in by the 
occurrence of repetitive mouth movements, vomiting, defaecation, and/ 
or urination - is characterized by hypoactivity and a crouching or 
bending down posture. Re-organization is characterized by the appearance 
of staccato-like head movements, limb movements, and postural changes 
which rapidly increase in rate and frequency; the movements are initial­
ly of disorderly character but become integrated into more complex be­
haviour patterns. Ritualization is characterized by the performance of 
ritualized and stereotyped behaviour patterns at a stable level. The 
morphine-induced movements and behaviour patterns are individual-
specific: the exact nature and the intensity of the behaviour differs 
between animals. Some animals develop vigorous motor activity, other 
animals show only movements of head and limbs maintaining their sphinx­
like posture. The sequence of behaviour events following morphine ad­
ministration is relatively constant over the animals in spite of the 
individualistic differences in the intensity of the morphine-induced 
behaviour phenomena. 
THE ANALYSIS OF THE BEHAVIOUR 
A general description of the behaviour analysis is given in this 
section; more details are given under the headings Materials and 
Methods in the various experimental sections. 
We have developed a detailed description of the morphine-induced 
behaviour of cats, which enables us to disclose subtle, experimentally-
evoked changes in their behaviour. As indicated in the previous section, 
the morphine-induced behaviour consists of three distinct behaviour 
phases which appear in succession: depression, re-organization and 
ritualization. The development of these phases is described both 
qualitatively and quantitatively. 
' · 9Н5іі£а£іУе_аі5£ЕІЕ£І2П· ^ 6 behaviour is described according to 
a standard ethogram (see section 2.5). Individual-specific behaviour 
patterns are described in detail. Special attention is paid to the 
spatio-temporal pattern of the behaviour. The presence of the mor-
phine-induced phases is determined by the various qualitative 
characteristics of these phases, mentioned in section 2.3. 
2. Quantitative description (Figs. 3.1, 3.12 and A.3). Frequencies of 
various behaviour items, e.g. head movements, limb movements, 
postural changes, locomotor patterns, etc. are recorded per min 
and are plotted as function of time. The presence of depression 
is characterized by low frequencies, the presence of re-organization 
by increasing frequencies, and the presence of ritualization by high, 
stabilized frequencies of the behaviour items. 
Thus, both qualitative and quantitative measures are used to determine 
the presence of depression, re-organization and ritualization. 
Experimentally-evoked changes in the morphine-induced behaviour may 
appear from the following: 
1. Changes in the onsets of the behaviour phases, which are measured 
by averaging the points of time at which the frequencies of the 
behaviour items start to increase (onset re-organization = end 
depression) or become stabilized (onset ritualization = end re-
organization) . 
2. Changes in the intensity of the behaviour phases, which are 
measured by changes in the frequencies of the various behaviour 
items with or without the display of new stereotyped and ritualized 
patterns. 
3 . Changes in the nature of the behaviour patterns, which are measured 
by the replacement of the stereotyped and ritualized behaviour pat-
terns, either by new stereotyped and ritualized behaviour patterns 
or by normal behaviour patterns. 
As a consequence of the individual-specific characteristics of the 
morphine-induced behaviour patterns, the frequencies of the behaviour 
items are only helpful in determining the changes in the behaviour of 
each individual animal. Averaging of the experimentally-evoked changes 
in the frequencies over the test group does, in general, not offer 
reliable indices for the drug-induced effects. Only after injections 
of drugs into the septal nuclei (Chapters 4 and 5), which primarily 
affected the frequencies rather than the nature of the behaviour pat-
terns, it appeared possible to describe the drug-induced effects 
purely in terms of changes in frequencies of behaviour items averaged 
over the test group. As behaviour is the consequence of changes occurr-
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ing within the brain, it can be expected that each distinct morphine-
induced phase will be accompanied by its own characteristic changes 
in central neurotransmission processes. Hence, we studied these phases 
in terms of relatively independent phases. 
ETHOGRAM 
The following ethogram is used for the description of the feline 
behaviour (see also: Cools and Van Rossum, 1970; Leyhausen, 1956; 
Norton and De Beer, 1956; Van Dongen, 1980). 
I. lying 
2. sitting 
3. standing 
4. walking 
5. turning 
6. sideward movements 
7. swinging 
8. jumping 
the body resting on the ground 
- forepaws extended forwards, 
hindpaws under the body 
- forepaws folded under the body, 
hindpaws under the body 
- forepaws beside the body, 
hindpaws under the body 
- forepaws and hindpaws on one side of 
the body 
the body upright, forelegs extended, and 
the hindquarters resting on the ground 
- position of the body low 
- position of the body high 
any forward or backward movement of the 
animal along a minimum distance of АО cm 
in the case of discontinuous locomotion 
or along a fixed distance of 80 cm in the 
case of continuous locomotion 
any turning movement of the animal around 
a minimum angle of 180 in the case of 
discontinuous turning or around a fixed 
angle of 360 in the case of continuous 
turning (i.e. circling) 
any turning movement of the animal around 
an angle of 90 
small sideward movements or small movements 
backward or forward 
9. rearing standing upright against the walls with 
only the hindlegs on the ground 
10. falling 
1 1 . rolling 
12. stretching 
13. sharpening of the nails 
14. digging 
15. sniffing 
16. eating 
17. emesis 
18. defaecation 
19. micturation 
20. grooming 
21. washing 
22. scratching 
23. rubbing 
24. head movements 
25. staring 
26. mouth movements 
27. tongue extrusions 
28. salivation 
29. swallowing 
30. yawning 
31. panting 
32. eyes 
33. pupil 
coming down suddenly from an upright 
position 
moving by turning around the head-tail 
axis 
extending the body and forelegs to full 
length 
chewing and swallowing of f.i. vomit 
(food is not present) 
licking the fur 
licking a forepaw and next rubbing it 
over its head 
the fur with the hindlegs 
pressing head and neck against cage or 
against observer's hands 
every movement of the head 
open/closed 
miosis/mydriasis/normal diameter 
61 
34. limb movements any movement of the limbs not involved in 
locomotion, rearing, digging, sharpening 
of the nails, washing, or scratching 
35. body movements any body movement involving limb movements 
36. postural movements any body movement that does not involve 
limb movements 
37. miaowing 
38. growling 
39. hissing 
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CHAPTER 3 
MORPHINE-INDUCED BEHAVIOUR OF CATS: A TOOL TO STUDY THE ACTION OF 
MORPHINE ON NEUROTRANSMISSION PROCESSES WITHIN RAPHE AND STRIATAL NUCLEI 
SITE OF ACTION OF DEVELOPMENT OF PARTIAL TOLERANCE TO MORPHINE IN CATS 
Summary 
a) A behavioural study on the ability of various agents, locally ad-
ministered into the nucleus linearis intermedius raphe, to modify 
morphine-induced behaviour in freely moving cats has provided evidence 
for the concept that changes within this nucleus and in the noradrener-
gic fibre system terminating therein are necessary for the development 
of partial tolerance. 
b) Compounds such as 1-propranolol and desglycinamide lysine-8-vaso-
pressin, which are known to influence the development of tolerance, 
accelerate its development after administration into the raphe nucleus 
mentioned. 
c) Selective, pharmacological manipulation with the B-like noradrenergic 
receptors within this raphe structure influenced the development of 
partial tolerance to morphine. 
d) The present article also summarizes evidence in favour of the fol-
lowing concepts: i) morphine suppresses neuronal activity within the 
locus coeruleus and, accordingly, decreases the pulse-flow in the 
arising, noradrenergic fibres resulting in a decreased release of 
noradrenaline within the mentioned raphe nucleus and ii) development 
of partial tolerance to morphine is at least partially due to the 
ability of the noradrenergic, coeruleo-raphe system to develop hyper-
activity after an initial hypoactivity. 
3.1.2 Introduction 
In a previous study (Cools et al., 1974), attention was focused on 
the role of the interrelationship between the dopaminergic fibres -
terminating within the rostromedial part of the head of the caudate 
nucleus - and the serotonergic fibres - arising from the nucleus 
linearis intermedius raphe (NRL) and terminating within the antero-
ventral part of the head of the caudate nucleus - in the morphine-
induced behaviour in cats. In the present article, the role of the 
noradrenergic fibres - terminating within the NRL - occupies a central 
position; some of the results have been published in condensed form 
(Cools et al., 1974; Cools, 1977d). 
Morphine elicits a complex behavioural syndrome in cats (Dhasmana 
et al., 1972; Loewe, 1956; Norton and De Beer, 1956; Sturtevant and 
Drill, 1957; Wikler, 1944). Under certain conditions (for details, 
see Cools et al., 1974) morphine elicits a syndrome, which is built 
up in three steps: a) depression phase, b) re-organization phase, and 
c) ritualization phase. Characteristic of the second phase is 1) the 
break-down of normal head movements into an increasing number of iso-
lated, staccato-like movements, and the subsequent appearance of new 
patterns in which these single units are re-integrated, and 2) the 
break-down of normal postural and body movements into single movements 
of the head, neck, trunk and limbs, and the subsequent appearance of 
novel patterns in which these single elements are re-integrated; the 
resulting patterns are both stereotyped, i.e. continuously repeated 
in a specific sequence, and ritualized, i.e. restricted to a certain 
number of senseless patterns. Characteristic of the last phase is the 
presence of purely stereotyped and ritualized head movements, postural 
changes and locomotor patterns. Since the nature of the patterns dis-
played during the last phase is to a large degree determined by the 
sensory information available during the re-organization phase, which 
is dependent on factors such as the individual's developmental history, 
acquaintance with the experimental environment, etc., descriptions of 
the morphine-induced behaviour in terms of mechanisms bringing about 
the induced behaviour (see above) are preferable to descriptions in 
terms of the consequences of the induced behaviour, i.e. frightened, 
avoids handling, aggressive, etc. 
It is known that the serotonin-containing cell bodies within the 
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raphe nuclei are innervated by noradrenergic fibres (Chu and Bloom, 
1974; Dahlström and Fuxe, 1965; Fuxe, 1965; Lindvall and Björklund, 
1974; Loizou, 1969; Swanson and Hartman, 1975). Behavioural studies 
using the micro-injection technique have shown that the raphe nuclei, 
especially the NRL, contain ß-like noradrenergic receptors (Cools and 
Janssen, 1974; Cools et al., 1975). Selective stimulation of these 
receptors by means of intracerebral injections of rather small doses 
of 1-noradrenaline suppresses the display of the stereotyped and ri-
tualized patterns elicited by acute morphine treatment (Cools et al., 
1974); selective inhibition of these receptors by means of 1-propra-
nolol potentiates the display of these patterns (Cools, 1977d). Since 
higher doses of 1-noradrenaline and 1-propranolol were required to 
influence the morphine-induced behaviour in cats which had developed 
a partial tolerance to morphine, it has been concluded that the de-
velopment of partial tolerance to morphine in cats is accompanied by 
the occurrence of clearcut changes in the noradrenergic activity with-
in the NRL (Cools, 1977d). This is in agreement with the general theory 
that brain noradrenaline is involved in some manifestations of acute 
and chronic morphine treatment of mice, rats and cats (for recent re-
views: Clouet and Iwatsubo, 1975; Herz and Bläsig, 1974; Takemori, 
1974). Apart from the fact that these findings suggested an important 
role for the noradrenergic mechanisms within the NRL in morphine-in-
duced effects, they opened the question of whether the changes within 
the NRL are necessary for the development of partial tolerance rather 
than epiphenomena of the presence of partial tolerance. 
In the present article, evidence is presented to demonstrate that 
selective, pharmacological interference with the noradrenergic activity 
within the NRL does influence the development of partial tolerance to 
morphine. Furthermore, evidence is presented to show that an endocrino-
logically inert fragment of vasopressin, i.e. desglycinamide lysine-8-
vasopressin, a neuropeptide that potentiates the development of toler-
ance to morphine-induced analgesia in mice (Krivoy et al., 1974) and 
restores the retarded development of tolerance to morphine-induced 
analgesia in homozygous rats with hereditary diabetes insipidus 
(De Wied and Gispen, 1976), accelerates the development of partial 
tolerance to morphine when locally applied to the NRL of cats. Both 
sets of data underline the hypothesis that characteristic changes with-
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in the NRL are necessary for the development of partial tolerance to 
morphine-induced behaviour in cats. 
3.1.3 Materials and methods 
Cats ranging in weight from 2.5 to 3.2 kg were used; the cats were 
not derived from an inbred strain. 
In the first series of experiments, daily injections of morphine 
(5 mg/kg, i.p. given between 9.00 and 12.00 a.m.) were administered on 
5 consecutive days in order to determine the changes characteristic of 
the development of tolerance (see also Cools, 1977d). 
In the second series of experiments, animals pretreated with an i.p. 
injection of morphine (5 mg/kg) received an intracerebral injection of 
0.9% NaCl, 1-noradrenaline or 1-propranolol into the NRL at the point 
of time that the ultimate morphine-induced syndrome was developed (see 
also Cools et al., 1974; Cools, 1977d). The purpose of these experiments 
was to determine the acute effects of these compounds. 
In the third series of experiments, animals pretreated with an intra-
cerebral injection of 0.9% NaCl, 1-noradrenaline or 1-propranolol into 
the NRL received an i.p. injection of morphine (5 mg/kg) 5-10 days after 
the intracerebral injection. The purpose of these experiments was to de-
termine whether selective, pharmacological manipulation with the ß-like 
noradrenergic receptors within the NRL produces long-term after-effects; 
these experiments were suggested by the finding that a single injection 
of 1-propranolol into the NRL resulted in a decreased sensitivity to a 
second injection of 1-propranolol (Gieles, Mortiaux, Megens and Cools, 
unpublished data). 
In the final series of experiments, animals pretreated with an i.p. 
injection of morphine (5 mg/kg) and an intracerebral injection of 1-pro-
pranolol or desglycinamide lysine-8-vasopressin (DG-LVP) given 40-50 min 
after the morphine injection received a second i.p. injection of morphine 
(5 mg/kg) on the day following this pretreatment; the purpose of these 
experiments was to determine whether compounds which accelerate the de-
velopment of partial tolerance in mice and rats after systemic admini-
stration (Cowan and MacFarlane, 1975; De Wied and Gispen, 1976; Krivoy 
et al., 1974) also accelerate the development of partial tolerance to 
morphine in cats when locally applied to the NRL. 
The spontaneously occurring and drug-induced behaviour was recorded 
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on videotapes by means of a closed TV circuit. The tapes provided ob­
jective and continuous records, which were analyzed with the help of 
the following parameters (Fig. 3.1): 1) determination of the frequency 
of head movements (Aa), body movements including the single movements 
of the limbs (Ab), postural movements (Ac) and distinct types of 
stereotyped and ritualized patterns (Ad); 2) determination of the on­
set of the re-organization phase (= end of the depression) by averag-
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ing the points of time at which the frequencies of the head, body and 
postural movements started to increase; 3) determination of the onset 
of the ritualization phase by averaging the points of time at which 
the frequencies of the head, body and postural movements became sta­
bilized and the stereotyped and ritualized patterns appeared. 
As illustrated in Fig. 3.2, the drug action was determined as fol­
lows: a) immediate onset of the display of the stereotyped and ritua­
lized patterns following intracerebral administration of the drug 
during the re-organization phase (= potentiation of the ritualization); 
b) increase in frequencies of head, body and postural movements with or 
without the display of new stereotyped and ritualized patterns follow-
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ing intracerebral administration of the drug during the ritualization 
(= potentiation of the ritualization). Since drugs which are able to 
produce effects a) and b) may produce slight changes in the "kinetic 
melody" of the ongoing stereotyped and ritualized patterns, which can­
not be described as completely new stereotypies, changes in the "kinetic 
melody" of the ongoing stereotypies following the administration of 
lower· concentrations of these agents are accordingly classified as 
potentiation, score 1 in contrast to the overt symptoms mentioned 
above, which are classified as potentiation, score 2 (see also Figs. 
3.6 and 3.7); c) partial or complete suppression of the ongoing stereo­
typed and ritualized patterns and/or decreased frequencies of the head, 
body and postural movements following intracerebral administration of 
the drug during the ritualization (• inhibition of the ritualization; 
see also Fig. 3.5). In the experiments discussed below, determinants 
b) and c) were used. 
Each observation period lasted 60 min; a period of 15 min preceding 
the first injection was used as control. In general, cats were placed 
in the observation cage (75 χ 75 χ 80 cm) 15 min before the control 
recordings. Precautions were taken in order to prevent the occurrence 
of changes in the external environment during the experimental session. 
All animals were habituated to the cage during two sessions of 1 hr 
each. Cats treated more than once on different days were always tested 
at the same time of day. The whole testing procedure, including the 
transport of the animal to and from the experimental cage, was kept as 
constant as possible. Since the sensitivity to morphine changes during 
the year (maximum sensitivity: March and July; minimum sensitivity: 
December and May (Mortiaux, Gieles, Megens, Jansen and Cools, unpublished 
data)), the experiments presented below were performed in periods marked 
by an intermediate sensitivity: January, April, June, September, October 
and November. 
Cats receiving intracerebral injections were prepared as previously 
described (Cools and Van Rossum, 1970). Short, double-barreled, stain­
less steel cannulae were stereotaxically implanted in such a way that 
the injection needle could reach the NRL (using the co-ordinates of 
Snider and Niemer (1964): A = 1.5, L » 0.3, Η = -4.0). Cannulae were 
placed at an angle of 10 in reference to the mid-sagittal plane (Cools 
and Janssen, 1974; Cools et al., 1975). Upon recovery from the operation, 
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placing responses, righting and pupillary reflexes were checked. In 
addition, food-intake, wakefulness and reactivity to visual and acoustic 
stimuli were estimated; only cats which responded normally during the 
second post-operation week were used in the experiments. 
Drug solutions (Ι μΐ) were injected through injection needles, which 
extended into the brain tissue about 2 mm below the tip of the embedded 
cannulae. The following substances were used: 1-noradrenaline HCl (Fluka 
A.G., Switzerland), 1-propranolol (gift of I.C.I., United Kingdom), des-
glycinamide lysine-8-vasopressin (gift of Organon International B.V., 
The Netherlands), and morphine Η-SO, (Chemische Pharmaceutische Fabrieken, 
The Netherlands). Apart from morphine, which was always dissolved in 0.9% 
NaCl, all compounds were dissolved either in 0.9% NaCl or in aqua bidest. 
Injections of solvents only produced a slight arousal during the first 
3 min following the injection regardless of the pretreatment. 
After completion of the experiments, the brain was removed and pre­
pared as previously described (Cools and Van Rossum, 1970); visual in­
spection of a series of brain slices (about 100 pm) caudally from a 
knife-cut along the track of the guide cannula was made to determine 
the sites of injections. Only experiments in which the injection sites 
were restricted to the target area shown in Fig. 3.3 are discussed be­
low. 
3.1.4 Results 
2fYÊÎ22S!êBÎ_2Ë_E§l£iêi_Î2ÎËïâD£Ë_ï°_™2EEbiîî5 
The effects of daily administration of morphine (n = 14) are shown in 
Fig. 3.4; this figure shows that the onset of the re-organization and 
ritualization phase was significantly retarded from the third day 
(p < 0.001; Students t-test). 
Acute effects_of_l-noradrenaline and 1зЕЕ2ЕЕ§22^2І HE011 morghine-induced 
behaviour 
1-Noradrenaline (10 yg), locally administered into the NRL during the 
ritualization phase triggered by a single injection of morphine, imme­
diately decreased the frequencies of the head, body and postural move­
ments and, in addition, suppressed the ongoing stereotyped and ritualized 
patterns during a period of about 7 min. An example is given in Fig. 3.5. 
The results of all experiments (n = 9) are summarized on the left side 
of Fig. 3.8, and show that 1-noradrenaline inhibited the morphine-induced 
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Fig. 3. 3 Semi-diagvammatio outline of one anterior frontal plane of 
the cat brain showing the nucleus linearis intermedius raphe. 
Aa - aquaduatus cerebri; Dt - deauseatio tegmenti; 
Mli = nucleus linearis intermedius raphe; Dp = decussatio 
pedunaularum; Ni - nucleus interpeduncularis; Sg = substantia 
grisea centralis. 
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Fig. 3.4 Effects of subsequent, daily injections of morphine upon the 
duration of morphine-induced depression, re-organization and 
ritualization (morphine: S mg/kg, i.p. given at time = 0, 
each day). 
» onset of re-organization on day 3-5 is significantly 
different from that on day 1 (p < 0.01; Students t-test) 
** onset of ritualization on day 3-5 is significantly dif-
ferent from that on day 1 (p < 0.001; Students t-teat) 
ritualization in all cases. 
1-Propranolol (8 yg), locally administered into the NRL during the 
ritualization phase triggered by a single injection of morphine, pro-
duced a slight change in the nature of the ongoing stereotyped and 
ritualized patterns in some animals (an example is given in Fig. 3.6), 
whereas the same dose produced increased frequencies of head, body and 
postural movements and/or the display of completely new types of stereo-
typed and ritualized patterns in other animals (an example is given in 
Fig. 3.7). A dose of 10 yg 1-propranolol always produced the last men-
tioned effects. The results of all experiments, in which 10 yg was given 
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Fig. S. 5 Behavioural effects of injections of l-noradrenaline 
(10 \ig/\il at time = 3S) into the nucleus linearis intev-
medius raphe upon the morphine-induced ritualization in 
a male cat (morphine: 6 mg/kg, i.p. given at time = 0): 
suppression of ongoing behaviour, 
(n = 7), are summarized on the left side of Fig. 3,8, and show that 
1-propranolol potentiated the morphine-induced ritualization phase in 
all cases. 
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Fig. 3.5 Behavioural effeats of injeetions of l-propranolol (8 \ig/\il 
at time = 40) into the nuoZeus linearis intermedius raphe 
upon the morphine-induaed ritualization in a male oat 
(morphine: 5 mg/kg, i.p. given at time = 0): change in 
"kinetio melody" of ongoing stereotypies. 
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As can be seen on the right side of Fig. 3.8, intracerebral injections 
of 1-noradrenaline (10 ug) and l-propranolol (10 pg) given 5-10 days 
prior to morphine, potentiated and suppressed respectively the display 
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Fig. 2.7 Behavioural effects of injections of l-propranolol (8 \ig/v.l 
at time = 35) into the nucleus linearis intermedius raphe 
upon the morphine-induced ritualization in a male cat 
(morphine: 5 mg/kg, i.p. given at time - 0): increased 
frequency of ongoing behaviour and display of new stereo-
typies. 
of stereotyped and ritualized patterns: 1-noradrenaline accelerated 
the onset of the ritualization phase (p < 0.05; Students t-test), 
whereas l-propranolol suppressed the ongoing behaviour during a period 
of about 12 min. In other words, a pretreatment with these noradrenergic 
agents produced effects diametrically opposite to those elicited by these 
agents in cats treated with morphine during the same session (Fig. 3.8, 
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Fig. 3.8 Left side: behavionral effects of injections of saline 
(1 vl: A)j l~noradrenaline (10 ug/]it: Б) and l-propranolol 
(10 vg/vl: C) into the nucleus linearis inbemediue raphe 
upon the behaviour elicited by morphine (5 mg/kg, i.p. given 
av time = 0) : В = inhibition of rituali га Hon; С = potentia­
tion of ritualization. 
Right side: effects of similar, intracerebral injections 
given 5-10 days prior to morphine (S mg/kg, i.p. given at 
time = 0): E = potentiation of ritualization; F - inhibition 
of ritualization. 
* onset of ritualization in E is significantly different 
from that in D (p < 0.05; Students t-test). 
** onset of re-organization in F is significantly different 
from that in Ό (p < 0.05; Students "t-test). 
cf. right and left side). 
Effects_of_desglYcinamide_l2sine-8-vaso£ressin §2d_l-£ro2ranolol_ugon 
develo2ment_of partial tolerance to morphine 
Desglycinamide lysine-8-vasopressin (DG-LVP: I yg), locally administered 
into the NRL during the ritualization phase triggered by a single injec­
tion of morphine, produced a) an increase in frequencies of the head, 
body and postural movements, and b) the display of new stereotyped and 
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9 Behavioural effects of injections of desglyainamide lysine-B-
vasopressin (DG-LVP: 1 vg/\xl at time = bO) into the nueleus 
linearis intermedius raphe upon the behaviour elicited by 
morphine (5 mg/kg, i.p.) given to a male oat at time = 0: 
potentiation of ritualisation. 
ritualized patterns; the number of new patterns varied from animal to 
animal. An example is given in Fig. 3.9. The results of all experiments 
(n = 6) are summarized on the left side of Fig. 3.11, and show that 
DG-LVP potentiates the morphine-induced ritualization phase in all 
cases. A second injection of morphine on the day following the above-
mentioned experiments resulted in a significant retardation of the 
onset of the ritualization phase (p < 0.001; Students t-test) . An 
example is given in Fig. 3.10. The result's of all experiments (n = 6) 
are summarized on the right side of Fig. 3.11, and show that a pre-
number of distinct types 
of stereotypies/Smin 
10- B 
DG-LVP 
on dayl 
л 
i 
31J5 3β-40 41-45 46-50 51-55 56-60 31-35 36-40 41-45 46-50 51-55 56-60 
time periods of 5 min after morphine-injection 
LJ effect of morphine 5 m g / k g i.p. given at t O 
Ц effect of an additional morphine injection on day 2 
A naive animal 
В naive animal treated with microinjection of desglycinamide lysine 
Vasopressine ( DG-LVP l ^ i g / l ^ i ) at t = 50) into the nucleus linearis 
intermedius raphe on day 1 
Vig. 5.10 Left side (A): behavioural effects of injections of morphine 
(S mg/kg, i.p. given at time - 0) upon the number of distinct 
types of stereotypies in a male oat on day 1 (open aolwm) 
and on day 2 following an additional injection of morphine 
(arced column; 5 mg/kg, i.p. given at time = 0). 
Right side (B): behavioural effects of injections of desgly­
cinamide Іузіпе-8-vasopressin (1 vg/vl, locally applied into 
the nucleus linearis intermedius raphe at time - SO) upon be­
haviour elicited by morphine (5 mg/kg, i.p, given at time = 0) 
in a male oat on day 1 (open column) and by an additional in­
jection of morphine (S mg/kg, i.p. given at time - 0) on day 
2 (arced column). Note that the increase on day 1 ft^-t.J 
is followed by a decrease on day 2 (t .-t J. 
о 1 4Ь 
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treatment with DG-LVP produced effects characteristic of chronic treat-
ment with morphine (cf. Fig. 3.4, day 3, 4 and 5, with Fig. 3.11, right 
side: C). The outcome of similar experiments with l-propranolol (10 yg) 
is presented in the same Fig. 3.11: pretreatment with l-propranolol also 
produced effects characteristic of chronic treatment with morphine (cf. 
Fig. 3.4, day 3, 4 and 5, with Fig. 3.11, right part: D) . 
day 1 
S.E.M SEM. 
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IdepressionOre-orgamzation • ntualization 
I Inhibition И potentiation, score 2: increased frequency 
of ongomg stereotypies and/or new stereotypies 
Fig. 3.11 Left side (day 1) : behavioural effects of injeation of des-
glyainamide lysine-3-vasoppessin (DG-LVP: 1 \ig/vl) and 
l-propranolol (10 vg/vl) into the nucleus linearis inter-
médius raphe upon the behaviour elioited by morphine given 
at time =0(5 mg/kg, i.p,): A and В = potentiation of 
ritualization. 
Right side (day 2): behavioural effects of an additional 
injection of morphine on day 2 at time = 0 (5 mg/kg, i.p.): 
С and D = inhibition of ritualization. 
* onset of the re-organization is significantly retarded 
of control 2 (p < 0.01; Students t-test). 
** onset of the ritualization is significantly retarded of 
control 2 (p < 0.001; Students t-test). 
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5 Discussion 
The data collected in the first series of experiments show that re-
peated exposure of cats to morphine results in the development of par-
tial tolerance. Our findings are in agreement with those reported by 
Djahanguire et al. (1966), Eddy and Himmelsbach (1936) and Seevers and 
Deneau (1963), who also used doses lower than 10 mg/kg; in this context, 
it is important to mention that tolerance to morphine does not develop 
when higher doses are used (cf. Huidobro and Lewin, 1969; Seevers and 
Deneau, 1963; Tatum et al., 1929). 
On the basis of the data collected in the second series of experiments 
and those reported earlier (Cools et al., 1974; Cools, 1977d), it can be 
concluded that increase and decrease of the noradrenergic activity with-
in the NRL suppresses and potentiates respectively the morphine-induced 
phase marked by the display of the stereotyped and ritualized patterns. 
This, together with the fact that morphine per se triggers the display 
of these patterns, suggests that an acute injection of morphine (5 mg/kg, 
i.p.) directly or indirectly decreases the noradrenergic activity within 
the NRL. The literature on decreased activity of brain noradrenaline in 
acute morphine intoxication is controversial (for recent reviews: see 
Clouet and Iwatsubo, 1975; Herz and Bläsig, 1974; Takemori, 1974), but 
findings such as a) potentiation of the morphine-induced analgesia fol-
lowing suppression of the noradrenergic activity (Watanebe et al., 1969), 
and b) potentiation of the morphine-induced effects upon the threshold 
for vocalization in rats following inhibition of the noradrenaline syn-
thesis (Dahlström et al., 1975), are not in conflict with our suggestion. 
In this context, it is important to realize that the available literature 
only deals with the effects of systemically given agents. 
Although various mechanisms of action such as a) decrease of the num-
ber of noradrenergic receptors, b) hyposensitivity of these receptors, 
c) inhibition of these receptors, d) increased re-uptake of noradrenaline, 
etc. might explain the occurrence of a decreased noradrenergic activity 
within the NRL of morphine-treated cats, changes triggered by morphine 
within the NRL can be excluded on the basis of the fact that morphine 
(1-10 ug) locally administered into this nucleus is behaviourally inert 
(Mortiaux and Cools, unpublished data). In this context, it is worth-
while to note that the ineffectiveness of locally applied morphine also 
excludes the possibility that putative interaction between propranolol 
and morphine or its receptors (De Feudis and Grosz, 1972; Goldstein, 
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1974) within the NRL underlies the ability of propranolol to influence 
morphine-induced behaviour. However, the ineffectiveness of locally ad-
ministered morphine indicates that morphine may only indirectly influ-
ence noradrenergic activity within the NRL. Indeed, the following data 
suggest a different site of action. First, the noradrenergic terminals 
within the raphe nuclei belong to noradrenergic fibres arising from the 
locus coeruleus and/or subcoeruleus (Chu and Bloom, 1974; Lindvall and 
Björklund, 1974; Loizou, 1969). Second, morphine receptors are present 
within the locus coeruleus (Pert et al., 1975). Third, morphine sup-
presses the neuronal activity of cells within the locus coeruleus (Korf 
et al., 1974). On the basis of these data, it can be suggested that 
morphine may suppress the neuronal activity within the locus coeruleus 
by interference with morphine receptors and, accordingly, suppress the 
pulse-flow in the arising noradrenergic fibres, of which at least a part 
terminates within the NRL (cf. Swanson and Hartman, 1975); this mechanism 
of action may explain the finding that acute morphine appears to result 
in a decreased noradrenergic activity within the NRL. From this point of 
view, it becomes understandable that the ability of a-noradrenergic 
agents to influence morphine-induced effects in rats (Cicero et al., 
1974) is not in conflict with the data in cats concerning the effective-
ness of propranolol since the α-noradrenergic agents may, in particular, 
affect the receptive sites within the locus coeruleus. The presence of 
morphine receptors within the locus coeruleus on the one hand (Pert et 
al., 1975) and the ability of α-noradrenergic blockers to inhibit the 
binding of naloxone to rat brain homogenates on the other hand (Cicero 
et al., 1975) point in this direction. 
The data collected in the third series of experiments show that nor­
adrenaline and propranolol given 5-10 days before the morphine injection 
produce effects that are diametrically opposite to those elicited by 
these agents when given together with morphine. In other words, a 6-nor-
adrenergic blockade given 5-10 days earlier produces effects identical to 
those elicited by stimulation of the S-noradrenergic receptors in acute 
experiments, whereas stimulation of these receptors 5-10 days prior to 
morphine produces effects identical to those elicited by a g-nor-
adrenergic blockade in acute experiments. These data clearly suggest 
that the noradrenergic mechanism within the NRL becomes hypoactive after 
a short-term increased exposure to noradrenaline and hyperactive after 
a short-term decreased exposure to noradrenaline;this fits in with the 
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Observation that a single injection of a behaviourally ineffective dose 
of propranolol (5 pg) into the NRL changes the sensitivity of the g-nor-
adrenergic mechanism in such a way that a behaviourally effective dose 
of propranolol (10 yg) given a few days later has lost its effectiveness 
(Gieles, Mortiaux, Megens and Cools, unpublished data). It is well-known 
that such phenomena follow a Long-term stimulation, inhibition or de-
nervation of noradrenergic postsynaptic receptors (Axelrod, 1974; Deguchi 
and Axelrod, 1973; Dismukes and Daly, 1974; Fleming and Trendelenburg, 
1961; Fleming et al., 1973; Kakiuchi and Rail, 1968; Kalisker et al., 
1973; Palmer, 1972; Palmer et al., 1976). The present data, however, 
suggest that such changes within the NRL appear after a short-term 
stimulation of the 3-like noradrenergic receptors triggered by a 
physiologically occurring substance, i.e. noradrenaline. On the basis 
of comparable findings in biochemical studies on the pineal gland, i.e. 
the rapid development of subsensitivity of postsynaptic 3-noradrenergic 
receptors after exposure to noradrenaline, Axelrod (1974) summarized the 
available evidence in favour of the concept that the mechanism respons-
ible for such changes in pharmacological experiments may play a similar 
role in the regulation of physiologic processes. 
Considering the above-mentioned properties of the noradrenergic 
raphe mechanism, and in view of the ability of a single injection of 
morphine to decrease the noradrenergic activity within the NRL, it be-
comes evident that animals treated with morphine must develop a long-
lasting, hyperactivity within the NRL following the short-term morphine-
induced hypoactivity. Furthermore, any subsequent injection of morphine 
should increase this after-effect more and more. It may then be expected 
that chronic treatment with morphine would be accompanied by an increased 
noradrenergic activity within the NRL; indeed, several studies have pre-
sented indirect evidence in favour of this (Ayhan and Randrup, 1972; 
Blas ig et al., 1975; Reis et al., 1970; Takagi and Kuriki, 1969; for 
reviews: Clouet and Iwatsubo, 1975; Cools, 1977d; Herz and Bläsig, 1974; 
Takemori, 1974). 
With this in mind, the final series of experiments dealing with the 
role of propranolol and desglycinamide lysine-8-vasopressin (DG-LVP) 
can be discussed. NRL-injections of propranolol given together with a 
systemic injection of morphine one day before a second morphine injec-
tion significantly retards the onset of the ritualization phase on the 
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second test-day, i.e. it produces an effect characteristic of the de-
velopment of partial tolerance to morphine (cf. Fig. 3.11, right part: 
D, with Fig. 3.4, day 3-5). Apart from the fact that these observations 
underline the notion that a pretreatment producing a short-term blockade 
of the g-like noradrenergic receptors within the NRL finally results in 
effects characteristic of a stimulation of these receptors in acute ex-
periments, these data clearly indicate that selective blockade of these 
receptors accelerates the development of partial tolerance to morphine. 
This conclusion fits in very well with the recent study of Cowan and 
MacFarlane (1975) who found that repeated administration of propranolol 
given just prior to morphine also enhances the onset of tolerance to 
the morphine-induced analgesia in mice. 
Summarizing the earlier mentioned considerations concerning the in-
volvement of the ß-like noradrenergic receptors within the NRL in some 
manifestations of morphine, it appears that: a) an acute morphine in-
jection triggers a decreased noradrenergic activity within the NRL; 
b) chronic morphine injections result in the development of partial 
tolerance; c) development of partial tolerance to morphine is accom-
panied by an increased noradrenergic activity within the NRL; and d) 
a hyperactive noradrenergic activity within the NRL following a short-
term blockade of this activity accelerates the development of partial 
tolerance to morphine. 
On this basis, it can be postulated that the hyperactive, nor-
adrenergic mechanism within the NRL - present in morphine-treated 
animals - significantly contributes to the development of partial 
tolerance to morphine. Considering the characteristic properties of 
this noradrenergic mechanism, it can also be postulated that the de-
velopment of partial tolerance to morphine is due to the ability of 
the S-like noradrenergic mechanism within the NRL to develop a hyper-
activity after a short-term suppression. Although it will be clear 
that this mechanism may be just one of the many factors contributing 
to the development of partial tolerance to morphine, it is highly im-
portant to realize that at least some aspects appear to be system-
dependent rather than drug-dependent. This implies: a) compounds which 
influence the noradrenergic activity within the NRL should influence 
the development of partial tolerance to morphine; as discussed above, 
the effectiveness of 1-propranolol in this respect points in this 
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direction, b) Manipulation with the system itself, i.e. the nor-
adrenergic, coeruleo-raphe system, should influence the development of 
partial tolerance to morphine. Two very recent studies provide indirect 
evidence in favour of this. Laschka et al. (1976), using the intracere-
bral injection technique to precipitate morphine withdrawal in rats by 
means of morphine antagonists, report that the strongest withdrawal 
symptoms are evoked by injections into areas located in the anterior 
parts of the floor of the 4th ventricle and caudal parts of the peri-
aqueductal grey matter, i.e. areas including the locus coeruleus and 
some raphe nuclei. Lewis et al. (1976), using the chemical lesion 
technique to modify the development of tolerance to morphine in rats, 
report that lesions in the mesencephalic noradrenergic bundle reduce 
various manifestations of chronic morphine administration. These data 
fit in with our above-mentioned hypothesis that morphine may suppress 
the neuronal activity in the locus coeruleus and, accordingly, decrease 
the pulse-flow in the arising noradrenergic fibres, resulting in a de-
creased release of noradrenaline within the NRL. c) Compounds which 
influence the development of partial tolerance to morphine should 
directly or indirectly influence the neurotransmitter systems within 
the NRL. The first piece of evidence in favour of this is provided by 
the present studies on the effectiveness of DG-LVP. As mentioned in 
the introduction, this neuropeptide is able to accelerate the develop-
ment of partial tolerance to morphine in mice and to restore the re-
tarded development of partial tolerance to morphine in rats with here-
ditary diabetes insipidus. As illustrated in Fig. 3.11, DG-LVP locally 
administered into the NRL produces a potentiation of the stereotyped 
and ritualized patterns elicited by morphine given 50 min prior to 
DG-LVP, whereas it retards the onset of such patterns elicited by a 
second morphine injection given on the next day. On the basis of these 
data, it can be concluded that DG-LVP not only mimics the effectiveness 
of 1-propranolol, but also accelerates the development of partial toler-
ance to the morphine-induced effects (cf. Fig. 3.11, right side: C, with 
Fig. 3.4, day 3-5). It remains to be determined whether DG-LVP produces 
its effects in a way similar to that of 1-propranolol, i.e. producing a 
short-term blockade of the ß-like noradrenergic mechanism, which is fol-
lowed by a long-term hyperactivity of this mechanism. 
Summarizing, the present study has provided evidence in favour of the con-
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cept that characteristic changes within the NRL - in particular, changes 
in the noradrenergic fibre system terminating within this structure -
are essential prerequisites for the development of partial tolerance to 
morphine-induced behaviour in cats: a) compounds such as 1-propranolol 
and DG-LVP, which are known to influence the development of tolerance, 
are highly effective in this respect after intracerebral administration 
of these agents into the NRL; and b) selective manipulation of the g-like 
noradrenergic receptors within the NRL does influence the development of 
tolerance to morphine. 
Furthermore, we have summarized indirect evidence in favour of the 
following concepts: 1) morphine, inter аЪга, suppresses the neuronal 
activity within the locus coeruleus, and accordingly, decreases the 
pulse-flow in the arising noradrenergic fibres resulting in a decreased 
release of noradrenaline within structures such as the NRL; and 2) the 
development of partial tolerance to morphine is at least partially due 
to the characteristic feature of the noradrenergic coeruleo-raphe system 
to develop a hyperactivity after an initially produced hypoactivity. 
MORPHINE AND ITS BIPHASIC INFLUENCE UPON PHARMACOLOGICALLY DISTINCT 
DOPAMINERGIC SYSTEMS WITHIN THE FELINE CAUDATE NUCLEUS: A BEHAVIOURAL 
STUDY 
Summary 
Behavioural changes subsequent to alterations in DA activity in the 
caudate nucleus were studied in freely moving cats pretreated with a 
systemic injection of morphine (5 mg/kg, i.p.)· Intracerebral, bilateral 
injections of dopamine (DA) and haloperidol into the rostromedial part 
of the caudate nucleus, respectively increased and decreased DA activity 
within this area; similar injections of (3,4-dihydroxyphenylamino)-2-
imidazoline (DPI) and ergometrine into the anterodorsal part of this 
nucleus respectively increased and decreased DA activity within this 
region. The ability of intracerebrally injected drugs to influence the 
morphine-induced successively appearing "depression", "re-organization" 
and "ritualization" was a central aspect of this study. Administration 
of DA into the rostromedial part a) during re-organization, intensified 
the symptoms characteristic of the re-organization and prolonged the 
duration of their display, b) before the re-organization, accelerated 
the onset of this re-organization and c) when made during ritualization 
suppressed this ritualization. Administration of haloperidol into this 
area a) during re-organization, suppressed the progressive development 
of the re-organization and b) when made during the ritualization, po-
tentiated the ritualization. Administration of DPI into the anterodorsal 
part a) during re-organization immediately triggered the ritualization 
and b) when made during ritualization potentiated this ritualization. 
Finally, administration of ergometrine into the anterodorsal area 
a) during re-organization, immediately triggered a short-lasting period 
marked by symptoms characteristic of ritualization and prolonged the 
duration of the subsequent re-organization and b) during ritualization, 
intensified the ritualization for a short time, then suppressed the 
characteristic symptoms during a variable number of short-term periods. 
It is concluded that a) administration of DA into the rostromedial part 
and of ergometrine into the anterodorsal part mainly potentiated the 
"relatively early" morphine effects and inhibited the "late" morphine 
effects, and b) administration of haloperidol into the rostromedial 
part and of DPI into the anterodorsal part inhibited the "relatively 
early" morphine effects and potentiated the "late" morphine effects. 
The hypothesis is put forward that an acute injection of morphine 
(5 mg/kg, i.p.) affects different DA systems in a differential way: 
it is suggested that morphine inter alia produces a time-dependent, 
biphasic shift in the normally occurring "balance" between the DA 
activity within the rostromedial part of the caudate nucleus (DAe 
activity) and the DA activity within the anterodorsal part of the 
caudate nucleus (DAi activity) from an initial predominant DAe activ-
ity during the "relatively early" morphine effects towards a predominant 
DAi activity during the "late" morphine effects. The mechanisms under-
lying the behavioural effects elicited by modulation of DAi activity 
in morphine-treated cats are discussed. The present study is believed 
to offer data which might bridge the gap between the two diametrically 
opposite hypotheses concerning morphine's ability to affect central DA 
activity. 
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3.2.2 Introduction 
While the interaction between morphine and central dopaminergic 
activity is the main point of many studies on morphine, the issue 
remains extremely controversial (for a recent review: Scheel-Krüger, 
1976). According to some workers, morphine decreases postsynaptic 
dopamine (DA) activity (Kuschinsky and Hornykiewicz, 1972; Lai et 
al., 1975; Puri and Lal, 1973). Other workers favour the concept that 
this narcotic analgesic somehow increases postsynaptic DA activity 
(Cools et al., 197A; Iwamoto et al., 1976; Iwatsubo, 1976; Nakamura 
et al., 1973; Scheel-Krüger et al., 1977). A third group offers evid-
ence that, depending on the dose used, morphine can both decrease and 
increase postsynaptic activity (for a review: Scheel-Krüger, 1976). 
As recent studies have shown that the brain contains more than one DA 
system, each one marked by its own functional and pharmacological prop-
erties (mice: Costentin et al., 1975; Di Chiara et al., 1976; rats: 
Cools, 1977a; guinea pigs: Costali and Naylor, 1975; cats: Cools et 
al., 1975; Cools and Van Rossum, 1976; Cools et al., 1976), it became 
attractive to investigate whether the apparent discrepancies in the 
literature might be ascribed to a differential action of morphine upon 
different DA systems within the brain. In the present study, this prob-
lem was attacked by studying the role of functionally, topographically 
and pharmacologically distinct DA sensitive striatal structures in the 
morphine-induced behavioural syndrome in cats. 
Under certain conditions (Cools et al., 1974), morphine (5 mg/kg, 
given i.p. to cats) elicits a syndrome which is built up in three 
successive steps: a) depression phase, b) re-organization phase, and 
c) ritualization phase. The second phase, which starts about 15 min 
after the morphine injection, is characterized by the break-down of 
normal head, body and postural movements, into an increasing number 
of isolated, staccato movements, and the subsequent appearance of new 
head, body and postural movements in which the single units are re-
integrated; the resulting patterns become both stereotyped, i.e. 
continuously repeated in a specific sequence, and ritualized, i.e. 
restricted to a certain number of senseless patterns. The last phase, 
which starts about 30 min after the morphine injection, is character-
ized by purely stereotyped and ritualized head movements, postural 
changes and locomotor patterns. An extensive description of this 
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Syndrome is given elsewhere (Cools et al., 197A; Fig. 3.12). 
Haloperidol, an antagonist of DA receptors, locally administered in-
to the caput nuclei caudati rostromedialis (CRM area), modifies this syn-
drome in two opposite directions (Cools et al., 1974): a) when given at 
the onset of this phase, it suppresses the re-organization phase, and 
b) when given somewhat later, it potentiates the subsequent ritualiza-
tion phase. Furthermore, it was shown that increased DA activity within 
the CRM area is an essential prerequisite for the development of the 
re-organization phase (Cools et al., 1974). 
There is evidence that the caudate nucleus of cats contains two func-
tionally and topographically distinct DA sensitive structures: a) the so-
called excitation-mediating DA sensitive system (DAe system), which 
mainly terminates within the above-mentioned CRM area, and b) the so-
called inhibition-mediating DA sensitive system (DAi system), which 
mainly terminates within the caput nuclei caudati anterodorsalis (r-CRM 
area) (Fig. 3.13; Cools et al., 1975, 1976; Cools and Van Rossum, 1976). 
Although it is not yet known whether there really exist two distinct 
types of DA receptors or, simply, two distinct states of one type of 
DA receptor (Creese et al., 1975), it has been found that each DA 
sensitive area can be selectively activated and inhibited by its own 
type of agonist and antagonist: the DAe system is activated by apo-
morphine and inhibited by low doses of haloperidol, and the DAi system 
is selectively activated by (3,4-dihydroxyphenylamino)-2-imidazoline 
(DPI) and inhibited by ergometrine (Cools et al., 1976); a similar 
differentiation between different DA receptors and/or DA sensitive 
substrates appears to exist in the snail Helix aspersa (Struyker 
Boudier et al., 1974) and in the rat (Cools, 1977a). 
As a decrease in the DAe activity within the CRM area produces 
symptoms which are to a large extent identical to those elicited by 
an increase in DAi activity within the r-CRM area (Cools et al., 1976; 
Cools, 1977c), the following questions emerged: Does morphine parti-
cularly affect DAe activity or does it also influence DAi activity in 
some way? If this is the case, does morphine also produce a biphasic 
change in this activity? 
In our first study dealing with the role of the DA activity within 
the CRM area in morphine-treated cats (Cools et al., 1974), a purely 
descriptive method was used to analyze the effects produced. Later on, 
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it turned out that this syndrome could also be analyzed more quanti-
tatively. In studies on the role of the noradrenergic coeruleo-raphe 
system in acute and chronic morphine-treated cats (Cools et al., 1977a), 
this semi-quantitative approach proved to be an considerable improve-
ment. In view of this, the experiments dealing with DA activity within 
the CRM area were first repeated and analyzed by means of this new 
method before they were extended in so as to answer the questions 
mentioned above. 
The data to be presented suggest that an acute injection of morphine 
directly or indirectly leads to a biphasic shift in the normally occur-
ring "balance" between the DAe and DAi activity within the caudate 
nucleus during the development of the morphine syndrome. 
Materials and methods 
Both male and female cats ranging in weight from 2.5 to 3.2 kg were 
used; the cats were not derived from an inbred strain. In all experi-
ments, the animals, which were chronically equipped with cannulae (see 
below), were pretreated with morphine (5 mg/kg, i.p. given between 9.00 
and 12.00 a.m.); each animal was used only once. In general, the cats 
were kept under natural illumination conditions; the experimental cage 
was illuminated in addition by means of a bulb (60 W) hanging about 
100 cm above its floor. 
In the first series of experiments, the pretreated animals received 
intracerebral injections of 0.9% NaCl, DA or haloperidol into the left 
and right CRM area at various time intervals after the morphine injec-
tion. In this context, it is worthwhile to note that DA was chosen 
instead of apomorphine because apomorphine, being a DAe agonist, can 
also inhibit DAi activity (Cools, 1977c). 
In the second series of experiments, the pretreated animals received 
intracerebral injections of 0.9% NaCl, DPI or ergometrine into the left 
and right r-CRM area at various time intervals after the morphine injec-
tion. Neither tests in which DPI or ergometrine was administered into 
the CRM area nor tests in which haloperidol was injected into the r-CRM 
area were included since such injections turned out to be ineffective 
(Cools et al., 1976). 
The drug-induced behaviour was recorded on videotapes by means of a 
closed TV circuit. The tapes provided continuous records, which were 
analyzed with the help of the following parameters (Fig. 3.12): 
1) determination of the frequency/min of a) head movements, b) body 
movements, including the single movements of the limbs, and c) postural 
movements, in order to facilitate the detection of qualitative changes 
(see also below); 2) determination of the onset of the re-organization 
phase (= end of the depression phase) by averaging the time points at 
which the frequencies of a) head, b) body and c) postural movements 
started to increase and continued to do so for a 15 min period; 3) de­
termination of the number of distinct types of stereotyped and ritua­
lized locomotor patterns/5 min; 4) determination of the onset of the 
ritualization phase (= end of the re-organization phase) by averaging 
the time points at which the frequencies of a) head, b) body and c) 
postural movements became stabilized for a 15 min period, and the 
stereotyped and ritualized locomotor patterns appeared; in this con­
text, it should be mentioned that the above definition of the onset 
of the ritualization phase implies that the cats already displayed 
stereotyped and ritualized head, body and postural movements before 
that time, but did not yet show the stereotyped and ritualized loco­
motor patterns (see 3.2.1). 
Each observation period lasted 60 min, and started immediately after 
the morphine injection. In general, the cats were placed in the observa­
tion cage (75 χ 75 χ 80 cm) 15 min before the morphine injection. Pre­
cautions were taken to prevent changes in the external environment 
during the experimental session. All animals were habituated to the 
cage in two 1 hr sessions. The whole testing procedure including the 
transport of the animal to the experimental cage was kept as constant 
as possible. Since the sensitivity of cats to morphine changes during 
the year (maximum sensitivity; March and July; minimum sensitivity: 
December and May) (Mortiaux, Gieles, Megens, Janssen and Cools, un­
published data), the experiments presented below were performed during 
periods of intermediate sensitivity: January, April, June, September, 
October and November. 
The influence of intracerebrally injected drugs upon the morphine-
induced re-organization was determined as follows: a) immediate onset 
of re-organization following intracerebral administration of the drug 
during depression; b) retardation of the onset of ritualization follow­
ing the intracerebral administration of the drug during re-organization; 
91 
7 0 
60-1 
4 0 
2 0 
neon head movements/5 mini S.EM 
ν 
/ 'a 
/ tw 
10-
mean body movements/ 5 min î S E M 
-\ 1 1 1 Г 
10 
mean postural movements / - 5 min S.E.M 
^г^ - і 1 1 г-
10-
П distinct types of stereotyp ι es/5 m ι η 
• disappearance of ongoing stereotypies/5min 
и ¥-m-m 
schematic diagram 
t = (a«b«c) t'(w«x<y»2) 
І 1-
10 20 30 4 0 5 0 6 0 mm 
Π depression nre-orgamzation •r i tua l i zat ion 
3.12 Behavioural effects following a syste'nio injection of 
morphine (5 rng/kg} i.p.) in a male oat: illustration of 
the determinants of morphine-induoed behaviour. The number 
of head, body and postural movements which were counted per 
min are represented as mean values/5 min + S.E.M. The on­
set/termination of the various phases in terms of min 
following the morphine injection are represented as vertical 
axis inside the diagram outlining the different blocks de­
picted. For definition of the onset: see text. 
and с) immediate termination of re-organization following the intra­
cerebral administration of the drug during this phase. In this context, 
it should be noted that a) and b) could also be used as measures of the 
effectiveness of the drug-induced influence upon depression and ritua-
lization respectively, i.e. a) = termination of depression, and b) = 
retardation of the onset of ritualization. 
From the methodological point of view, it is useful to consider the 
following: as already mentioned, the morphine-induced syndrome is built 
up as three successively appearing phases. The characteristic features of 
each phase differ qualitatively from each other. Accordingly, the abil­
ity of an intracerebrally injected drug to accelerate the onset of a 
particular phase or to prolong its duration should simply be determined 
by analyzing the qualitative changes produced by that drug. As the re­
cognition of such changes, however, required extensive and long-term 
training of the observers and, even thus errors remained possible, only 
a double-blind study with at least two independent observers per experi­
ment could have offered reliable data. We therefore searched for quanti­
tative parameters to facilitate the detection of qualitative changes. 
Thus, the onset of re-organization which is marked by the sudden appear­
ance of isolated, staccato movements - which are recognizable by a well-
trained observer - was in practice determined with the help of the number 
of movements which immediately increased because of the appearance of the 
isolated, staccato movements. In other words, the above-mentioned quanti­
tative parameters were only used as tools to detect the occurrence of 
qualitative changes; no further use was made of the frequencies so ob­
tained since neither calculation of group means of the absolute values 
nor calculation of group means of the relative changes offered a useful 
index for the changes occurring during or just before re-organization. 
Finally, all 4rugs which accelerated the onset of re-organization both 
increased the intensity of the symptoms characteristic of this phase 
and prolonged the duration of the phase, when these drugs were given 
shortly after the onset of re-organization. Since changes in the in­
tensity were difficult to measure quantitatively, measurements of 
quantitative shifts in time were preferred to measurements of quali­
tative shifts in intensity for detecting the occurrence of drug-induced 
potentiation. 
The influence of intracerebrally injected drugs upon the morphine-
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induced ritualization was determined as follows: a) immediate onset of 
the display of the stereotyped and ritualized patterns following the 
intracerebral administration of the drug during re-organization; this 
effect could also be used as measure for the drug-induced influence 
upon re-organization, i.e. termination of re-organization; b) increase 
in the mean frequencies of head, body and postural movements for a 
period of at least 10 min and/or the display of new stereotyped and 
ritualized patterns following the intracerebral administration of the 
drug during ritualization; and c) partial or complete suppression of 
the ongoing stereotyped and ritualized patterns following the intra-
cerebral administration of the drug during ritualization (= termination 
of ritualization). Since low doses of drugs - which given in higher 
doses are able to produce effects a) and b) - may produce slight changes 
in the nature of the head, body and postural movements without changing 
the overall nature of the stereotyped and ritualized patterns, such 
changes in the "kinetic melody" of the ongoing stereotypies were accord-
ingly classified as potentiation, soore 1 in contrast to the overt symp-
toms mentioned above, which were classified as potentiation, score 2 
(Cools et al., 1977a). 
In order to allow intracerebral injections into conscious, freely 
moving cats, the animals were prepared as previously described (Cools and 
Van Rossum, 1970). Short, double-barreled, stainless steel cannulae were 
stereotaxically implanted in such a way that the injection needle could 
reach the caput nuclei caudati rostromedialis (CRM area; co-ordinates 
according to Snider and Niemer (1974): A = 14-16, H = 14-16, L = 4-6) or 
the caput nuclei caudati anterodorsalis (r-CRM area; co-ordinates accord-
ing to Snider and Niemer (1964): A = 18-19.5, H = 14-16, L = 3-5). 
Cannulae directed to the r-CRM area were placed at an angle of 10 in 
reference to the mid-sagittal plane in order to bypass the lateral ven-
tricle. Placing responses, righting and pupillary reflexes were checked 
upon recovery from the operation. In addition, food-intake, wakefulness 
and reactivity to visual and acoustic stimuli were estimated; only cats 
which responded normally during the second post-operation week were used 
in the experiments, which started at that time. 
Drug solutions (5 yl) were injected through injection needles which 
extended into the brain tissue about 2 mm below the tip of the embedded 
cannulae. The following substances were used: dopamine hydrochloride 
(Koch-Light), haloperidol (Serenase , Janssen Pharmaceutica), (3,4-di-
hydroxyphenylamino)-2-imidazoline hydrochloride (DPI, Wander), ergo-
94 
metrine maléate (Haiewood Chemicals) and morphine sulphate (Chemische 
Farmaceutische Fabrieken), The doses shown in section 3.2.4 were based 
on the outcome of earlier studies (Cools et al., 1976) and refer to the 
salts. Apart from morphine which was always dissolved in 0.9% NaCl, all 
compounds were dissolved in either 0.9% NaCl or double-distilled water. 
Injections of solvents only produced slight arousal during the first 
1-3 min following the injection regardless of the pretreatment. 
After completion of the experiments, the brain was removed and pre-
pared as previously described (Cools and Van Rossum, 1970); visual in-
spection of a series of brain slices (about 100 ym), caudally from a 
knife-cut along the track of the guide cannulae, was made to determine 
the sites of injections. Only experiments in which the injection sites 
were restricted to the target areas shown in Fig. 3.13 are discussed 
below. 
Fig. 3.13 Semi-diagrammatic outline of the funationally and pharmaoo-
logiaally distinat intraoaudate dopamine-sensitive areas. 
All injections into the so-called CRM area were restricted 
to the shaded areas (CRM), whereas all injections into the 
so-called r-CEM area were restricted to the open area (r-CRM). 
Aab = nucleus aaaumbens; CA = aommissura anterior; CC = corpus 
calloswn; Cd = nucleus aaudatus; Ci = capsula interna; 
Cl = alaustrwn; CRM = caput nuclei caudati, rostromedial part; 
Put = putamen; r-CRM = caput nuclei caudati, anterodorsal 
part; TbOf - tuberculum olfactorium; VL = ventriculus lateralis. 
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Fig. 3.14 Behavioural effect of bilateral injeations of dopamine (10 \xg/ 
b \il given at time = 10) into the CRM area upon the morphine-
indueed depression in a male aat (morphine: S mg/kg, i.p. 
given at time = 0): immediate onset of the re-organization in 
the "dopamine-morphine"-treated aat. The control diagram at 
the bottom of the figure shows the effects of saline injea­
tions into the СШ area of morphine-treated oats (n=7). The 
number of head, body and postural movemems counted per min 
are represented as mean values/S mir. + SEM. The onset/ter­
mination of the various phases in terms of min following the 
morphine injection (diagram of the "drug-morphine"-treated 
aat) or their mean values +_ SEM (control diagram of the 
"saline-morphine"-treated cats; η = number of cats tested) 
are indicated by the vertical axes outlining the blocks. The 
percentage of animals showing a particular phase is given 
along the ordinate. The time of the intracerebral injections 
is indicated by the wave-like line. 
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3.2.4 Results 
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DA (10 Mg/5 μΐ per side), administered locally into the CRM area at the 
time when the morphine-induced depression had fully developed, imme­
diately disrupted the ongoing depression, increased the frequencies of 
head, body and postural movements, and immediately triggered the dis­
play of the staccato movements. An example is given in Fig. 3.14; 
saline given at the same time remained ineffective in this respect. 
The results of all experiments (n = 9) are summarized in Fig. 3.16Λ, 
and show that the onset of re-organization was significantly acce­
lerated by DA given under the conditions mentioned (p < 0.05; Students 
t-test). If a similar dose of DA was given at the time when the mor­
phine-induced re-organization had fully developed (17-19 min following 
the morphine injection), it significantly retarded the onset of ritua-
lization and, accordingly, prolonged the duration of re-organization 
from 16+2 min in "saline-morphine"-treated cats (n = 8) to 24jKZ min 
in "dopamine-morphine"-treated cats (n = 7; ρ < 0.05; Students t-test). 
From the qualitative point of view, the intensity of the symptoms pres­
ent during re-organization was strongly increased in comparison with 
that of symptoms in morphine-treated cats which received a placebo 
(saline) injection. The results, however, could not be analyzed quan­
titatively because: a) differences in frequencies of the head, body.or 
postural movements did not simply reflect differences in intensities, 
b) no intra-individual comparison between placebo and drug injections 
could be made, and c) the inter-individual variability greatly varied. 
Haloperidol (12.5 ug/S yl per side), administered locally into the 
CRM area at the time when the morphine-induced re-organization had al­
ready developed, decreased the frequencies of the head, body and pos­
tural movements and suppressed the display of the staccato movements; 
those head movements which were already integrated in stereotyped and 
ritualized patterns remained unaffected (n = 9). An example is given 
in Fig. 3.15. If a similar dose of haloperidol was administered when 
the morphine-induced depression was still present, it completely sup­
pressed the development of re-organization and ritualization. The re­
sults of the last-mentioned series of experiments (n = 11) are summa­
rized in Fig. 3.16B. 
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^ig. 3.15 Behavioural effect of bilateral -injections of haloperidol 
(12.6 yj/S \il given at time = 20) into the СШ area upon 
the morphine-induaed re-organization in a male oat (morphine: 
6 mg/kg, i.p. given at time = 0): inhibition of re-organiza­
tion and ritualization in the "haloperidol-morphine"-treated 
cat. The control diagram at the bottom of the figure shows 
the effects of saline injections into the CRM area of mor­
phine-treated cats (n=8). For further explanations: see 
Fig. 3.14. 
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given at time = \ ) , dopamine (10 vg/S ці given at time = \ ) 
and haloperidol (12. S \ig/S μΖ given at time = t ) into the 
CRM area upon the morphine-induaed re-organization and 
ritualization (morphine: S mg/kg, i.p. given at time = 0): 
A = immediate onset of re-organization; В = immediate ter­
mination of re-organization, and inhibition of ritualization; 
С = immediate termination of ritualization followed by a 
short-term period marked by features of re-organization, and 
final return of ritualization; Ό = potentiation of ritualiza­
tion. In the control diagram, morphine-treated oats having 
received intracerebral placebo injections at t = 10-12 min 
(n=7) and those having received placebo injections at t = 
34-36 min (n=?ì are taken together. For further explanations: 
see Fig. ¿.14. 
* onset of re-organization is significantly different from 
that in controls (p < 0.05; Students t-test). 
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DA (10 Mg/5 μΐ per side), administered locally into the CRM area at the 
time when the morphine-induced ritualization had fully developed, imme­
diately suppressed the display of the ongoing stereotyped and ritualized 
patterns for a period of about 7 min; the ritualization then returned 
after a short period marked by features characteristic of re-organiza­
tion. Saline injections given at the same time remained ineffective in 
this respect. The results of these experiments (n = 8) are summarized 
in Fig. 3.16C. 
Haloperidol (12.5 iJg/5 ul per side), administered locally into the 
CRM area at the time when the morphine-induced ritualization was fully 
developed, immediately increased the mean frequencies of the head, body 
or postural movements during the next 10 min and, in addition, produced 
new types of stereotypies (Table 3.1). The results of these experiments 
(n = 10) are summarized in Fig. 3.16D. 
TABLE 3.1 
Effects of bilateral injections of haloperidol (12.5 vg/5 vl per 
side) applied locally into the CRM area at about 34-36 min after 
an i.p. injection of morphine '5 mg/kg) in cats (n = 10), 
head movements 
body movements 
postural movements 
Τ, cats showing 
stereotypies 
new 
Controls 
(n=7) 
Xpost"Xpre 
-1 + 21 
5+11 
6 + h 
0 
Haloperidol 
(n=10) 
X -X 
post pre 
170+35 
140 + 20 
7 7 + 6 
100 
Mann-Whitney 
U-test 
ρ < 0.002 
ρ < 0.002 
ρ < 0.002 
The difference between the total number of each type of movements dis­
played during the 10 min period following the intracerebral injection 
(post) and that displayed during vhe 10 min period preceding the intra­
cerebral injection (pre) is calculated for each animal. 
^еап differences +_ S.C.M. are given. 
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DPI (10 ijg/5 μΐ per side), administered locally into the r-CRM area at 
the time when the morphine-induced re-organization had fully developed 
immediately introduced a shift from this phase towards the ritualization 
phase; saline injections remained ineffective in this respect. An example 
is given in Fig. 3.17. All cats (n = 7) immediately showed stereotyped 
and ritualized head, body and postural movements whose nature depended 
on the nature of the behavioural patterns displayed during the first 
1-5 min following the injection. The following observation illustrates 
this point: cat no. 7745 defecated at a particular spot in the cage 
during the first post-injection minutes. The animal returned many times 
to that spot during the next 45 min, then displayed all the movements 
characteristic of defecation. If a similar dose of DPI was administered 
when the morphine-induced depression was still present (n = 3), the 
animals maintained their lying posture and repeated those head movements 
which had been displayed during the first post-injection minutes; most 
often, lowering of the nose towards the floor was seen. In other words, 
DPI immediately ritualized the ongoing behaviour. About 15-20 min after 
DPI injection, i.e. when the morphine-induced ritualization normally 
started in morphine-treated cats with either no intracerebral injection 
at all or a placebo (saline) injection, the number of distinct types of 
stereotypies increased. An example is given in Fig. 3.18. In 80Я of the 
animals tested, an additional change in the form of increased intensity 
occurred at about 25-30 min after the DPI injection (not shown). The 
results of these experiments (n = 10) are summarized in Fig. 3.20C, and 
show that DPI given under the conditions described immediately triggered 
the display of the ritualization. 
Ergometrine (10 ug/5 ul per side), administered locally into the r-CRM 
area at the time when the morphine-induced re-organization was fully de­
veloped, initially introduced a shift from this phase towards a rituali-
zation-like phase, i.e. the isolated, staccato head movements and single 
movements of the head, neck, trunk and limbs were integrated into com­
plete patterns which were repeated from time to time during a period of 
3-7 min. These patterns subsequently disappeared and symptoms character­
istic of re-organization appeared. Finally, the ritualization phase 
started; the onset of the last phase was significantly retarded (p < 0.05; 
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Fig. 3.17 Behavioural effect of bilateral injeations of (3,4-dihydpoxy-
phenylanino)-'¿-imidazoline (DPI, 10 vg/5 \il given at time = 
15) into the r-CRM area upon the morphine-induaed re-organiza-
tion in a male oat (morphine: 5 mg/kg, i.p. given at time = 0): 
immediate onset of the ritualisation in the "DPI-morphine"-
treated aat. The control diagram at the bottom of the figure 
shows the effects of saline injections into the r-CRM area of 
morphine-treated cats (n=8). For further explanations: see 
Fig'. 3.14. 
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Fig. 3.18 Behavioupal effect of bilateval injeations of ГЗ,^ -dife/dmcz/-
phenylamino)-2~imidazoline (DPI, 10 uff/S vl given at time -
IS) into the v-CRU area upon the movphine-induaed depression 
in a male oat (morphine: 5 mg/kg, i.p. given at time = 0): 
irmediate onset of the ritualization of the ongoing behaviour 
and additional potentiation at time = 3S in the "DPI-morphine" 
treated oat. The control diagram at the bottom of the figure 
shows the effects of saline injections into the r-CRM area 
of morphine-treated eats (n=7). For further explanations: 
see Fig. 3.14. 
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ig. 3.19 Behavioural effeot of bilateral -injeetions of ergometrïne 
(10 MJ/S vl given at time = 25) into the r-CRM area upon 
the morphine-induoed behaviour in a male oat (morphine: 
S mg/kg, i.p. given at time = 0): immediate onset of a 
short-term ritualisation3 prolongation of the subsequently 
appearing re-organization and retardation of the onset of 
the subsequent ritualization in the "ergometrine-morphine"-
treated cat. The control diagram at the bottom of the figure 
shows the effects of saline injections into the r-CRM area 
of morphine-treated cats (n=8). For further explanations: 
see Fig. 3.14. 
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Students t-test). An example is given in Fig. 3.19. From the qualitative 
point of view, the intensity of the symptoms present during re-organiza­
tion and ritualization was strongly increased in comparison with that of 
symptoms in morphine-treated cats with either no intracerebral injection 
at all or a placebo (saline) injection. As already mentioned, the results 
could not be analyzed statistically. The results of this series of ex­
periments (n = 10) are summarized in Fig. 3.20D and show that under the 
conditions described initially triggered symptoms characteristic of ri­
tualization, intensified the successive re-organization and ritualization 
(not shown) and significantly retarded the onset of ritualization. 
DPI (10 yg/5 μΐ per side), administered locally into the r-CRM area at 
the time when the morphine-induced ritualization had fully developed, 
produced an increase in the mean frequencies of the head, body or pos­
tural movements (86% of the tested animals) and in the number of distinct 
types of stereotyped and ritualized patterns (100% of the tested animals); 
saline injections remained ineffective in this respect (Table 3.2). The 
results of these experiments (n = 7) are summarized in Fig. 3.20A, and 
show that DPI potentiated the morphine-induced ritualization. 
Ergometrine (10 ug/5 μΐ per side), administered locally into the 
r-CRM area at the time when the morphine-induced ritualization was ful­
ly developed, produced a complex picture. In 80% of the animals (n = 10), 
there was an increase in the mean frequencies of the stereotyped and 
ritualized head, body or postural movements within the first 1-7 min 
(mean duration: 5 + 1 . 8 min) following the injection; in 62.5% of these 
animals, the increase was accompanied by changes in the "kinetic melody" 
of the ongoing stereotypies. In the remaining 20% of the animals, there 
was no increase in frequency but there were slight changes in the nature 
of the ongoing stereotypies, i.e. changes in the "kinetic melody". Fol­
lowing this initial period, in which the morphine-induced ritualization 
was apparently potentiated, all animals showed a variable number (3-5) 
of short-lasting periods (1-2 min), in which the stereotyped and ritua­
lized patterns completely disappeared and were replaced by normal be­
havioural patterns; as the animals remained very active during these 
periods, only changes in the number of distinct types of stereotypies 
and not changes in the frequencies of the head, body and postural move-
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TABLE 3.2 
Effects of bilateral· injections of DPI (10 vg/S \¡l per side) 
applied locally into the v-CR'A area at about 40-42 nin after 
an i.p. injection of norphine (5 ng/kg) in cats (n - 7). 
head movements 
body movements 
postural movements 
% cats showing 
stereotypies 
new 
Controls 
(n=6) 
X -X post pre 
-1 + 21 
5+11 
6 + 4 
о 
DPI 
(n=7) 
X -X post pre 
50 + 60 
99 + 59 
2 4 + 1 8 
100 
Mann-Whitney 
U-test 
1 
n.s. 
1 
n.s. 
1 
n.s. 
The difference between the total number of each type of movements 
displayed during the 10 min period folioving the intracerebral 
injection (post) and that disvlayed during the 10 min period 
preceding zhe intracerebral injection (pre) is calculated for 
each animal. Чеап differences + З.Е.Ч. are given. 
1 = as mentioned in the text, 86% of the "DPI-morphine "-treated 
cats did show increased frequencies, ù'ote that all "DPI"-
treated cats showed new stereotypies during the 10 min period 
following the DPI injection. 
ments could be used as objective variables. These periods were, in turn, 
followed by short-lasting time blocks (about 1 min), in which the cha-
racteristic features of re-organization appeared. In two animals, normal 
behaviour and re-organization succeeded each other during a period of 
7-9 min; ritualization then returned and remained unaffected. In most 
animals (n = 8), however, the short-lasting periods marked by normal 
behaviour did not return until re-organization had been followed by a 
short-term period of ritualization; in these animals, the sequence was 
repeated 3-6 times. The mean time during which ritualization was com-
pletely absent was 1 1 +_ 2 min. The results of this group of experiments 
(n = 10) are partly summarized in Fig. 20B, and show that ergometrine 
initially potentiated the ongoing ritualization and, subsequently, in-
hibited this phase. 
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Fig. 3.20 Behavioural effects of bilateral injections of saline (5 vl 
given at time = \ ) , (S34-dihydroxyphenylamino)-2-imidazoline (DPI, 10 д/Ь v-l given at time =\ Ì and ergometrine (10 \ig/ 
5 \il given at time = t ) into the r-CRM area upon the morphine-
indueed re-organization and ritualization (morphine: 5 mg/kg, 
i.p. given at time = 0): A - potentiation of the ritualiza-
tion; В = short-term potentiation of the ritualization fol­
lowed by inhibition of the ritualization; С = immediate ri­
tualization of ongoing behaviour; D = short-term ritualiza­
tion of ongoing behaviour, prolongation of the subsequent 
re-organization and retardation of the subsequent ritualiza­
tion. In the control diagram, morphine-treated oats having 
received intracerebral placebo injections at t - 17-19 min 
(п=в) and those having received placebo injections at t = 
40-42 min (n=6) are lumped together. For further explanations: 
see Fig. 3.14. 
* onset of ritualization is significantly different from 
that in controls (p < 0.05; Students t-test). 
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DA, locally administered into the caput nuclei caudati rostromedialis 
(CRM area) at different time intervals after an acute injection of i.p. 
given morphine, was found to: la) accelerate the onset of re-organiza-
tion if given during the depression; lb) prolong the duration of re-
organization, retard the onset of ritualization and increase the in-
tensity of the symptoms present during re-organization if given during 
re-organization; and 2) suppress the display of the stereotyped and 
ritualized patterns if given during ritualization. The results summar-
ized in la-b suggest that re-organization, i.e. all effects appearing 
immediately after the depression and lumped together as "relatively 
early" morphine effects, required at least a relatively increased DA 
activity within the CRM area. In contrast, the results summarized in 
2 suggest that ritualization, i.e. all effects appearing immediately 
after re-organization and lumped together as "late" morphine effects, 
required instead a relatively decreased DA activity within the CRM 
area. Haloperidol given under experimental conditions comparable to 
those used for DA also elicited two distinct types of effects: 1) if 
given during re-organization, haloperidol suppressed the progressive 
development of re-organization, and 2) if given during ritualization, 
haloperidol increased the number of distinct types of stereotypies. 
Thus, haloperidol produced effects diametrically opposite to those 
elicited by DA: a) inhibition of the "relatively early" morphine ef-
fects, and b) potentiation of the "late" morphine effects. These find-
ings confirm the outcome of an earlier study (Cools et al., 1974). As 
haloperidol in the dose used inhibited DAe activity within the CRM area 
in a selective way, most likely via postsynaptic DA receptor blockade 
(Cools et al., 1976), it can be concluded that the effects observed 
were due to specific changes in DAe activity within the CRM area. 
ЗЕУёІіВаУЕЁ^ changes in_the_DAi_activit2_within_the_r-CRM 5rea_of 
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DPI, a selective stimulant of DAi activity within the caput nuclei 
caudati anterodorsalis (r-CRM area) and administered into the r-CRM 
area at different time intervals after the morphine injection, was 
found to produce: 1) if given during re-organization, immediate re-
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placement of the symptoms characteristic of re-organization by symptoms 
characteristic of ritualization, and 2) if given during ritualization, 
an increase in the number of distinct types of stereotypies. Thus, DPI 
also produced two distinct types of changes: a) suppression of the "re-
latively early" morphine effects, and b) potentiation of the "late" 
morphine effects. Ergometrine given under experimental conditions com-
parable to those used for DPI elicited the following effects at about 
7 min after its administration: 1) if given during re-organization, an 
increased intensity of the symptoms displayed during re-organization in 
all cats and retardation of the onset of ritualization, and 2) if given 
during ritualization, suppression of the symptoms characteristic of ri-
tualization. In other words, about 7 min after its injection ergometrine 
produced effects opposite to those elicited by DPI: a) potentiation of 
the "relatively early" morphine effects, and b) inhibition of the "late" 
morphine effects. Considering the specificity of the drugs in the doses 
used (Cools et al., 1976), it can be concluded that the effects observed 
were due to specific changes in DAi activity within the r-CRM area. 
Ergometrine given at the onset of re-organization initially produced 
effects comparable to those triggered by injections of DPI (cf. Fig. 
3.20D and C); the same holds true for the effects elicited by ergometrine 
given during ritualization (cf. Fig. 3.20B and A). Apart from its ability 
to produce a long-lasting decrease of DAi activity in rats (Cools et al., 
1977b), ergometrine has recently been found to elicit a short-lasting' 
increase in DAi activity before the decrease in DAi activity (Cools, 
1977b). Although such a biphasic effect of ergometrine administered in-
to the r-CRM area of naive cats was not detected, the ergometrine-induced 
inhibition of DAi activity only became visible after a period of 10-15 
min (Cools et al., 1975). Considering the data from the present study 
in thelight of the earlier results with rats and cats, it is tempting 
to postulate that the effects induced by ergometrine immediately after 
its administration were also due to a short-term increase of DAi activ-
ity; additional experiments are however required to support this postulate. 
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There may exist a DAe-DAi "balance" within the brain of rats and cats 
(Cools and Van Rossum, 1976; Cools, 1977a-c). The present data support 
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Fig. 3.21 Schenatia representation of the data aolleated in the present 
study. Hatched area: drug-induaed increased activity. Blaak 
area: drug-induced decreased activity. 
this concept (Fig. 3.21): 1) both DA administered into the CRM area 
and increasing DAe activity and ergometrine administered into the r-CRM 
area and decreasing DAi activity could potentiate the "relatively early" 
morphine effects and suppress the "late" morphine effects; 2) both halo-
peridol administered into the CRM area and decreasing DAe activity and 
DPI administered into the r-CRM area and increasing DAi activity could 
suppress the "relatively early" morphine effects and potentiated the 
"late" morphine effects. From this point of view, it appears difficult 
to exclude the possibility that "relatively early" morphine effects 
requiring predominantly DAe activity (Fig. 3.21) were due to a) a mor-
phine-induced increase in DAe activity, b) a morphine-induced decrease 
in DAi activity, or c) a combination of a) and b). The same holds true 
for the "late" morphine effects which required predominantly DAi activ-
ity (Fig. 3.21). Detailed inspection of the data, however, reveals that 
the development of the whole morphine syndrome could only be prevented 
by suppression of DAe activity with haloperidol (Fig. 3.16B); in con-
trast, stimulation of DAi activity with DPI given under the same con-
ditions did not inhibit, but actually accelerated the development of 
the morphine syndrome (cf. Figs. 3.16B and 3.20C). In other words, 
restoration of the disrupted DAe-DAi "balance" during the "relatively 
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early" morphine effects could only be achieved by inhibition of DAe 
activity. Accordingly, it can be concluded that only an increased DAe 
activity within the CRM area might underly the "relatively early" 
morphine effects. 
With respect to morphine's ability to influence DAe and/or DAi 
activity during the "late" morphine effects, the situation is some-
what more complicated. As summarized in Fig. 3.21, DAi activity pre-
dominates during ritualization, i.e. the period marked by the presence 
of the "late" morphine effects. As suppression of DAi activity by means 
of ergometrine administration into the r-CRM area during ritualization 
did not result in a continuous display of normal behaviour but in 
periods marked by symptoms characteristic of re-organization, it can 
be concluded that DAe activity was still increased at that time. Ac-
cordingly, the "late" morphine effects were certainly not due to the 
presence of decreased DAe activity. All the data taken together suggest 
that the "late" morphine effects required strongly increased DAi activ-
ity within the r-CRM area, i.e. that they overcame the increased DAe 
activity within the CRM area. 
Summarizing, it appears that morphine initially increased DAe activ-
ity within the CRM area and, subsequently, also increased DAi activity 
within the r-CRM area in such a way that the increased DAi activity 
could overcome the increased DAe activity. This hypothesis is con-
sistent with the outcome of a recent study on morphine in rats (Moleman, 
1977). The biochemical data collected in this elegant study also suggest 
that morphine affects the DA activity differently in different brain 
regions. 
Finally it is of interest that a) suppression of DAe activity pre-
vented the occurrence of phenomena triggered by changes in DAi activity, 
and b) changes in DAe activity immediately affected the symptoms eli-
cited by changes in the DAi system; there is, indeed, some indirect 
evidence that these systems might be connected via GABA-ergic neurons 
(Cools, 1977c). 
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Two opposing hypotheses emerge from the literature on morphine's ability 
to modify DA activity (see 3.2.1): 1) morphine may somehow decrease post-
synaptic DA activity; and 2) morphine may somehow increase postsynaptic 
DA activity. 
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In particular the observation that there was some resemblance be-
tween the behavioural effects, often labelled as catalepsia or cata-
tonia, elicited by high doses of morphine in rats and those produced 
by antagonists of DA receptors had led to the idea that morphine might 
inhibit DA activity. Additional data which are more or less in line with 
this concept have recently been summarized (Lai et al., 1975). In con-
trast, there is an increasing number of studies which indicate that 
morphine increases rather than decreases DA activity within the brain 
of mice, rats and cats. In mice, both blockade of postsynaptic DA re-
ceptors and the postulated stimulation of presynaptic DA receptors by 
extremely low doses of apomorphine - which is assumed to decrease DA 
release - can suppress the "running fit" (Scheel-Krüger et al., 1977). 
In rats also both blockade of postsynaptic DA receptors and the postu-
lated stimulation of presynaptic DA receptors suppress both the behav-
ioural activation characteristic of low doses of morphine and the so-
called "late" behavioural activation following higher doses of morphine 
(Scheel-Krüger, 1976; Scheel-Krüger et al., 1977). In rats, morphine 
also increased the firing rate of DA cells within the substantia nigra 
(Iwatsubo, 1976; Lichtensteiger and Lienhart, 1975), the striatal DA 
turnover rate, the striatal DA-dependent adenylate cyclase activity, 
and the striatal DA-specific cyclic AMP concentration (Bonnett, 1975; 
Clouet et al., 1975; Costa et al., 1973; Iwatsubo and Clouet, 1975; 
Puri et al., 1975, 1976) and potentiates the stereotyped behaviour in-
duced by intermediate doses of apomorphine (McKenzie and Sadof, 1974; 
Scheel-Krüger, 1976; Scheel-Krüger et al., 1977; Vedernikow, 1970). 
In cats, blockade of DA receptors attenuates the morphine-induced be-
haviour (Cools et al., 1974; Dhasmana et al., 1972). These and related 
data suggest that morphine somehow increases DA activity (see also: 
Iwamoto et al., 1976; Nakamura et al., 1973). 
The present data are consistent with this hypothesis. Are they thus 
in conflict with the concept that morphine somehow inhibits DA activity? 
It is questionable whether or not morphine produces true catalepsy 
(Janssen, 1964; Papeschi et al., 1976) and whether, accordingly, mor-
phine-induced effects such as the increased DA turnover rate are due 
to a direct or indirect postsynaptic DA receptor blockade. The fact 
that the ability of morphine to suppress certain behavioural symptoms 
is a characteristic feature of dopaminergic inhibitors (Lai et al., 
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1975) points to a more complex situation. The present study, however, 
offers data which might bridge the gap between the apparent discrepancies: 
haloperidol did not only suppress the effects at least partly due to in-
creased DA activity within the rostromedial part (the so-called increased 
DA.e activity present during the re-organization) by inhibiting the DAe 
receptors, but it also potentiated those effects which were at least 
partly due to an increased DA activity within the anterodorsal part 
(the so-called increased DAi activity present during the ritualization) 
by increasing the difference between DAe and DAi activity. The present 
data suggest the following explanation for the results which led to the 
hypothesis that morphine may somehow inhibit DA activity: the so-called 
"late" morphine effects produced by a predominance of the DAi activity 
are 1) potentiated by antagonists of DAe activity, i.e. classic neuro-
leptics, because of the ability of neuroleptics to increase the DAe-DAi 
imbalance marked by a predominant DAi activity, and 2) inhibited by 
agonists of DAe activity, i.e. compounds such as apomorphine, because 
of their ability to correct this DAe-DAi imbalance. This, and the fact 
that the so-called "relatively early" effects of predominant DAe activ-
ity are inhibited by classic neuroleptics and potentiated by compounds 
such as apomorphine, indicates that the outcome of studies on the abil-
ity of DA agonists and antagonists to influence the morphine symptoms 
depends on the cluster of morphine-induced symptoms selected. As dif-
ferent clusters e.g. those described in the present study, follow one 
another it is clear that the time schedule used plays a crucial role 
in studies on morphine-DA interaction. The fact that morphine given to 
guinea pigs hardly affects the L-DOPA-induced dyskinesias, but sup-
presses the apomorphine-induced biting (Costali and Naylor, 1976) also 
points in this direction. 
Apart from the fact that the present study may help to solve some of 
the discrepancies in the literature, it stresses that selective DAe and 
DAi agonists or antagonists, might be considered as essential tools for 
the determination of the actual influence of morphine upon central DA ac-
tivity. It is noteworthy that in studies on the behavioural effectiveness 
of morphine applied locally to the caudate nucleus of cats, doses varying 
from 1 to 10 yg morphine sulphate dissolved in saline remained completely 
ineffective, under the conditions used in the present study (unpublished 
data). In contrast, intracerebral administration of morphine into the 
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substantia nigra was effective, although the symptoms were not identical 
to those elicited by an i.p. injection of morphine (Broekkamp, 1975). The 
ability of morphine to trigger an increase in DA activity within the cau-
date nucleus might thus be due to direct or indirect interference with 
the DA cell bodies rather than to a direct interference with structures 
within the DA synapses. This suggestion is supported by several studies 
in which the rat was used as experimental animal (Broekkamp, 1976; Broek-
kamp et al., 1976; Carenzi et al., 1975; Lienhart et al., 1975; Wiegant 
et al., 1977). It is important to note that this statement does not ex-
clude the possibility that morphine may affect non-dopaminergic sub-
strates within the caudate nucleus; actually, both the presence of 
morphine receptors within the neostriatum (Pert and Snyder, 1973; Pert 
et al., 1976) and the ability of striatally applied morphine (1-10 yg) 
to modify the flinch and jump thresholds in rats (Jacquet and Lajtha, 
1973) point in this direction. 
Finally, the dissimilarity between the behavioural effects elicited 
by intranigral injections of morphine and those triggered by morphine 
applied systemically in cats emphasizes the nearly "classic" view that 
morphine needs to affect many different systems within the brain in 
order to produce its complex effects. The present study only points 
out that particular changes in central dopaminergic systems do play 
a role in eliciting the morphine-induced behavioural symptoms. Whether 
or not these changes in the DA systems are triggered by interaction of 
morphine with endorphin, enkephalin or other receptors remains an open 
question. 
Functional asgects_of_the DAi_s2Stem 
In previous discussions of the role of the DA system (Cools, 1973, 1975; 
Cools and Van den Bereken, 1977) it has been suggested that increased 
DAe activity results in a) a break-down of previously established chains 
of motor responses enabling the organism to establish completely new 
behavioural patterns (Cools, 1973), and b) a break-down of previously 
established links between different concepts and conceptual frames en-
abling the organism to establish completely new concepts and conceptual 
frames (Cools, 1975). The mechanism underlying these phenomena has been 
described elsewhere (Cools and Van den Bereken, 1977). Although the 
present data are not sufficient to delineate the role of the DAi system 
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in this respect, they do show that stimulation of the DAi system pre-
vents the display of completely new patterns and triggers a process 
resulting in the more or less permanent display of the behaviour present 
at the onset of the drug action. Considering the functional changes in-
duced by modulation of the DAi system in morphine-treated cats, the 
characteristic features of the DAe-DAi "balance" and the function of 
the DAe system, it is tempting to postulate that the DAi system may 
actually inhibit the process activated by the DAe system, i.e. it may 
prevent the break-down of the previously established chains of motor 
responses and, as a result, hinder the organism in the introduction 
of new patterns. In this respect the DAi system appears to differ from 
the serotonergic, raphe-striatal system whose functioning is indirectly 
activated by the DAe system, since the 5-HT system appears to hinder 
the organism in the introduction of new patterns through its ability 
to condition ongoing behaviour (Cools et al., 1974). This postulate 
requires further investigation. 
3.3 GENERAL COMMENTS 
The studies presented in this chapter deal with morphine's action 
on pharmacologically defined neurotransmission processes within ana-
tomically circumscribed regions of the brain, i.e. 1) noradrenergic 
processes within the nucleus linearis intermedius raphe (section 3.1), 
and 2) dopaminergic processes within the caudate nucleus (section 3.2). 
The results show that morphine's effect on behaviour is related to the 
activity of these neuronal systems. Accordingly, they may form crucial 
links between specific target sites of morphine in the brain and the 
behavioural consequences of morphine's central action. 
The results also demonstrate that administration of morphine suppresses 
the activity of the noradrenergic processes in the raphe nuclei and in-
creases the activity of the dopaminergic processes in the caudate 
nucleus. In other words, modulation of morphine-induced behaviour by 
intracerebrally injected drugs has proven to be a valuable method for 
the study of morphine's action on specific neurotransmission processes 
in the brain. 
Much controversy exists in literature about the development of 
tolerance to morphine's behaviour effects in cats (section 1.3.2: 
chronic effects) . In the present study, a semi-quantitative approach 
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is used for the analysis of the morphine-induced behaviour effects. 
This approach enabled us to demonstrate partial tolerance to morphine's 
behaviour effects after administration of morphine (5 mg/kg/day) for a 
short period of only 3 days (section 3.1). This result may attest to 
the sensitivity of the analysis-method used since in other studies 
dealing with this subject higher doses of morphine and/or longer 
periods of treatment were required to reveal the development of 
tolerance to the behaviour effects of morphine (section 1.3.2: chronic 
effects). 
Considering the involvement of the noradrenergic, coeruleo-raphe 
system in the development of tolerance to morphine's behaviour effects 
(section 3.1), a few additional remarks have to be made. The depressant 
action of morphine and related opioid peptides on neuronal cells within 
the locus coeruleus seems established (North, 1979; Strahlendorf et al., 
1980), and the development of tolerance to this action of morphine has 
been demonstrated (Aghajanian, 1978). Furthermore, naloxone injected 
into the locus coeruleus region partially antagonizes the behaviour 
responses of cats to morphine administration (Van Dongen et al., 1979). 
All this data is on line with a role for the noradrenergic, coeruleo-
raphe system in the development of tolerance to the behaviour effects 
of morphine in cats. 
Noradrenergic processes within the raphe nuclei become hypoactive 
after a short-term increased exposure to noradrenaline ¿md hyperactive 
after a short-term decreased exposure to noradrenaline. It is now wide-
ly documented that target cells are able to respond to changes in 
ambient ligand concentration, e.g. by changing the number and/or af-
finity of their surface receptors, and various mechanisms have been 
proposed to explain these phenomena (Catt et al., 1979; Triggle, 1980). 
It is indicated in the present study that the flexibility of noradren-
ergic processes plays an important role in the development of tolerance 
to the effects of morphine. Presumably, it may play a similar role in 
the development of tolerance to the effects of other drugs (cf. Taba-
koff et al., 1978, 1979) . 
Morphine exerts a differential, biphasic influence on the activity 
of two pharmacologically distinct dopaminergic systems in the caudate 
nucleus, i.e. the DAe- and the DAi-systems (section 3.2). It has been 
suggested that the DAe-system receives its neurons from the substantia 
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nigra and that the DAi-system receives its neurons from the ventral 
tegmental area (Cools and Van Rossum, 1980). Hence, it might be that 
morphine interacts differentially with the activity of the dopamin-
ergic systems originating in these brain regions. Such a differential 
action of morphine on distinct dopaminergic systems has been previously 
reported (Alper et al., 1980¡ Moleman and Bruinvels, 1979; Nazarro et 
al., 1980). The present results indicate that it is important in studies 
on morphine's central action 1) to specify in detail which neuronal sys-
tem is studied, and 2) to indicate the time-course of the morphine-in-
duced effects. 
The exact way in which morphine affects dopaminergic activity in the 
caudate nucleus is unclear. Systemic administration of morphine produces 
an increase in the activity of the dopaminergic, nigro-striatal neurons 
(Jurna, 1981; Iwatsubo and Clouet, 1977; Lee et al., 1977; Nowycky et 
al., 1978) . Morphine may produce this effect via a direct or indirect 
action on the mesencephalic, dopaminergic cell bodies (cf. Broekkamp 
et al., 1979a, b; Joyce and Iversen, 1979; Phillips and Le Piane, 1980; 
Stinus et al., 1980; Van Dongen et al., 1979). On the other hand, the 
dopaminergic terminals in the striatum contain presynaptically loca-
lized opiate receptors (Gardner et al., 1980; Murrin et al., 1980; 
Pollard et al., 1978), and locally applied opiate agents affect the 
metabolism and release of striatal dopamine (Biggio et al., 1978; 
Chesselet et al., 1981). Therefore, morphine may affect dopaminergic 
activity in the striatum alternatively via an action on the dopamin-
ergic terminals. Consequently, morphine's action on striatal dopamin-
ergic activity has to be considered as an overall effect of the opiate 
agonist on both the cell bodies and the terminals of the dopaminergic 
neurons. 
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CHAPTER 't 
MORPHINE-INDUCED BEHAVIOUR OF CATS: A TOOL TO STUDY 
NEUROTRANSMISSION PROCESSES WITHIN THE SEPTAL REGION 
THE SEPTAL REGION: AN INTRODUCTION 
1 Introduction 
The septal region, or septum, is a midline brain structure located 
in the telencephalon ventral to the anterior portion of the corpus 
callosum and connected with many other brain structures, particularly 
the hippocampus and the hypothalamus (see section 4.1.2). In humans, 
little is known about the function of the septum in behaviour. A kind 
of coma has been reported with lesions of the septum (Smythies, 1970), 
while hyperreactivity has been found with tumors of the septum 
(Smythies, 1970; Zeman, 1958). Septal structures have been, further-
more, implicated in the etiology of memory deficits (Smythies, 1970) 
and schizophrenia (Domino, 1976; Farley et al., 1978). Numerous animal 
studies have been performed to extend our knowledge of septal function-
ing in behaviour. The results of these experiments showed involvement 
of the septum in a wide variety of behaviours and led to theories about 
a critical role of septal structures in e.g. emotionality, response 
inhibition, incentive motivation, or integration of information (for 
reviews: Fried, 1972; Grossman, 1976; Donovick et al., 1979b). An 
orderly pattern of function, however, has not yet emerged. Recent 
years have provided evidence that the septum is a heterogeneous struc-
ture with regard to its cytoarchitectonics, neurochemistry and anatomical 
connections. Only a few behaviour studies have taken into account this 
heterogeneity of the septum. Most studies used the lesion or electrical 
stimulation technique to change experimentally septal activity. Such 
techniques are rather aspecific as they affect whole brain structures 
rather than single neuronal systems. Moreover, brain lesions cause 
secondary changes in the brain, which may partly account for the ef-
fects following the lesions, and electrical stimulation affects fibres 
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passing through the stimulated brain region. In other words, interpreta-
tion of the effects observed in those studies is not easy. It is not 
surprising, therefore, that a uniform theory about septal function in 
behaviour is still lacking. 
More knowledge of the pharmacological and functional properties of 
single neuronal systems within the septum is a prerequisite to enable 
investigators to study septal function in behaviour in more detail. In 
the present study, therefore, we introduce the morphine-induced behav-
iour of cats in combination with intracerebral injection of drugs as a 
new method for the study of the pharmacological and functional proper-
ties of neurotransmission processes within the septum. This method, 
i.e. the analysis of the effects of intraseptally injected drugs on 
the morphine-induced behaviour of cats, may have substantial advantages 
compared to other methods as has been discussed in the Preface of this 
thesis. Several aspects of septal neurotransmission processes are se-
lected in order to investigate whether the present method is indeed 
suitable for the purpose mentioned above: e.g. 1) the functional 
activity of specific neurotransmission processes within the septum 
at the behaviour level, 2) the pharmacological character of specific 
receptor sites within the septum, 3) the functional relationship be-
tween distinct neurotransmission processes within the septum, 4) the 
action of morphine on the activity of specific neurotransmission 
processes within the septum, and 5) the action of morphine on septal 
opiate receptors. Cholinergic (section 4.2), dopaminergic and nor-
adrenergic (section 4.3), endorphinergic and enkephalinergic (section 
4.4), and glutamatergic processes (section 4.5) are studied within this 
context since the existence of these processes within the septum has 
been extensively demonstrated (section 4.1.4). As a general intro-
duction to the experimental studies, a survey is given of the morphology 
(section 4.1.2), anatomical connections (section 4.1.3), and neuro-
chemistry (section 4.1.4) of the septum. 
4.1.2 The morphology of the septum 
The septal region comprises a collection of basal, medial telen-
cephalic nuclei. The boundaries of this group of nuclei are the fornicai 
commissure which is posteriorly situated, the anterior rudiment of the 
hippocampus anteriorly, the corpus callosum dorsally, the lateral ven-
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tríele and the nucleus accumbens laterally, and the olfactory tubercle 
and the preoptic area ventrally. The septum is elongated anteriorly and 
tends to become wider posteriorly. In the human, the septum is divided 
into septum pellucidum and septum verum, the dorsal and ventral division 
respectively. 
Most investigators have the conception that the septum consists of 
two principal divisions: a medial and a lateral division. Nevertheless, 
the comparative studies of Andy and Stephan (1959, 1961, 1964, 1966, 
1968, and 1976) suggest a different organizational plan. The major 
septal divisions recognized in those studies are the medial, dorsal, 
lateral, and caudal groups. Andy and Stephan's subdivision of the 
septum in the cat is given in Table 4.1; the dimensions and the re-
lative anatomical position of the various septal nuclei are visualized 
in Fig. 4.1. This subdivision of the septum is used in the experimental 
TABLE 4.1 
Subdivision of the septum in the oat 
as proposed by Andy and Stephan (1964) 
Dorsal group 
Ventral group 
Medial group 
Caudal group 
nucleus septalis dorsalis, - pars anterior (DA) 
- pars externa (DE) 
- pars intermedius (DM) 
- pars interna (DI) 
nucleus septalis lateralis, - pars externa (LE) 
- pars interna (LI) 
nucleus septalis medialis, - pars anterior (MA) 
- pars posterior (MP) 
nucleus of the diagonal bond of Broca, 
- pars dorsalis (BD) 
- pars ventralis (BV) 
nucleus septalis fimbrialis (F) 
nucleus septalis triangularis (A) 
bed nucleus of the anterior commissure (C) 
bed nucleus of the stria terminalis, 
- pars anterior (TA) 
- pars externa (TE) 
- pars interna (TI) 
The abbreviations between brackets refer to Fig. 4.1. 
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Тгд. 4.1 Subdivision of the septum in the cat as proposed by Andy 
and Stephan (1Э64). The figure shows 6 transversal sections 
(stereotaxic co-ordinates: A 13.0 - A 18.0). 
Abbreviations: 
A - nucleus septalis triangularis; Ac = nucleus accumbens; 
An = nucleus anterodorsalis thalamic BD - nucleus of the 
diagonal band of Broca pars dorsalis; BV = nucleus of zhe 
diagonal band of Broca pars venLralis; С = bed nucleus of 
the anterior commissure; CA = aommissura anterior; 
DE - nucleus septalis dorsalis pars externa; DI = nucleus 
septalis dorsalis pars interna; DM = nucleus septalis 
dorsalis pars intemedius; F - nucleus septalis fimbrialis; 
Fx = fornix; H = anterior continuation of the hippocanpus; 
1С = islands of Calleja; LE = nucleus septalis lateralis 
pars externa; LI = nucleus septalis lateralis pars interna; 
14A - nucleus septalis nedialis pars anterior; MP = nucleus 
septalis medialis pars posterior; NC = nucleus caudatus; 
ОТ = olfactory tubercle; PM = nucleus prfopticus medianas; 
ST - stria terminalis; ТА - bed nucleus of the stria ver-
minalis pars anterior; ТЕ = bed nucleus of the stria ter­
minalis pars externa; TI - bed nucleus of the stria ter­
minalis pars interna. 
129 
sections of this chapter to describe the localization of the injection 
sites. Most anatomical studies on the septum, however, use a subdivision 
similar to that described by Swanson and Cowan (1979) for the rat. Hence, 
Swanson and Cowan's subdivision is used for the description of the ana­
tomical connections of the septum in section 4.1.2. Table 4.2 indicates 
how the various septal divisions recognized by Swanson and Cowan corre­
spond to the nuclear groups of Andy and Stephan. 
TABLE 4.2 
Subdivision of the septum in the rat 
as proposed by Swanson and Co-jan (1979) 
Lateral division lateral septal nucleus, - dorsal part (DA,DE,DM,DI) 
, - ventral part (LE,LI) 
, - intermediate part 
septohippocampal nucleus 
Medial division medial septal nucleus (BD) 
nucleus of the diagonal band (BV) 
Posterior division septofimbrial nucleus (F) 
triangular septal nucleus (A) 
Ventral division bed nucleus of the stria terminals (TA,TE,TI,С) 
The abbreviations between brackets refer to the corresponding septal 
division of Andy and Stephan in Table 4.1. 
The cytoarchitectonic structure of the septum is extremely complex 
(Andy and Stephan, 1964; Swanson and Cowan, 1979). More than one class 
of neurons is found within each of the septal nuclei. The dendrites of 
many of the cells in the medial septal and diagonal band nuclei extend 
for considerable distances beyond the cytoarchitectonic boundaries of 
these nuclei. Accordingly, neuronal activity in adjoining nuclei may 
influence directly the activity of neurons in the medial and diagonal 
band nuclei, and indirectly the neuronal centers to which these latter 
nuclei project. The dendrites of the cells in other nuclei tend to be 
more restricted but potentially they have the same property, especially 
when they adjoin the medial and diagonal band nuclei. 
J> (MA,MP) 
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4.1.3 The anatomical connections of the septum 
This section gives a survey of the anatomical connections of the 
septum. The evidence for the existence of these connections is derived 
from the anatomical studies referred to in Table 4.3. This table shows, 
furthermore, which anatomical techniques (degeneration, horseradish 
peroxidase, or autoradiography) and which experimental animals were 
used in those studies. The connections demonstrated in cats and rats 
are discussed below. References to the anatomical studies are numbered 
in brackets in the text and listed in Table 4.3. Electrophysiological, 
biochemical and/or histochemical data are mentioned to supplement the 
anatomical evidence. The neurochemistry of the septum is discussed in 
more detail in section 4.1.4. 
The cortex. The most important connections of the septum with cortical 
regions are those with hippocampal and adjacent subicular and entorhinal 
areas (see below: hippocampal formation). Septal connections with other 
cortical areas have been reported rarely. 
Fibres afferent to the septum and arising in the pyriform cortex 
have been reported to terminate in the diagonal band nucleus (41). 
Fibres efferent from the septum have been reported to course from 
the diagonal band nucleus to the anterior limbic cortex in the cat 
(27). In the rat, the diagonal band nucleus projects to the occipital 
cortex; this projection may be cholinergic (20). 
The hippocampal fovmabbon. Massive reciprocal connections of the septum 
with the hippocampal formation (including the hippocampus proper, the 
dendate gyrus, and the adjacent subicular and entorhinal regions) be-
long to the best identified neuronal pathways in the brain. 
Fibres afferent to the septum arising in the hippocampal formation 
have been reported in both the cat (51, 53, 54) and the rat (10, 34, 41, 
53, 54, 59, 60). In the cat, it has been demonstrated (51, 53, 54) that 
degenerating fibres arising in ventral parts of the hippocampal forma-
tion pass through the fimbria and lateral aspect of the fornix to ter-
minate in massive quantities throughout the lateral septal nucleus; 
degenerating fibres arising in dorsal parts of the hippocampal formation 
pass through the medial aspect of the fornix and terminate, to a lesser 
extent, in the medial septal nucleus. In the rat, this topographical 
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TABLE 4.3 
Af f event eonneatiaas of the septum 
degeneration 
anatomical techniques 
horseradish peroxidase autoradiography 
Telencephalon 
cortex (with exception of 
hippocampal formation) 
hippocampal formation 
olfactory tubercle 
amygdala 
Diencephalon 
habenula 
thalamus 
hypothalamus 
Mesencephalon 
ventral tegmental area 
interpeduncular nucleus 
raphe nuclei 
4l(r) 
51,53,54(c);41,53,54(r); 
53,54(rb);53,54(ge) 
41 (r) 
41 (r) 
9(c);4I(r) 
30,31,35,41(r) 
ll(r) 
28 (ra) 
10(r);26(m) 
48(r) 
2(r) 
2,48(r);28(m) 
2,17,31,35(r);28(m) 
2,48(r);28(m) 
34,59,60(r) 
29(c);29(r) 
22(r) 
44,46,61(c);12,43,44,45, 
58,60(r);44,46(m);l(gu) 
4,I7,35,56(r) 
6(c);3,7,ll(r) 
Rombencephalon 
locus coeruleus 31,35(r) 2,32,35,48(r);28(m) 
Efferent oonneations of the septum 
anatomical techniques 
degeneration horeseradish peroxidase autoradiography 
Telencephalon 
cortex (with exception of 23(l);24(m) 
hippocampal formation) 
hippocampal formation 
olfactory tubercle 
amygdala 
36,41(r);52(c) 
52(c);4l(r) 
20 (r) 
27(c);33,42,47(r);l6(m); 
25 (p) 
15(c);50(r) 
27(c) 
27(c);12,33,60(r);25(p) 
12(r) 
27(c);12,33,60(r) 
Diencephalon 
habenula 
thalamus 
hypothalamus 
39,52(c);39,41(r);39(m) 
52(c);40(m);23(l) 
52(c);41(r);55(m);23(l) 
37(c);14,21,37(r);37(m) 
33(r) 
5,33(r);8(p) 
27(c);12
>
33,60(r);25(p) 
27(c);12,33(r);25(p) 
27,57(c);12,18,33,60(r); 
25 (p) 
Mesencephalon 
ventral tegmental area 
interpeduncular nucleus 
raphe nuclei 
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38(r) 
13(r) 
27(c);12,33,60(r);25(p) 
27(c);60(r) 
60(r) 
Rombencephalon 
locus coeruleus 19(c) 
The numbers refer to the appended list of references (page 124) and the letters in brackets to the experimental 
animals used: с = cat, ge = gerbil, gu - guinea pig, 1 - lizard, m - monkey, ρ - pigeon, r - rat, rb - rabbit 
List of références (appendix Table 4.S) 
1 = Anderson and Shen, 1980 
2 = Assaf and Miller, 197'/ 
¿ - Azmitia and Segal, 1978 
4 - Beokstead et al., 1979 
5 = Berk and Finkelstein, 1981 
6 = Bobillier et al., 1976 
7 = Bobillier et al., 1979 
8 = Bouille et al., 1977 
9 = Chi and Flynn, 1Э71 
10 = Chronister and De France, 1979 
11 = Conrad et al., 1974 
12 = Conrad and Ρfaff, 1976 
13 = Contestabile and Flumerfelt, 
1981 
14 = Crutoher and Davis, 1980 
15 - Dennis and Kerr, 1976 
16 = De Vito, 1980 
17 = Fallon and Moore, 1978 
18 = Garris, 1979 
19 - Heath and Harper, 1976 
20 - Henderson, 1981 
21 - Herkenham and Nauta, 1977 
22 = Herkenham and Ilauta, 1979 
26 - Hoogland et al., 1978 
24 = Kemper et al., 1972 
25 - Krayniak and Siegel, 1978 
26 = Krayniak et al., 1979 
27 - Krayniak et al., 1980 
28 = Krayniak et al., 1981 
29 = Krettek and Price, 1978 
30 = Lindvall, 1975 
31 = Lindvall and Stenevi, 1978 
32 = Mason and Fibiger, 1979 
33 = Meibach and Siegel, 1977a 
34 = Meibach and Siegel, 1Э77Ь 
35 = Moore, 1978 
36 = Mosko et al., 1973 
37 = Parent et al., 1981 
38 = PhilUpson, 1979 
39 - Powell, 1968 
40 = Powell, 1973 
41 = Raisman, 1966 
42 = Sakandka et al., 1980 
43 = Saper et al., 1976 
44 = Saper et al., 1978 
45 = Saper et al., 1979a 
46 = Saper et al., 1979b 
47 = Segal and Landis, 1974a 
48 = Segal and Landis, 1974b 
49 = Segal, 1976 
50 = Shafa and Meisani, 1977 
51 = Siegel and Tassoni, 1971a 
52 = Siegel and Tassoni, 1971b 
53 = Siegel et al., 1974 
54 = Siegel and Edinger, 1976 
55 = Simmons and Powell, 1972 
56 = Simon et al., 1979 
57 - Stoddard-Ар ter and Mac-
Donnell, 1980 
58 = Swanson, 1976 
59 = Swanson and Cowan, 1977 
60 = Swanson and Cowan, 1979 
61 - Troiano and Siegel, 1975 
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organization has been somewhat more specified in studies utilizing the 
horseradish peroxidase and the autoradiography technique (34, 59, 60): 
fibres arising in the rostro-dorsal part of the hippocampal formation 
project to the dorsal part of the lateral septal nucleus, while those 
from successively more caudo-ventral parts of the hippocampal formation 
project to progressively more ventral parts of the lateral septal 
nucleus. The majority of the hippocampo-septal fibres are excitatory 
(De France, 1976; De France et al., 1973a, b, 1976; Edinger et al., 
1973; Gutnick and Feldman, 1977; McLennan and Miller, 1974a). Most of 
the hippocampo-septal neurons use glutamate as neurotransmitter (Fonnum 
and Walaas, 1978; Fonnum et al., 1979; Malthe-Sörenssen et al., 1980a, 
b; Witsch et al., 1979; Storm-Mathisen and Opsahl, 1980; Taxt and 
Stonn-Mathisen, 1979; Walaas and Fonnum, 1980b; Zaczek et al., 1979). 
Fibres efferent from the septum and terminating in the hippocampal 
formation have been reported in both the cat (27, 52) and the rat (33, 
36, 41, 42, 47, 60). In both species, the fibres arise in the medial 
septal nucleus/diagonal band complex, course by way of the dorsal for-
nix and the fimbria, and distribute widely to most parts of the hippo-
campal formation. The septo-hippocampal pathway is topographically or-
ganized in both the cat (27, 52) and the rat (33, 47): septal cells 
positioned near the midline project through medial parts of the dorsal 
fornix to terminate in the dorsal hippocampal formation, while fibres 
originating from cells situated more laterally project through pro-
gressively more lateral parts of the fimbria to terminate in progress-
ively more posteroventral regions of the hippocampal formation. The 
septo-hippocampal neurons are excitatory (Andersen et al., 1961; Bird 
and Aghajanian, 1975; Biscoe and Straughan, 1966; Bland et al., 1974; 
Brücke et al., 1963) and use acetylcholine as neurotransmitter (Bajgar 
et al., 1977; Dudar, 1975, 1977; Lewis and Shute, 1967; Mellgren and 
Srebro, 1973; Moroni et al., 1978b; Mosko et al., 1973; Sethy et al., 
1973; Smyth, 1974). 
The olfactory tubercle. Evidence is scarce for afférents to the septum 
originating from the olfactory tubercle. In the rat, it has been re-
ported that degenerating fibres arising in the olfactory tubercle 
course to the rostral aspect of the lateral septal nucleus (41). On 
the other hand, the existence of fibres efferent from the septum and 
terminating in the olfactory tubercle seems well established both in 
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the cat (15, 52) and the rat (12, 41, 50). This projection originates, 
particularly, in the diagonal band nucleus. 
The amygdala. Afférents to the septum arising in the amygdala have been 
reported in both the cat (29) and the rat (29, 41). In both species, the 
amygdala projects via the stria terminalis to the bed nucleus of the 
stria terminalis in a topographically ordered way (29): the medial and 
posterior amygdaloid nuclei and the amygdalo-hippocampal area project 
to the medial part of the bed nucleus, the basolateral and the central 
amygdaloid nuclei project to the lateral part of the bed nucleus, and 
the basomedial amygdaloid nucleus projects to a region partly over-
lapping the medial and lateral divisions of the bed nucleus of the 
stria terminalis. A minor projection was also reported (29) from the 
amygdala to the ventral part of the lateral septal nucleus. 
Also fibres efferent from the septum and terminating in the amygdala 
have been reported. In the cat, the vertical limb of the diagonal band 
nucleus projects partly via the medial forebrain bundle to the medial 
amygdaloid nucleus (27) . In the rat, the septum projects in two dis-
tinct pathways to the amygdala: 1) the bed nucleus of the stria ter-
minalis projects via the stria itself to the medial, central and an-
terior amygdaloid nuclei (12, 60), 2) the diagonal band nucleus pro-
jects partly via the medial forebrain bundle to the anterior and basal 
amygdaloid nuclei (12, 33). The latter projection may be cholinergic 
(Bajgar, 1977). 
The habenuLa. Evidence is scarce for afférents to the septum originat-
ing in the habenular complex. The existence of such connections has 
been reported in the rat (22, 48) but not in the cat: the medial 
habenula projects sparsely via the stria medullaris to the septo-
fimbrial and triangular nuclei (22, 48), whereas the lateral habenula 
projects, more heavily, to the ventrolateral septum by way of the fas-
ciculus retroflexus and the medial forebrain bundle (22). 
The existence of fibres efferent from the septum and terminating in 
the habenula have been extensively reported in both the cat (27, 37, 
39, 52) and the rat (14, 21, 33, 37, 39, 41, 60). In both species, 
the projection arises particularly in the septofimbrial nucleus. 
Projections from the septofimbrial nucleus, the vertical limb of the 
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diagonal band nucleus, and the ventral part of the lateral septal 
nucleus course via the stria medullaris to the medial habenular nucleus. 
In addition, fibres arising in the bed nucleus of the stria terminalis 
have been reported to terminate in the habenula (37, 39). In the cat, 
a projection has been reported from the bed nucleus of the anterior 
commissure to the lateral habenula. In the rat, it has been demon-
strated (60) that the projection from the septofimbrial nucleus to the 
medial habenular nucleus is topographically organized such that axons 
of cells in the anterodorsal part of the nucleus end in a vertical band 
within the medial part of the medial habenular nucleus, and progress-
ively more ventrolaterally placed neurons in the septofimbrial nucleus 
innervate progressively more lateral bands within the habenula. More-
over, the anterodorsal part of the septofimbrial nucleus projects to 
the rostral two-thirds of the medial habenular nucleus while the 
posteroventral part of the septofimbrial nucleus projects to the 
entire rostrocaudal extent of the medial habenular nucleus (60). 
Also the projection from the vertical limb of the diagonal band 
nucleus is topographically organized as demonstrated in the rat (21, 
33): cells situated near the midline project to the medial habenula 
while progressively more laterally positioned cells project to pro-
gressively more lateral parts of the habenula. Electrophysiological 
support for the existence of septal projections to the lateral habenula 
is given by the studies of Mok and Mogenson (1972a, b). The septal pro-
jection to the habenula complex are at least partly cholinergic (Gottes-
feld and Jacobowitz, 1979; Kataoka et al., 1977). 
The thalamus. Afférents to the septum arising in the thalamus have not 
been reported in the cat. In the rat, a projection has been reported 
from the anterior thalamic nuclei to the lateral septal nucleus (2). 
Efferents from the septum to the thalamus have been reported more 
extensively, both in the cat (27, 52) and in the rat (12, 33). In the 
cat, the lateral and medial septal nuclei project to the nucleus re-
uniens (27, 52) and the nucleus anterior medialis (52). In the rat, 
efferents from the diagonal band nucleus distribute to the anteromedial 
nucleus (33) , the parataenial nucleus (33), and the mediodorsal thala-
mic nucleus (12, 33). This projection is topographically organized (33): 
a) fibres from the midline region of the vertical limb of the diagonal 
band nucleus and medial septal nucleus project to the anteromedial 
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nucleus, b) fibres of cells situated in slightly more lateral portions 
of the vertical limb and medial septum project to the parataenial 
nucleus, c) fibres of cells positioned still more laterally project to 
the mediodorsal nucleus. The dorsal septum appears to have a sparse 
projection to the midline thalamus (33). From the bed nucleus of the 
stria terminalis axons course to the parataenial and periventricular 
nuclei (12). 
The hypothalamus. Projections afferent to the septal nuclei arising in 
the hypothalamus have been reported in both the cat (44, 46, 60) and 
the rat (2, 9, 12, 41, 43, 44, 45, 48, 58, 60). In the cat, the ventro-
medial nucleus projects through the medial forebrain bundle to the 
medial part of the bed nucleus of the stria terminalis, and the ventral 
part of the lateral septal nucleus (46). Furthermore, the anterior hypo-
thalamic area projects to the zone between the medial and lateral septal 
nuclei and to the ventral part of the lateral septal nucleus (44, 46). 
Fibres have been reported that arise in the lateral preoptic-hypothalamic 
area and course via the medial forebrain bundle to terminate in the 
lateral septal nucleus and in the intermediate zone between the lateral 
and medial septal nuclei (61). In the rat, it is demonstrated (45, 58, 
60) that the lateral preoptic and lateral hypothalamic areas, from the 
level of the premammillary nucleus caudally and the supraoptic nucleus 
rostrally, project to the medial septal-diagonal band complex. This pro-
jection is topographically organized in such a manner that the more cau-
dal cells in the lateral hypothalamic area project diffusely to the 
nucleus of the diagonal band, while the more rostral cells in the la-
teral preoptic area project to the medial septal nucleus as well. Other 
studies suggest that the lateral hypothalamic area projects to the la-
teral septal nucleus (2), that the anterior hypothalamic area projects 
to the ventral part of the lateral septal nucleus (44) , that the ventro-
medial nucleus projects to the bed nucleus of the stria terminalis and 
the adjacent part of the lateral septal nucleus (43), and that the 
medial preoptic area projects to the septum via the diagonal band (12). 
Septal afférents arising in the arcuate nucleus contain ß-endorphin and 
adrenocorticotrophic hormone (Bloom et al., 1978; Rossier et al., 1977; 
Watson et al., 1977b, 1978a). Other hypothalamic-septal neurons contain 
vasopressin and oxytocin (Buijs, 1978; Buijs et al., 1978; Dogterora et 
al., 1978). The innervation from the lateral preoptic area may be cholin-
ergic (Emson, 1978). 
Septal efferente coursing to the hypothalamus have been reported in 
both the cat (27, 52, 57) and the rat (12, 18, 33, Al, 60). In the cat, 
the lateral septal nucleus projects to the preoptic area (27, 52), the 
lateral hypothalamus (27, 52) and supraraammillary region (27). The dia-
gonal band nucleus projects to the preoptic area and the lateral hypo-
thalamus (27, 52). Fibres arising in the bed nucleus of the anterior 
commissure are distributed to the preoptic region, lateral hypothalamus, 
supramammillary region, and the posterioraspect of the medial mammillary 
nucleus (27) . Septal efferents have also been reported to terminate in 
the medial hypothalamus (57). In the rat, the lateral septal nucleus 
sends fibres through the medial forebrain bundle to the medial preoptic 
and anterior hypothalamic areas (5, 18, 60), the dorsomedial nucleus 
(5, 33, 60), the lateral hypothalamic area (5, 18, 33, 60), the mammil-
lary body (60), the posterior hypothalamic nucleus (5), the ventromedial 
hypothalamic nucleus (5), and the paraventricular hypothalamic nucleus 
(5). Furthermore, the medial septal nucleus/diagonal band complex pro-
jects through the medial forebrain bundle to the medial and lateral 
preoptic areas (18, 60), to the lateral hypothalamic area (18, 60), 
and the mammillary complex (18, 33, 60). The bed nucleus of the stria 
terminalis projects through the medial forebrain bundle to most parts 
of the hypothalamus, including the preoptic area (12, 60). The dorsal 
septal nucleus projects to the lateral preoptic area, lateral hypo-
thalamus, and periventricular hypothalamus (33). Some of the septo-· 
hypothalamic connections may be cholinergic (Bajgar et al., 1977). 
Mesenceghalon 
The ventral tegmental area. Fibres efferent to the septal nuclei aris-
ing from the ventral tegmental area have been extensively reported in 
the rat (2, 4, 17, 30, 31, 35, 41, 56) but not in the cat. The fibres 
originate from the ventral part of the ventral tegmental area and course 
via the medial forebrain bundle to terminate mainly in the medial part 
of the lateral septal nucleus (31, 35). The projection is topographical-
ly organized (17): more rostrally located cells project more laterally 
in the septum, whereas more caudally situated cells project to a more 
medial septal region. The axons arising in the ventral tegmental area 
are, at least partly, excitatory (Assaf and Miller, 1977). Moreover, 
the majority of the neurons are dopaminergic (Lindvall and Stenevi, 
1978; Moore, 1978) although also non-dopaminergic cells have been re-
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ported to project from the ventral tegmental area to the septum (Deniau 
et al., 1980; Thierry et al., 1980). 
Septal efferente to the ventral tegmental area have been reported in 
both the cat (27) and the rat (33, 38, 60). In the cat, the fibres ori-
ginate in the horizontal limb of the diagonal band nucleus and course 
via the medial forebrain bundle (27). In the rat, the fibres arise in 
the ventral part of the lateral septal nucleus (60), the horizontal 
limb of the diagonal band nucleus (33, 38), the medial septal nucleus 
(60), and the bed nucleus of the stria terminalis (38, 60). 
The interpeduneular nualeus. Septal afférents arising in the inter-
peduncular nucleus have not yet been demonstrated. On the other hand, 
there is some evidence for septal efferents to the interpeduncular 
nucleus in both the cat (27) and the rat (13, 60). In the cat, the 
fibres arise in the diagonal band nucleus (27). In the rat, the fibres 
arise in the diagonal band nucleus, septo-fimbrial and triangular nuclei, 
and course via the stria medullaris, the nucleus habenularis and the 
formatio retroflexus (13, 60). The neurons originating in the diagonal 
band are thought to be cholinergic (Gottesfeld and Jacobowitz, 1978; 
Kataoka et al., 1977; McGeer et al., 1979). 
The raphe nuclei. Septal afférents arising in the raphe nuclei have 
been reported in the cat (6) and the rat (2, 3, 7, 11, 48). In the cat, 
the fibres arise in the dorsal and central superior nuclei (6). In the 
rat, the fibres arise in the central superior nucleus (2, 3, 7, 11, 48) 
and, to a lesser extent, in the dorsal raphe nucleus (3, 11). The cen-
tral superior raphe cells project to the medial septal nucleus, where-
as the dorsal raphe cells project to the lateral septal nucleus (3). 
The responses of septal cells to stimulation of the medial and dorsal 
raphe nuclei are complex (Segal, 1976), but the projection from the 
central superior nucleus to the medial septal nucleus is thought to be 
predominantly inhibitory (Assaf and Miller, 1978) . The projections from 
the raphe nuclei to the septal nuclei are mainly serotonergic (Assaf 
and Miller, 1978; Geyer et al., 1976; Halaris et al., 1976; Kellar et 
al., 1971). 
Septal efferents to the raphe nuclei have been reported in the rat 
(60). The fibres arise in the medial septal nucleus and the bed nucleus 
of the stria terminalis, and terminate in the dorsal and central superior 
raphe nuclei, 
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Rhombenceghalon 
The locus coeruleus. Septal afférents from the locus coeruleus have 
been reported in the rat (31, 32, 35, 48) but not in the cat. The pro-
jection arises from the dorsal part of the locus coeruleus, courses via 
the medial forebrain bundle, and terminates particularly in the medial 
septal and diagonal band nuclei, the bed nucleus of the stria terminalis 
and, to a lesser extent, in the lateral septal and the septofimbrial 
nuclei (31, 35). These neurons are, at least partly, noradrenergic 
(Lindvall and Stenevi, 1978; Moore, 1978; Segal, 1976). 
Septal efferents to the locus coeruleus have been reported only in 
the cat (19). These fibres arise in the rostral part of the septum. 
Summary; 
Summarizing, the septum is connected with several other brain regions 
(Fig. 4.2). These connections take three major routes: 1) the medial 
forebrain bundle (particularly the connections with the hypothalamus), 
2) the dorsal fornix/fimbria (particularly the connections with the 
hippocampal formation), and 3) the stria medullaris (particularly the 
connections with the habenular complex). Most of the connections are 
reciprocal. The afferent fibres terminate mainly in the lateral septal 
nuclei while the efferent fibres arise chiefly in the medial septal 
nuclei. It has to be taken into account, however, that the dendrites 
of medial septal cells extend for considerable distances in lateral 
septal regions (section 4.1.2) and that intrinsic connections exist 
between the lateral and medial septal nuclei (Krayniak et al., 1980; 
Raisman, 1966; Swanson and Cowan, 1979). Hence, the afferent fibres 
terminating in the lateral septal nuclei may also influence both 
directly and indirectly the activity of neurons in the medial septal 
nuclei, and, consequently, the activity of the septal efferent fibres 
arising in the medial septal nuclei. This internal organization of the 
septum provides the basis for "feed-back" circuits involving the septum 
and brain regions with which it is reciprocally connected, e.g. the 
hippocampal formation, the hypothalamus and the ventral tegmental area. 
The best documented input of the septum arises from the hippocampal 
formation, the hypothalamus, the ventral tegmental area, the raphe 
nuclei, and the locus coeruleus. Each of the various neuronal pathways 
terminating within the septum uses its own characteristic neurotrans-
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ЬЧд. 4.2 Brain regions oonneated with the septum; modified diagram 
after Nieuwenhuys et al. (1979) 
1 = nuclei septales; 2 = nucleus of the diagonal band of 
Broca; 3 - tuberculum olfactorium; 4 = nuclei amygdalae; 
5 = bed nucleus of the stria terminalis; 6 - nuclei pre­
optici; 7 = nuclei hypothalami; 8 - nuclei marmillares; 
9 = nuclei thalami; 10 = nuclei habenulae; 11 = nucleus 
interpeduncularis; 12 = area ventralis tegmenti; 
13 = formatio hippocampi; 14 = nucleus raphe dorsalis; 
15 = nucleus raphe centralis superior; 16 = locus 
coeruleus. 
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mitter, e.g. glutamate for fibres arising in the hippocampal formation, 
acetylcholine, 6-endorphin, adrenocorticotrophic hormone, vasopressin 
and oxytocin for fibres arising in hypothalamic regions, dopamine for 
fibres arising in the ventral tegmental area, serotonin for fibres aris-
ing in the raphe nuclei, and noradrenaline for fibres arising in the 
locus coeruleus. (The neurochemistry of the septum is discussed in more 
detail in section 4.1.4) In the present study, the functional and 
pharmacological properties are investigated of cholinergic (section 
4.2), dopaminergic and noradrenergic (section 4.3), endorphinergic and 
enkephalinergic (section 4.4), and glutamatergic (section 4.5) neuro-
transmission processes within the septum. 
The output of the septum is directed to the hippocampal formation, 
the hypothalamus, the habenula, and, to a lesser extent, the amygdala, 
the thalamus, the ventral tegmental area, and the interpeduncular 
nucleus. Most of these efferent connections seem to be cholinergic. 
The data that 1) septal output is mainly cholinergic, 2) septal input 
arises from such neuronal centers as the noradrenergic locus coeruleus, 
the serotonergic raphe nuclei, and the dopaminergic ventral tegmental 
area, and 3) most of the connections are reciprocal, suggest a critical 
role for septal structures in mediating reciprocal interactions between 
cholinergic and other neurotransmission processes. In Chapter 5, we pay 
attention to a role of septal structures in the interactions between 
central cholinergic and dopaminergic neurotransmission processes. An 
imbalance of such interactions, particularly within the caudate nucleus, 
is generally thought to be one of the etiological factors in Parkinson's 
disease. As described in Chapter 5, it will be investigated whether also 
septal structures may be involved in such interactions. 
4.1.4 The neurochemistry of the septum 
A wide variety of chemical substances can act as neurotransmitter in 
the brain (Barchas et al., 1978). Some of these substances may act with-
in the septum. Functional and pharmacological properties of several 
neurotransmission processes within the septum are investigated within 
this study: 1) cholinergic processes (section 4.2), 2) dopaminergic and 
noradrenergic processes (section 4.3), 3) endorphinergic and enkephalin-
ergic processes (section 4.4), and 4) glutamatergic processes (section 
4.5). This section is an introduction to this subject and gives a survey 
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of these septal neurotransmission processes with special attention to 
the aspects investigated within the present study. For the sake of com-
pleteness, septal neurotransmission processes that are not the subject 
of the present study are also discussed. 
Acetylcholine 
Acetylcholine and its synthetizing and degrading enzymes (cholineacetyl-
transferase and acetylcholine-esterase, respectively) are present within 
the septum (Chronister et al., 1976; Domino, 1976; Fonnum and Walaas, 
1978; Harkmark et al., 1975; Hoover et al., 1978; Jacobowitz and Pal-
kovits, 1974; Kimura et al., 1981; Palkovits et al., 1974; Srebro et al., 
1976; Uchimura et al., 1978). The presence of these cholinergic markers 
is not surprising in view of the existence of massive cholinergic pro-
jections of the septum to e.g. the hippocampal formation, the hypotha-
lamus, the habenula, the nucleus interpeduncularis, and the amygdala 
(section 4.1.2). On the other hand, acetylcholine is also active within 
the septum itself: I) intraseptal injections of cholinergics affect 
several aspects of behaviour and physiological functioning, such as 
avoidance behaviour (Hamilton and Grossman, 1964; Hamilton et al., 
1968; Kelsey and Grossman, 1975), emotional behaviour (Hernandez-Peon 
et al., 1963; MacPhail and Miller, 1968), anti-nociception (Metys et 
al., 1979), food- and water-intake (Grossman, 1964), and urinary ex-
cretion (Saad, 1975), 2) intraseptal administration of acetylcholine 
depresses septal neuronal activity (Segal, 1974), and 3) histochemical 
studies suggest that the septum is innervated by cholinergic fibres 
(Chronister et al., 1976; Emson, 1978; Harkmark et al., 1975; Srebro 
et al., 1976). The origin of the cholinergic fibres afferent to the 
septum is unknown at present: they may be either intrinsic, cholinergic 
neurons with the septum itself (Chronister et al., 1976; Harkmark et 
al., 1975; Srebro et al., 1976), or axon collaterals of the cholinergic, 
septo-hippocampal pathway (Harkmark et al., 1975; Srebro et al., 1976; 
Swanson and Cowan, 1979), or fibres from extraseptal origin, e.g. from 
the lateral preoptic area (Emson, 1978) . The studies dealing with the 
effects of intraseptally injected cholinergic agents (see above) used 
drugs with a predominantly muscarinic character; the effectiveness of 
these drugs suggest that septal acetylcholine receptors are, at least 
partly, muscarinic ones. 
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One of the aims of the present study is to investigate whether 
morphine-induced behaviour of cats, in combination with intraseptal 
injection of drugs, may serve as a suitable method for the study of 
pharmacological and functional properties of septal neurotransmission 
processes (section 4.1.1). A prerequisite for the successful use of 
this method is that the morphine-induced behaviour of cats has to be 
related to septal neuronal activity. As intraseptal injection of 
cholinergic drugs has been demonstrated to affect septal neuronal 
activity, and to produce a variety of behaviour and physiological 
effects (see above), intraseptal injection of cholinergics is chosen 
as a tool to investigate whether morphine-induced behaviour of cats 
may indeed serve as a suitable variable for experimentally-evoked 
changes in septal neuronal activity (section 4.2). 
Dopamine 
Recent histochemical, pharmacological, and biochemical studies have 
indicated the existence of a substantial dopaminergic innervation of 
the septum (Brownstein et al., 1974b; Collu et al., 1980; Fallon and 
Moore, 1978; Garey, 1976; Garey and Heath, 1974; Kizer et al., 1976; 
Koslow et al., 1974; Lindvall, 1975; Lindvall and Stenevi, 1978; Moore, 
1978; Robinson et al., 1979; Saavedra and Zivin, 1976; Versteeg et al., 
1976). The dopamine containing fibres - belonging to the mesolimbic 
dopamine system - arise from the mesencephalic ventral tegmental area 
(A-10 cell group) and terminate heavily in the medial part of the 
lateral septal nucleus (Lindvall and Stenevi, 1978; Moore, 1978). The 
dopaminergic innervation of the septum is at least partly excitatory 
(Assaf and Miller, 1977). The dopaminergic afférents of the septum 
exert a tonic inhibitory action on the cholinergic, septo-hippocampal 
neurons (Robinson et al., 1979). This action on the septo-hippocampal 
pathway is presumably mediated via inhibitory, γ-aminobutyric acid 
containing interneurons (Wood et al., 1979). The dopamine containing 
neurons innervate the septum in two distinct histochemical patterns, 
viz. "smooth" and "fine-varicose" patterns (Lindvall and Stenevi, 1978; 
Moore, 1978), which may reflect the presence of distinct types of dopa­
mine receptors (Cools and Van Rossum, 1976). Binding studies have also 
suggested the existence of a particular subpopulation of dopamine re­
ceptors within the septum (Howlett et al., 1979; Köhler et al., 1979). 
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Binding to this type of dopamine receptor is not "classical", i.e. 
the "classical" dopamine agonist apomorphine and antagonist haloperi-
dol show low affinity for this binding site (Howlett et al., 1979). 
Nevertheless, both apomorphine and haloperidol do affect septal neuronal 
activity (Assaf and Miller, 1977; Robinson et al., 1979). Accordingly, 
more than one type of dopamine receptor may be present within the sep-
tum. In this context, it is useful to note that septal dopamine is not 
adenyl-cyclase linked (Collu et al., 1980). 
Little is known about the functional activity of the septal dopamin-
ergic processes at the behaviour level. Hence, the ability of intra-
septally injected dopaminergic agents to affect behaviour is investi-
gated (section 4.3). Attention is also paid to the possible existence 
of more than one type of dopamine receptor within the septum (section 
4.3). 
Noradrenaline 
The septal nuclei are relatively rich in noradrenaline (Brownstein et 
al., 1974b; Garey, 1976; Koslow et al., 1974; Lindvall and Stenevi, 
1978; Moore, 1978; Versteeg et al., 1976). The noradrenergic innerva-
tion of the septum arises almost equally from the locus coeruleus and 
from nuclei in the caudal brain stem (Lindvall and Stenevi, 1978; Moore, 
1978). The axons originating in the locus coeruleus form a dense in-
nervation of medial septal structures (anterior hippocampus, medial 
septal nucleus, and the diagonal band nucleus) and the bed nucleus of 
the stria terminalis, whereas the noradrenergic innervation arising 
from the brain stem is most pronounced in lateral septal structures 
(lateral septal nucleus and the bed nucleus of the stria terminalis) 
(Lindvall and Stenevi, 1978; Moore, 1978). Stimulation of locus coeru-
leus neurons or intraseptal application of noradrenaline decreases 
spontaneous neuronal activity within the septum (Segal, 1974, 1976; 
Winokur and Beekman, 1978). Hence, at least the innervation originat-
ing from the locus coeruleus is inhibitory. The noradrenergic afférents 
of the septum exert an excitatory influence on the cholinergic, septo-
hippocampal neurons (Robinson et al., 1978). Binding studies have de-
monstrated the existence of both a- and ß-noradrenergic receptors 
within the septum (U'Prichard et al., 1980). Intraseptal injections 
of noradrenergic agents affect avoidance behaviour (Grossman, 1964; 
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Kelsey, 1976), operant responding (Kelsey, 1976), and urinary excretion 
(Camargo et al., 1979). 
In the present study, the ability of intraseptally injected α-nor­
adrenergic agents to affect behaviour is investigated (section 4.3). 
Opioid peptides 
The septal nuclei, particularly the lateral septal nucleus, the diagonal 
band nucleus, and the rostral part of the bed nucleus of the stria ter-
minalis, receive afférents originating in the basal hypothalamus that 
secrete the opioid peptide 0-endorphin (Bloom et al., 1978; Law et al., 
1979; Rossier et al., 1977; Watson et al., 1977b). Enkephalins are also 
present in the septum (Hökfelt et al., 1977; Hong et al., 1977; Johansson 
et al., 1978; Rossier et al., 1977; Sar et al., 1978; Simantov et al., 
1977; Wamsley et al., 1980; Watson et al., 1977a). Cell bodies of enke-
phalin containing neurons are present in the caudal ventromedial part 
of the lateral septal nucleus, and in the lateral part of the bed 
nucleus of the stria terminalis, whereas terminals are found in the 
medial part of the lateral septal nucleus, and in the bed nucleus of 
the stria terminalis. The medial septal nuclei do not contain enke-
phalins. The septal nuclei, with exception of the bed nucleus of the 
stria terminalis and the triangular nucleus, show a low density of 
opiate receptors as measured by autoradiographic localization of di-
prenorphine binding (Atweh and Kuhar, 1977; Pert et al., 1976). The 
existence of multiple types of opiate receptors within the septum has 
been reported. The medial, lateral, and triangular septal nuclei con-
tain δ-receptors; the bed nucleus of the stria terminalis contains 
μ-receptors; the diagonal band nucleus contains both types of opiate 
receptors; the presence of <-receptors within the septum seems less 
established (Duka et al., 1981; Wood and Stotland, 1980). Septal cells 
respond to administration of morphine (Dafny et al., 1979; Dafny and 
Rigor, 1980; Robinson and Wang, 1979). Moreover, intraseptally applied 
opiate agents, particularly 0-endorphin, depress the activity of the 
cholinergic, septo-hippocampal neurons (Botticelli and Wurtman, 1981; 
Moroni et al., 1977, 1978a). This inhibitory effect is mediated via 
intrinsic, -y-aminobutyric acid containing interneurons in the septum 
(Wood et al., 1979). The inhibitory effect on the septo-hippocampal 
neurons is not mediated via an action of morphine on the dopaminergic 
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terminals in the septum (Wood et al., 1979) although it has been re-
ported that the dopaminergic afférents of the septum contain pre-
synaptically localized opiate receptors (Pollard et al., 1977). 
As mentioned above, morphine affects septal neuronal activity. 
It is investigated in the present study (section 4.4) whether this 
effect of morphine is mediated via a direct action on septal opiate 
receptors or via an indirect action on afférents to the septum. 
Moreover, it is investigated whether septal opiate receptors are a 
site of action for morphine to produce its behaviour effects. In 
addition, septal opiate receptors are characterized pharmacologically. 
Glutamate 
High levels of glutamate are present in the lateral septal nucleus 
and the anterior diagonal band nucleus (Walaas and Fonnum, 1980). 
Microiontophoretically applied glutamate has an excitatory effect on 
cells in the dorsal part of the lateral septal nucleus (McLennan and 
Miller, 1974). The hippocampo-septal projection uses, at least partly, 
glutamate as neurotransmitter (Fonnum and Walaas, 1978; Fonnum et al., 
1979; Malthe-Sörenssen et al., 1980a, Ъ; Nitsch et al., 1979; Storm-
Mathisen and Opsahl, 1980; Taxt and Storm-Mathisen, 1979; Walaas and 
Fonnum, 1980; Wood et al., 1979; Zaczek et al., 1979). The lateral 
septal cells which receive the glutamatergic afférents from the hippo-
campus are most probably intrinsic, γ-aminobutyric acid containing 
interneurons (Malthe-Sörenssen et al., 1980a). 
In the present study (section 4.5), it is investigated whether the 
septal glutamatergic processes are functionally active at the behaviour 
level. 
Serotonin 
Serotonin is present within the septum (Koslow et al., 1974; Schofield 
and Everitt, 1981; Steinbusch, 1981). The serotonergic afférents of 
the septum arise from the central superior and dorsal raphe nuclei 
(Assaf and Miller, 1978; Geyer et al., 1976; Halaris et al., 1976; 
Kellar et al., 1971). The central superior nucleus projects to the 
medial septal nucleus whereas the dorsal raphe cells terminate in the 
lateral septal nucleus (Azmitia and Segal, 1978). The responses of 
septal cells to stimulation of the serotonergic afférents are quite 
complex (Segal, 1976); at least the afférents arising from the central 
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superior nucleus may be inhibitory (Assaf and Miller, 1978), which is 
further strenghtened by the data that septal neuronal activity is sup-
pressed by intraseptally applied serotonin (Segal, 1974). 
GABA and its synthetizing enzym glutamate decarboxylase are present 
within the septum (Earley and Leonard, 1978; Fonnum et al., 1979; Pal-
kovits et al·., 1974; Tappaz et al., 1976), and particularly concentra-
ted in the diagonal band and lateral septal nuclei (Walaas and Fonnum, 
1980). High affinity uptake of GABA is lower in the medial than in the 
lateral septal nucleus (Taxt and Storm-Mathisen, 1979). GABA-ergic 
drugs are functionally active in the septum (De France et al., 1975; 
Wood et al., 1979), and microiontophoretically applied GABA depresses 
the activity of septal cells (Herz and Gogolak, 1965; McLennan and 
Miller, 1974b; Segal, 1974). Septal interneurons may use GABA as neuro-
transmitter (De France et al., 1975; Fonnum et al., 1979; McLennan and 
Miller, 1974b). Septal GABA containing neurons exert an inhibitory 
action on the cholinergic, septo-hippocampal neurons (Revueita et al., 
1979). 
Adrenocorticotro¡)hic_hormone (ACTH) 
The ventral part of the lateral septal nucleus and the bed nucleus of 
the stria terminalis are innervated by ACTH-containing neurons arising 
in the basal hypothalamus (Hostetter et al., 1979; Krieger et al., 
1977; Pelletier and Leclerc, 1979; Watson et al., 1978a). Intraseptally 
applied ACTH increases the activity of the cholinergic, septo-hippo-
campal neurons (Botticelli and Wurtman, 1981). Specific uptake of a 
behaviourally potent ACTH,
 Q analog in the septum has been reported 
(Rees et al., 1980; Verhoef et al., 1977a, b ) . 
Substançe_P_^SP) 
SP-containing neurons are present in the septum (Cuello and Kanazawa, 
1978; Kerdelhue et al., 1981). SP-containing cell bodies are concen-
trated in the medial and ventromedial part of the lateral septal nucleus 
and in the bed nucleus of the stria terminalis (Ljungdahl et al., 1978a, 
b). The lateral septal nucleus is innervated by SP-containing neurons 
arising from a region ventral to it (Paxinos et al., 1978). Intrasep-
tally applied SP decreases the activity of the cholinergic, septo-
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hippocampal neurons; this effect is not mediated via septal γ-amino-
butyric acid containing interneurons (Malthe-Sörenssen et al., 1978; 
Wood et al., 1979). Intraseptally applied SP also affects avoidance 
behaviour (Stäubli and Huston, 1980). 
YeS2Eíe§2iD_ÍY22 
VP-containing neurons originating from the hypothalamus terminate 
within the lateral and dorsal septal nuclei (Brownfield et al., 
1978; Buijs, 1978; Buijs and Swaab, 1979; Buijs et al., 1978; 
Dogterom et al., 1978; Click and Brownstein, 1980). VP, locally 
applied in the dorsal septal nucleus affects avoidance behaviour 
(Kovacs et al. , 1979). 
Luteinizing hormone-releasing factor ^LRF) 
LRF-containing cells are found throughout the septal nuclei; some 
of these cells project to the habenula and interpeduncular nuclei, 
while others form small clusters within the septum itself (Barry, 
1978; Kerdelhue et al., 1981; Silverman and Krey, 1978). Septal 
cells respond to microiontophoretically applied LRF (Poulain and 
Carette, 1977). 
Angiont ens in_II_(A-II) 
Specific A-II binding and A-II containing nerve terminals are pres-
ent in the lateral septal nucleus (Fuxe et al., 1976; Sirett et al., 
1977) . Septal cells respond to intravenously or microiontophoretic-
ally applied A-II (Huwyler and Felix, 1980; Simonnet et al., 1980). 
ïÎÎZï2££°2i2lESlË§SiDS_!ï2E52DS_iî5S2 
Particularly the lateral and dorsal septal nuclei contain TRH 
(Brownstein et al., 1974a; Kerdelhue et al., 1981). Septal cells 
respond to microiontophoretically applied TRH (Winokur and Beck-
man, 1978). 
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Histamine 
Histamine receptors of the HI type are found in the bed nucleus of 
the stria terminalis and in the diagonal band nucleus; lower levels 
occur in the lateral septal nucleus (Palacios et al., 1981). Cells 
in the medial septal and diagonal band nuclei respond to ionto-
phoretically applied histamine (Carette, 1978). 
Oxytocin 
Septal afférents originating from the hypothalamus contain oxytocin 
(Buijs, 1978; Buijs et al., 1978; Dogterom et al., 1978). Oxytocin 
is not found in the lateral septal nucleus (Buijs and Swaab, 1979). 
Oxytocin, locally applied in the dorsal septal nucleus affects 
avoidance behaviour (Kovacz et al., 1979). 
Neurons containing gonadotropin releasing hormone are present 
throughout the septal nuclei (Marshall and Goldsmith, 1980). 
ct-Melanocyte stimulating hormone is found particularly in the 
bed nucleus of the stria terminalis (Jacobowitz and O'Donohue, 
1978; O'Donohue et al., 1979). Neurotensin occurs in the lateral 
septal and diagonal band nuclei and in the bed nucleus of the 
stria terminalis (Young and Kuhar, 1981). These latter nuclei 
contain also somatostatin (Bennett-Clarke et al., 1980). 
Androgen receptors are present in the septum (Liederberg et al., 
1980). Septal cells respond to iontophoretically applied testo-
sterone (Yamada, 1979). Estrogen binding sites are found in the 
lateral septal nucleus, the triangular nucleus, and the bed nu-
cleus of the stria terminalis (Keefer and Stumpf, 1975; Martinez-
Vargas et al., 1976). 
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4.2 EFFECTS OF INTRASEPTAL ADMINISTRATION OF CHOLINERGIC AGENTS ON 
MORPHINE-INDUCED BEHAVIOUR OF CATS 
4.2.1 Summary 
Behavioural effects of intraseptal administration of cholinergic 
agents were analyzed in cats pretreated with morphine 15-20 min or 
40 min earlier. Drug-induced changes were measured both quantitatively 
(onset, duration, and frequency of behavioural items) and qualitatively 
(presence or absence of stereotyped and ritualized behaviour patterns). 
Carbachol and scopolamine given 15-20 min after morphine accelerated 
and retarded, respectively, the normal development of the morphine 
syndrome: carbachol resulted in the display of stereotyped and ri-
tualized patterns, i.e. symptoms characteristic of cats pretreated 
30-40 min earlier with morphine, whereas scopolamine reduced the 
frequency of the behavioural items in comparison with controls, and 
retarded the onset of stereotyped and ritualized patterns. Carbachol 
given 40 min after morphine also affected the fully developed morphine 
syndrome: it increased the frequency of stereotyped and ritualized pat-
terns displayed at that time. This dose-dependent effect, mimicked by 
arecoline and the combination of acetylcholine and physostigmine, could 
be antagonized by atropine and scopolamine, which per se had no influence 
on the stereotyped and ritualized patterns. It is concluded that the de-
gree of cholinergic muscarinic activity within the septal nuclei at'least 
partly determines the genesis of the morphine syndrome in cats. The data 
are discussed in view of the hypothesis that systemically administered 
morphine and intraseptally applied cholinergic agents affect the cholin-
ergic septo-hippocampal system in a common way via distinct sites of 
action at the level of the septal nuclei. 
4.2.2 Introduction 
Septal nuclei play an important role in the effects of morphine on 
hippocampal acetylcholine (ACh) release (Moroni et al., 1978a). Further-
more, relatively high concentrations of morphine receptors and endo-
genous ligands are present in this brain area (Pert et al., 1976; Rossier 
et al., 1977). Still, direct evidence for a role of the septal nuclei in 
the behavioural effects of morphine is not yet available. 
Cholinergic terminals are present within the septal nuclei (Chronister 
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et al., 1976; Fonnum and Walaas, 1978b; Harkmark et al., 1975; Hoover 
et al., 1978; Kobayashi et al., 1978); moreover, ACh is functionally 
active in this brain area (Grossman, 1976; Segal, 197A). Alteration of 
intraseptal cholinergic activity via the intracerebral injection tech-
nique was, therefore, chosen as a tool to affect septal activity in 
morphine-treated cats and to study involvement of the septal nuclei in 
morphine-induced behaviour of cats. 
The behavioural effects of morphine as shown in our laboratory during 
the last few years, are described elsewhere in detail (Cools et al., 
1974, 1977, 1978). In summary, morphine (5 mg/kg, i.p.) elicits a syn-
drome which is built up in three successive steps: depression phase, 
re-organization phase, and ritualization phase. The second phase (start-
ing 10-20 min after morphine injection) is characterized by the break-
down of normal head, limb and postural movements into an increasing 
number of isolated, staccato movements and the subsequent appearance 
of new head, limb and postural movements in which the single units are 
re-integrated. The resulting abnormal patterns are stereotyped, i.e. 
the way in which the single units are integrated into particular spatio-
temporal patterns is completely fixed, and they become ritualized in the 
sense that they are repeated in random order at variable time intervals. 
The last phase (starting 25-35 min after morphine injection) is charac-
terized by the display of stereotyped and ritualized behaviour patterns 
which have reached a more or less stabilized level of frequency. This 
syndrome can be analyzed in terms of 1) changes in onset, duration, and 
frequency of operationally defined behavioural items, and 2) presence or 
absence of stereotyped and ritualized patterns (Fig. 4.3) (Cools et al., 
1977, 1978). 
There is considerable evidence that the intracerebral administration 
of the same compound can influence the nature of morphine-induced re-
organization and ritualization in a different manner (Cools et al., 
1978). Therefore, the current study investigated the effects of cholin-
ergic agents administered intraseptally during the re-organization and 
ritualization phases. 
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Fig. 4.3 Behavioural effects following morphine (S mg/kg, г.p.) in a 
male oat: illustration of the determinants of morphine-induaed 
behaviour. The number of head, limb, and postural movements 
oounted per min are represented as mean values/5 min + S.E.M. 
The onset and termination (min) of the phases following mor­
phine injection are represented as vertical axis inside the 
diagram outlining the different blocks, 
For definition of the onset, see text. 
Reproduced from Cools et al. (1978). 
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4.2.3 Materials and methods 
Adult cats of both sexes (2.0 - 3.5 kg) were used. Cannulae aimed at 
the septal area were bilaterally implanted under pentobarbital anes­
thesia (Nembutal, 40 mg/kg, i.p.). The diameters of the inner and guide 
cannulae were 0.5 and 0.8 mm, respectively (Cools and Van Rossum, 1970). 
After 14 days the animals were inspected and cats showing behavioural 
signs of brain damage were discarded. The intracerebrally administered 
drugs were injected bilaterally with a Hamilton injection syringe. Each 
injection took about 3 s; a volume of 0.5 μΐ was used in all experiments, 
except for the experiment in which a combined ACh/physostigmine injection 
was given (1.0 yl). The solutions were freshly prepared before each ex­
periment. 
The following agents were used: acetylcholine jodide (Fluka); areco-
line bromide (Serva); atropine sulphate (De Onderlinge Pharmaceutische 
Groothandel); carbamylcholine chloride (carbachol; Sigma); physostigmine 
sulphate (De Onderlinge Pharmaceutische Groothandel); scopolamine bromide 
(De Onderlinge Pharmaceutische Groothandel); and morphine chloride (De 
Onderlinge Pharmaceutische Groothandel). All agents were dissolved in 
distilled water, except for morphine which was dissolved in saline (0.9% 
NaCl) . The doses (referring to salts) were selected on the basis of pilot 
studies and earlier data (Hamilton and Grossman, 1969; Kelsey and Gross­
man, 1969; Macphail and Miller, 1968). All animals were pretreated with 
morphine (5 mg/kg, i.p.), except for cats used in the final series of 
experiments. 
In the first series of experiments, cholinergic agonists and antag­
onists were intraseptally administered to cats pretreated 15-20 min 
earlier with morphine. In the second series of experiments, these agents 
were intraseptally administered to cats pretreated 40 min earlier with 
morphine; particular attention was paid to the muscarinic nature and 
dose-dependency of the effects elicited. In the final series of experi­
ments, cholinergic agents were intraseptally administered to non-pre-
treated cats to detect their effectiveness per se. 
After completion of the experiments, the animals were killed with an 
overdose of pentobarbital and transcardially perfused with saline (0.9% 
NaCl) and formaldehyde solution (4%). Brain slices (about 100 um) were 
made along the tracks of the guide cannulae to determine the sites of 
injection. The injection sites were mapped with the help of the atlas 
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of Snider and Niemer (1964). Only experiments in which both left and 
right injection sites were restricted to the septal nuclei are discussed. 
Observation Erocedure_and_behavioural_anal^sis 
First, each animal was familiarized with the observation cage during two 
1 hr periods and adapted to the intracerebral injection procedure by in­
serting an empty needle into the target area. The observation cage (88 χ 
66 χ 61 cm) was soundproof and equipped with a ventilator producing back­
ground noise. The animals were placed into the observation cage 15 min be­
fore the experiments. The observation started immediately after the mor­
phine injection and lasted 60 min. Morphine was administered not more 
than four times to the same animal with a minimum intertrial interval of 
10 days. This dose and schedule resulted in no signs of abstinence and 
tolerance, except for increased salivation. 
The morphine-induced behaviour was recorded on videotapes by means of 
a closed-circuit television. The tapes provided continuous records which 
were analyzed according to the following parameters (Fig. 4.3; Cools et 
al., 1978): number/min of 1) head movements, 2) limb movements, 3) pos­
tural movements, and 4) individual-specific stereotyped and ritualized 
patterns; onset of the re-organization phase (i.e. the end of the de­
pression phase) by averaging the points of time at which the frequencies 
of 1) head, 2) limb, and 3) postural movements started to increase and 
continued to do so for a period of 15 min; onset of the ritualization 
phase (i.e. the end of the re-organization phase) by averaging the points 
of time at which the frequencies of 1) head, 2) limb, and 3) postural 
movements became stabilized for a period of 15 min, and the stereotyped 
and ritualized limb movements or turning and walking patterns appeared. 
In this context, it should be mentioned that some animals showed only 
stereotyped and ritualized limb movements, whereas other animals initial­
ly showed these movements and, later on, integrated them into walking and/ 
or turning patterns. As an increase of such locomotor patterns always im­
plied an increase in limb movements, changes in the number of limb move­
ments were only measured in case no changes in the number of ritualized 
locomotor patterns were elicited. 
The effects of intracerebrally injected agents upon morphine-induced 
behaviour were analyzed in terms of changes in the same parameters. In 
cats receiving intraseptal injections 40 min after morphine, the follow­
ing procedure was chosen to detect significant changes in ongoing behav­
iour: first, the number of stereotyped and ritualized limb movements or 
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turning and walking patterns was counted for 10 min before and after the 
intracerebral injection; second, the differences between both periods 
were calculated per animal; and, finally, these differences in drug-
treated cats were compared with those in controls (Mann-Whitney U-test). 
As the stereotyped and ritualized turning and walking patterns were the 
most characteristic features of the fully developed syndrome, the ana­
lysis of changes in animals which showed stereotyped and ritualized 
locomotor patterns was restricted to these turning and walking patterns. 
4.2.4 Results 
Al ter a ti on of _2Ϊί21 inergi c_ac t ivi t^_in_ the sep t al_nuc 1 e i_dur ing_ the 
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The overall effects were analyzed with the parameters summarized in 
Table 4.4. A qualitative description of these effects is given below. 
Carbachol (1.0 \ig/0.5 μΐ per side, η = 8) given 17 +_ 1 min after 
morphine interrupted the normal development of morphine-induced be­
haviour. In contrast to distilled water-treated control animals, which 
continued to show increased head, limb and postural movements until 24 
min after morphine (8 min after intraseptal injection) (Table 4.4), 
all carbachol-treated animals almost immediately maintained the fre­
quencies of these items at a more or less fixed level and displayed 
individual-specific stereotyped patterns which became ritualized. 
Within 2 +_ 1 min after intraseptal injection, during which two animals 
exhibited short-lasting (2-3 min) hyperactivity, the carbachol-treated 
cats in fact showed all symptoms characteristic of the ritualization 
phase. As shown in Table 4.4, the ritualization period I started at a 
significantly earlier point of time and lasted 8-17 min (mean +_ S.E.M. 
11+^1 min) . Next, the frequencies of behavioural items started to in­
crease for about 6 min, whereas the ritualized stereotyped patterns 
disappeared at the same time; i.e. some patterns disappeared and new 
patterns were introduced. In other words, a second re-organization 
phase appeared (Table 4.4). Finally, the animals started again to main­
tain the frequencies of behavioural items at a more or less fixed level 
and to display stereotyped patterns, which became ritualized for the 
remaining part of the observation period (Table 4.4, ritualization II). 
The cholinergic antagonist scopolamine (10 pg/0.5 μΐ per side, η = 
10) given 16 min after morphine also affected the normal development of 
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TABLE 4.4 
Behavioural effects caused by intraseptal administration 
of distilled water (n=7)3 carbaahol (n=8), and scopolamine 
(n=10) during the morphine-induoed re-organization phase 
distilled , , . scopol-
carbachol 
water amine 
morphine injection 0 0 0 
re-organization I, 
onset 1 0 + 1 1 2 + 1 1 1 + 1 
intraseptal injection 16 17 +_ 1 16 
re-organization I, 
end 24 + 2 17+1 
ritualization I, , 
onset 2 4 + 2 (19 + l) a (41 + 3) 
( 2 + 1) C (25 + 2) c 
end 60 „ 30 + 1 60 
(11 i 1) (> 19Γ 
re-organization II, 
onset - 30+1 
end - 36 + 3 . 
( 6 + 2) d 
ritualization II, 
onset - 36 j+ 3 
end - 60 , 
(> 24)d 
Charaoteristic points of time are represented as number of minutes 
after morphine injection (mean +_ S.E.M.) 
a - carbachol vs. control: ρ < 0.014, two-tailed Mann-Whitney U-test 
b = scopolamine vs. control: ρ < 0.002, two-tailed Mann-Whitney U-test 
с = interval after intraseptal injection (min) 
d = duration (min) 
10 
16 
24 
(8 
4 
(8 
 
(> 
+ 
+ 
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+ 
1 
2 
) C 
2 
2 ) C 
3 6 ) d 
the morphine syndrome. In this case, however, the animals started to 
show fluctuations in frequencies of head, limb and postural movements; 
the ongoing increase in frequency was suppressed for a period of about 
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25 min. About 41 min after morphine, the cats started to maintain the 
frequencies at a more or less stabilized level and to display indi-
vidual-specific stereotyped patterns which then became ritualized. 
In other words, scopolamine retarded the progress of the re-organiza-
tion phase and delayed the ritualization phase in a significant way 
(Table 4.4, ritualization I, onset). 
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morphine-induced_rituaiization_ghase 
Carbachol (1.0 yg/O.S μΐ per side, η = 20) given 40 min after morphine 
resulted in increased frequencies of ritualized turning and walking 
patterns within 1-2 min. As shown in Fig, 4.4, this effect was signi­
ficant in comparison to controls. The movements became even more com­
pulsive and ritualized; in fact, all behaviour patterns were persistently 
repeated in exactly the same way. The duration of this effect was longer 
than the observation period of 60 min, although intermittent periods of 
turning patterns walking patterns 
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Fig. 4.4 Behavioural effects oaused by intraseptal administration of 
distilled water (AQUA, n=8), 0.5 \tg aarbaahol (CAR 1, n=8), 
and 1.0 \ig aarbaahol (CAR 2, n=20) at 40 min after morphine 
during the ritualization phase: mean differences in numbers 
of two ritualized locomotor patterns 10 min before and after 
intracerebral injection. For statistical analysis the indi­
vidual differences measured in drug-treated oats were oom-
pccred with those of controls (Mann-Whitney U-testj 
* one-tailed, it two-tailed). 
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of lower activity were sometimes seen. As shown in Fig. 4.4, the effects 
were dose-dependent: 0.5 ug carbachol (n = 8) was less effective than 
1.0 ug. 
The muscarinic agonist arecoline (5 yg/0.5 μΐ per side, η = 5) given 
40 min after morphine produced a significant increase in the number of 
ritualized limb movements when compared with controls (Fig. 4.5). Figure 
4.5 shows that the same holds true for the injection of a combined solu­
tion of ACh and the acetylcholinesterase (AChE) inhibitor physostigmine 
(respectively, 8.0 and 6.0 ug/1.0 yl per side, η = 3). 
Local pretreatment with the cholinergic blockers scopolamine (10 yg/ 
0.5 μΐ per side, η = 9) or atropine (10 yg/0.5 μΐ per side, η = 2) given 
5 min earlier antagonized the effect of 1.0 ug carbachol (Fig. 4,6). 
Intraseptal scopolamine (10 yg/0.5 yl per side, η = 4) or atropine 
(10 yg/0.5 yl per side, η = 4) alone had no effect on the behavioural 
items displayed at that time. 
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Hg, 4.5 Behavioural effects caused by intraseptal administration of 
distilled water (AQUA, n=8)3 areaoline (ARE, n=b) and 
aoetyloholine/eserine (ACH, n=3) 40 min after morphine during 
the ritualization phase: mean differences in number of ritua­
lized limb movements 10 min before and after intracerebral 
injection. For statistical analysis the individual differ­
ences measured in drug-treated cats were compared with those 
in controls (one-tailed Mann-Whitney U-test). 
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Fig. 4.6 Behavioural effects caused by intraseptal administration of 
distilled water (AQUA, n~8), carbaahol (CAR, n=Z0)3 scopol­
amine/oarbaahol (SCO/CAR, n=9), and atropine/oarbaahol 
(ATR/CAR, n=2) 40 min after morphine during the ritualization 
phase: mean differences in numbers of two ritualized locomotor 
patterns 10 min before and after the intracerebral injection. 
For statistical analysis the individual differences measured 
in aarhaohol-treated cats were compared with those of controls 
(two-tailed Mann-Whitney U-test), whereas the individual dif­
ferences in the scopolamine/carbachol and in the atropine/ 
carbaahol treated animals were compared with those in the 
carbaahol treated animals (one-tailed Mann-Whitney U-test). 
Мі2ЕЁ£і22_2І_£!і2ІіВеЕ2І£_2££ііі£2_І2_£ЬЁ_а£Е£2І_5УЕІЁІ_2Ё_ПеіУЁ_£Ё£5 
Intraseptal arecoline (5 yg/0.5 μΐ per side, η = 6), scopolamine (10 yg/ 
0.5 μΐ per side, η = 2), or atropine (10 yg/0.5 μΐ per side, η = 2) did 
not affect the scores of the behavioural items used in the analysis of 
the morphine-induced behaviour in an unequivocal way. Carbachol (1.0 yg/ 
0.5 yl per side, η = 9), however, resulted in a slight but not signi­
ficant increase in locomotor activity during the 10 min observation 
period (n = 7, Mann-Whitney U-test). Two cats showing mydriasis started 
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to growl after 5-6 min, and one cat showed swallowing movements after 
5 min. Furthermore, all cats displayed a number of threat, fear, and 
flee expressions and/or postures as soon as the experimenter approached 
the cage at the end of the observation period (cf. "affective defensive 
reaction", Macphail and Miller (1968)). Finally, two cats which were 
observed for a longer period exhibited hyperventilation and tongue 
protrusions about 20 min after injection. These effects were less 
pronounced in cats receiving a smaller dose of carbachol (0.5 vg/0.5 yl 
per side, η = 3). 
4.2.5 Discussion 
The present study indicates that cholinergics applied into the septal 
nuclei of morphine-treated cats affect the behaviour of these animals. 
Although leakage of the intraseptally injected drugs to the lateral 
ventricles might have occurred, the small injection volume used (0.5 yl) 
together with the short latency (within 1-2 min also for medial sites) 
justifies the assumption that the drugs injected have mainly affected 
the cholinergic mechanisms within the septal nuclei. In this context, 
it is of interest to note that the display of a symptom like hyper­
ventilation required a much longer latency, suggesting that this effect 
was not mediated via septal cholinergic processes (cf. Macphail and 
Miller, 1968). 
In general, both quantitative (onset, duration, and frequency of · 
behavioural items) and qualitative (presence or absence of stereotyped 
and ritualized behaviour patterns) measures were used to describe the 
changes in the morphine-induced behaviour following the intracerebral 
injections. 
The drug-induced changes elicited by injections given 15-20 min after 
systemic morphine were, in fact, qualitative in nature: 1) display of 
stereotyped and ritualized patterns during a period in which the controls 
had just shown an ongoing increase in the frequencies of head, limb and 
postural movements (this apparent shift from the re-organization phase 
towards the ritualization phase was seen in carbachol-treated cats); 
and 2) interruption of the ongoing increase in the frequencies of the 
various items together with postponement of the onset of stereotyped 
and ritualized patterns (this apparent retardation of the development 
of the morphine-induced behaviour was seen in scopolamine-treated cats). 
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The drug-induced changes elicited by agents given 40 min after sys-
temic morphine were, in fact, quantitative in nature, i.e. increase in 
the number of stereotyped and ritualized limb movements during the period 
in which controls had maintained the frequencies of these movements at a 
stabilized level. This effect was seen in arecoline-treated cats and, to 
a different degree, in ACh/physostigmine-treated animals. A comparable 
effect, i.e. an increase in the number of stereotyped and ritualized 
walking and turning patterns (which implies an increase in limb move-
ments) was seen in carbachol-treated cats. 
Considering the specificity of the observed effects, the following 
arguments are offered to emphasize the involvement of cholinergic, 
especially muscarinic, processes. First, the carbachol-induced effect 
was dose-dependent (Fig. 4.4). In this context, it is useful to mention 
that 0.5 vg carbachol appeared to be a threshold dose (Fig. 4.4), where-
as 1.0 yg carbachol had already affected the behaviour of naive cats 
slightly (thus, testing lower or higher doses was not considered). 
Second, the muscarinic agent arecoline and the combination of ACh and 
physostigmine (agents lacking the aspecific effects of carbachol) mi-
micked the effects of carbachol given 40 min after morphine administra-
tion. As it might be expected, due to different potencies of carbachol, 
arecoline, and ACh/physostigmine, these drugs produced quantitatively 
different, but qualitatively similar effects (Figs. 4.4 and 4.5). And, 
finally, the muscarinic cholinergic antagonists scopolamine and atropine 
inhibited the carbachol-induced effect in a qualitatively similar way 
(Fig. 4.6). All these findings support the conclusion that the carba-
chol-induced changes were mediated through muscarinic, cholinergic 
processes within the septal nuclei. Indeed, it is known that muscarinic 
receptors are present within this brain structure (Grossman, 1976; 
Kobayashi et al., 1978). 
The final question deals with the possible role of these cholinergic 
processes in the genesis of morphine-induced behaviour. As mentioned, 
the development of the syndrome could be accelerated by carbachol and 
retarded by scopolamine. Especially the scopolamine-induced inhibition 
of the normal development of the morphine syndrome suggests that septal 
cholinergic processes are essential links in the chain of responses 
triggered by morphine. This, together with the observation that admin-
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istration of cholinergics into the septum of naive cats resulted in no 
significant effect on the scores of the behavioural elements investi-
gated, makes it rather unlikely that the observed effects were simply 
the sum of morphine- and cholinergic-induced behavioural changes. The 
present data, however, are insufficient to exclude this possibility. 
On the other hand, there is hard evidence that both systemic morphine 
and intraseptally applied cholinergic agents can affect the cholinergic 
septo-hippocampal system. 
1. Intraseptal or systemic morphine decreases the turnover rate of 
ACh within the hippocampus of the rat (Moroni et al., 1978a; Schmidt 
and Buxbaum, 1978). Such a decreased hippocampal ACh turnover rate 
appears to be due to a morphine-induced decrease in activity of cholin-
ergic septo-hippocampal neurons originating from the medial septal nuclei 
(Dudar, 1975; Lewis and Shute, 1967; Mellgren and Srebro, 1973; Moroni et 
al., 1978b; Ronunelspacher and Kuhar, 1974; Sethy et al., 1973). 
2. Local application of ACh inhibits the neural activity of cells in 
the medial septal nuclei, in which cholinergic terminals are concentrated 
(Fonnum and Walaas, 1978b; Harkmark et al., 1975; Segal, 1974). 
Thus, both systemic morphine and intraseptally applied cholinergic 
drugs can affect the same cholinergic septo-hippocampal system. Never-
theless, the fact that morphine is unable to change the turnover rate 
of ACh within the septal nuclei (Zsilla et al., 1977) excludes the pos-
sibility that morphine might have affected the cholinergic septo-hippo-
campal neurons by modifying the cholinergic input of the medial septal 
cells. Accordingly, it is attractive to postulate that systemic morphine 
and intraseptally applied cholinergic agents did affect the cholinergic 
septo-hippocampal system in a common way via two distinct sites of action 
at the level of the septal nuclei: cholinergics via interference with a 
direct or indirect cholinergic input on medial septal cells, and morphine 
via interference with a direct or indirect noncholinergic input on these 
cells. From this point of view, it becomes possible to understand why the 
cholinolytics given 40 min after morphine injection did not affect the 
display of stereotyped and ritualized patterns although the cholino-
mimetics did. At that time, the influence of septal cholinergic mech-
anisms on the septo-hippocampal system might have been so small, in 
comparison to that of morphine, that a further decrease of the cholin-
ergic influence on the septal cells remained ineffective. 
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As a final remark, the morphine-induced behaviour proved to be a 
reliable tool for detecting functional deficits of the septal nuclei. 
Although the present paradigm is insufficient to examine the nature of 
the deficit itself (cf. Donovick et al., 1979a), it appeared to be a 
valid and reliable tool for examining the nature and specificity of 
the neurotransmission processes underlying septal deficiencies. In 
more sophisticated paradigms, this knowledge can be used in studies 
analyzing the nature of the deficit itself. 
The present study shows that the degree of activity in septal 
muscarinic processes at least partly determines the genesis of the 
morphine-induced behaviour in cats. On the basis of the present and 
earlier reported behavioural, biochemical, and electrophysiological 
data, it is suggested that systemic morphine and intraseptally applied 
cholinergic agents affect the cholinergic septo-hippocampal system in 
a common way via two distinct sites of action at the level of the 
septal nuclei. 
4.3 PRESENCE OF A PARTICULAR SUBPOPULATION OF DOPAMINE RECEPTORS WITHIN 
THE SEPTAL NUCLEI: A BEHAVIOURAL STUDY ON CATS 
4.3.1 Summary 
The behavioural effects of intraseptal administration of dopaminergic 
drugs (apomorphine, haloperidol, (3,4-dihydroxy-phenylamino)-2-imidazo-
line (DPI), ergometrine and dopamine) and α-noradrenergic drugs (oxy-
metazoline, noradrenaline and phentolamine) were analyzed in cats pre-
treated with morphine (5 mg/kg, i.p.). Changes in frequencies of stereo­
typed locomotor patterns were used for statistical evaluation of drug-
induced effects. Taking advantage of the specificity of the drugs men­
tioned, a distinction could be made between effects mediated via 
excitation-mediating dopamine (DAe), inhibition-mediating dopamine (DAi) 
and α-noradrenaline (a-NA) receptors. Intraseptal injection of the DAi 
agonist DPI resulted in a decrease in the frequency of stereotyped loco­
motor patterns. This effect was dose-dependent and mimicked by that of 
intraseptally applied dopamine but not of any of the other drugs. More­
over, intraseptal injection of the DAi antagonist ergometrine inhibited 
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the effect of DPI. The DAe agonist apomorphine as well as the DAe antag-
onist haloperidol remained ineffective when applied in low doses. The 
a-NA antagonist phentolamine and a rather high dose of haloperidol pro-
duced a slight but significant increase in the frequency of locomotor 
patterns; intraseptally applied oxymetazoline counteracted the phentol-
amine-induced effect. It is concluded that the septal nuclei of cats 
contain functionally active, a-NA receptors as well as functionally 
active, dopamine (DA) receptors having pharmacological properties 
identical to those of DA receptors present within mesolimbic structures 
such as the nucleus accumbens: the so-called inhibition-mediating DAi 
receptors. 
2 Introduction 
In the past few years, evidence has been accumulated for the existence 
of more than one type of dopamine (DA) receptor in the brain (Cools and 
Van Rossum, 1976, 1980; Creese and Sibley, 1979; Garau et al., 1978; 
Kebabian and Calne, 1979; Norcross and Spehlmann, 1978; Roth, 1979; 
Titeler et al., 1978). The septal nuclei are one of the brain areas 
with a relatively high dopamine content (Brownstein et al., 1974b; Collu 
et al., 1980; Carey, 1976; Klemm et al., 1979; Saavedra and Zivin, 1976; 
Versteeg et al., 1976). Dopamine-containing neurons innervating the sep-
tal nuclei and arising from the mesencephalic ventral tegmental area 
(AIO cell group; Assaf and Miller, 1977; Lindvall and Stenevi, 1978-; 
Moore, 1978) can be classified into two distinct groups, viz. "smooth" 
and "fine-varicose" dopamine neurons (Lindvall and Stenevi, 1978; Moore, 
1978) which might reflect the presence of distinct types of DA receptors 
(Cools and Van Rossum, 1976, 1980). Binding studies also suggest the 
existence of more than one type of DA receptor in septal and other lim-
bic brain areas(Blackburn et al., 1978; Howlett et al., 1979). In the 
present study, an attempt was made to elucidate the pharmacological 
nature of the DA receptors within the septal nuclei by analyzing the 
behavioural effectiveness of intraseptally applied agents that selective-
ly interact with the so-called excitation-mediating dopamine (DAe) and 
inhibition-mediating dopamine (DAi) receptors (Cools and Van Rossum, 
1976, 1980). DAe receptors are rather selectively activated by apo-
morphine and inhibited by haloperidol; in contrast, DAi receptors are 
selectively activated by (3,4-dihydroxy-phenylamino)-2-iraidazoline (DPI) 
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and inhibited by ergometrine. Accordingly, attention was focussed on 
the effectiveness of these agents, 
Besides dopaminergic afférents the septal nuclei also receive nor-
adrenergic afférents from the locus coeruleus and other structures in 
the lower brain stem (Lindvall and Steveni, 1978; Moore, 1978). In 
addition, noradrenaline and noradrenaline (NA) receptors are present 
and functionally active within the septal nuclei (Brownstein et al., 
1974b; Camargo et al., 1977, 1979; Kelsey, 1976; Robinson et al., 1978; 
Segal, 1974; Swanson and Hartman, 1975; U'Prichard et al., 1980; Young 
and Kuhar, 1980). As the DAe antagonist haloperidol and the DAi agonist 
DPI are not devoid of o-noradrenergic (a-NA) properties (Bevan et al., 
1979; Cools, 1978; Peroutka et al., 1977; Struyker Boudier et al., 1975), 
some α-ΝΑ agents were also tested to determine the specific dopaminergic 
character of the effects elicited by the DA drugs. 
The morphine-induced behaviour of cats has been demonstrated to be a 
reliable model to disclose changes in the functional activity of the 
septal nuclei (Megens and Cools, 1979). Consequently, this behavioural 
model was chosen as a tool in the present study to investigate the ef­
fects elicited by intraseptal microinjection of DA and NA agents. The 
results provide evidence for the existence of the DAi type of receptor 
within the septal nuclei and for their involvement in the regulation of 
morphine-induced behaviour of cats. 
4.3.3 Materials and methods 
General 
Adult cats (2.0-3.5 kg) of both sexes were used. The animals were ob­
tained from the breeding colony of the Central Animal Laboratory Uni­
versity of Nijmegen, and housed and fed under standard laboratory 
conditions. Cannulae aimed at the septal area were bilaterally implanted 
by means of a stereotaxic procedure under pentobarbital anaesthesia 
ρ 
(Nembutal , 50 mg/kg, i.p.). The double-barrelled, stainless steel can­
nulae were fixed on the skull with acrylic dental cement; the diameter 
of the guide and inner cannulae were 0.8 mm and 0.5 mm respectively, 
After a 2 week recovery period, the animals showing no overt behavioural 
signs of brain destruction were habituated to the experimental cage and 
the injection procedure for two separate periods of 1 hr each. A quarter 
of an hour prior to each experiment, the animal was placed in this obser-
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vation cage. The observation cage (88 χ 66 χ 61 cm) was soundproof and 
equipped with a ventilator producing background noise. With exception 
of the perspex front window the walls were opaque. During the experi­
ments care was taken to prevent the occurrence of changes in the imme­
diate surroundings of the cage. Behaviour was recorded on videotapes by 
means of closed-circuit television. 
Drugs administered intracerebrally were injected manually by means of 
Hamilton injection syringes (diameter of the needle: 0.4 mm). Each in­
jection took about 3 sec. In general, the volume injected was 0.5 yl. 
The drugs were dissolved in distilled water apart from the higher dose 
of haloperidol (10 yg), which was dissolved in 1% ascorbic acid solution 
to achieve better solubility. The solvents were sterile and apyrogenic. 
The solutions were prepared freshly before each experiment. The doses 
refer to the salts. The following agents were used: apomorphine hydro­
chloride (De Onderlinge Pharmaceutische Groothandel), ascorbic acid 
(Merck AG), (3,4-dihydroxy-phenylamino)-2-imidazoline hydrochloride 
(DPI; Wander), dopamine hydrochloride (De Onderlinge Pharmaceutische 
Groothandel), ergometrine maléate (Haiewood Chemicals), haloperidol 
hydrochloride (Janssen Pharmaceutica), 1-noradrenaline hydrochloride 
(Fluka AG), oxymetazoline hydrochloride (Ciba-Geigy), phentolamine 
methane-sulphonate (Ciba-Geigy), and yohimbine hydrochloride (Nogepha). 
All intracerebrally applied drugs were tested in cats pretreated 
with a systemic injection of morphine dissolved in saline (morphine 
hydrochloride, De Onderlinge Pharmaceutische Groothandel, 5 mg/kg, 
i.p.). Agents proven to be effective in morphine-pretreated cats were 
also tested in non-pretreated cats to determine their effectiveness 
per se. The experiments were performed between 8.00 a.m. and 4.00 p.m. 
When animals were tested more than once, an intertrial interval of at 
least two weeks was used. Using this time-interval, no signs of toler-
ance or abstinence were seen apart from increasing salivation. 
After the experiments the animals were sacrificed with an overdose 
of pentobarbital (Nembutal ) and perfused intracardially with a formal-
dehyde solution (4-10%) containing the anticoagulant heparin (50 mg/1). 
Brain sections (ca. 100 μτη) were made along the tracks of the guide can-
nulae. The injection sites were localized with the help of the atlas of 
Snider and Niemer (1964). Effects caused by bilateral injections into 
sites only one of which was localized within the septal nuclei were dis­
carded. 
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Animals receiving an intraperitoneal (i.p.) injection of morphine were 
observed for a period of 60 min immediately following morphine admin-
istration. The morphine-induced behaviour of cats has been described 
extensively elsewhere (Cools et al., 1974, 1977, 1978; Megens and Cools, 
1979). All intraseptally injected drugs were given 40-41 min after 
morphine: at that point of time, the animals normally show stereotyped 
behaviour. Changes in frequencies of stereotyped locomotor patterns 
were used for statistical evaluation of the drug-induced effects. In 
this study, single locomotor patterns were defined as: 1) any forward 
or backward movement of the animal along a minimum distance of 40 cm 
in the case of discontinuous locomotion, 2) any forward or backward 
movement of the animal along a fixed distance of 80 cm in the case of 
continuous locomotion, 3) any turning movement of the animal around a 
minimum angle of 180 in the case of discontinuous turning, 4) any 
turning movement of the animal around a fixed angle of 360 in the 
case of continuous turning. Both the total score of locomotor patterns 
over 10 min immediately preceding the intraseptal injection (X ) and 
the total score of locomotor patterns over 10 min following the intra-
septal injection (X ) were determined per animal. Behaviour was not 
analyzed during the 2 min injection period. 
Drug-induced inoreases in locomotor activity were assessed by measur-
ing the absolute difference per animal in number of locomotor patterns 
scored per animal during the pre- and post-injection period: 
abs post pre 
This variable was calculated for all animals. The values obtained in 
that manner per test group were compared with the corresponding values 
for the appropriate control group. 
As decreases in locomotor activity only occur in animals showing 
at least some locomotion during the pre-injection period, only animals 
with a minimal number of 10 locomotor patterns during the pre-injection 
period were used in the assessment of drug-induced decreases. Further-
more, since a decrease in the number of locomotor patterns measured by 
the variable Δ ^ is limited by the pre-injection value X , the dif-abs j f j р
Г е
» 
ferences between pre- and post-injection values were expressed as per­
centage of the sunimated pre- and post-injection values: 
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Δ . = / 0 S t " V e χ 100% (Χ > 10) 
rel Χ ^ + Χ pre 
post pre 
The values thus obtained per test group were compared with the corre­
sponding values for the appropriate control group. Note the difference 
between this definition of relative changes and the more conventional 
definition of relative changes 
Xpo St -
 Xpre
 χ 1 0 0 % < 
pre 
All statistical tests were two-tailed. When test and control group 
were composed of the same animals, the Wilcoxon matched pairs signed 
rank test was used; the Mann-Whitney U-test was applied in the remain­
ing experiments. Note that the data in the tables are given as mean 
values jb S.E.M. notwithstanding the non-parametric statistics used. 
Although values of both Δ , and Δ , were calculated for all drug 
" abs rel 
treatments, only values of Δ . are decisive for the presence of a 
' abs 
drug-induced increase in contrast to the values of Λ , which are 0
 rel 
decisive for the presence of a drug-induced decrease in number of 
locomotor patterns. 
Behavioural analysis in non-mor£hinized_cats 
After a habituation period of a quarter of an hour the inner cannulae 
were unscrewed and a 10 min observation period started. Immediately 
after this reference period the injections were given; next, the ani­
mals were observed for another 20 min period. Since these experiments 
served as controls for drug effects in morphine-pretreated cats par­
ticular attention was paid to the items used in the analysis of 
morphine-induced behaviour. 
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TABLE Д.5 
Behavioural effects elicited by drugs applied intraseptally 
40-41 min after systemic morphine. Frequencies of stereo­
typed locomotor patterns are used as dependent variables 
d r u g
 a,b treament ' 
distilled water 
apomorphine 
Haloperidol 
haloperidol 
DPI 
DPI 
DPI 
ergometrine 
oxymetazoline 
noradrenaline 
phentolamine 
phentolamine 
oxymetazoline 
2 
2 
2 
2 
2 
2 
1 
2 
2 
2 
2 
2 
2 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
0.5 
5.0 
5.0 
10.0 
10.0 
4.3 
5.0 
10.0 
10.0 
10.0 
10.0 
10.0 
10.0 
Jil 
УЕ 
yg 
Ug 
Ug 
Ug 
Ug 
Ug 
Ug 
Ug 
yg 
ygi 
yg/ 
η 
15 
16 
11 
10 
15 
7 
12 
10 
8 
9 
19 
8 
ab s 
(mean+SEM) 
6 + 
14 + 
13 + 
19 + 
-11 + 
-19 + 
-36 + 
14 + 
7 + 
13 + 
18 + 
1 + 
3f 
io n s 
4ns 
5d 
6d 
.o
e 
16e 
6ns 
6ns 
8 n s 
4 e 
2ns,g 
с 
η 
9 
11 
4 
4 
9 
6 
5 
4 
4 
7 
10 
4 
A
re l m 
(mean+SEM) 
13 
10 
23 
28 
-36 
-28 
-32 
6 
11 
6 
16 
-16 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
8 f 
10ns 
ins 
iins 
15d 
.3d 
8 e 
9ns 
10ns 
llns 
3 n s 
15ns 
For each drug treatment mean values +_ S.E.M, averaged over the whole 
test group are given for both Д , (defined as X . - X Ì and Δ , a r J
 * aos
 J
 post pre rel 
(deHned as (X .-* )/(X +X ) χ 100%); for details see section post pre post pre ' · 
Behavioural analysis in morphine-pretreated cats. 
a = all drugs were administered in a volume of O.b ul apart from halo­
peridol, which was given in a volume of 1.0 \ιΙ. 
b - the agents were given bilaterally (2x) apart from 5 ug DPI, which 
was injected unilaterally (lx). 
с = only animals with Xp
re
 (number of locomotor patterns displayed 
during the pre-injeation period) > 10. 
d = ρ < 0.05, e - ρ < 0.02, ns - not significant, 
f = not tested (drugs vs. distilled water) 
g - ρ < 0.0?, (phentolamine vs. phentolamine/oxymetazoline) 
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4.3.4 Results 
Alteration_of_DAe_activitj;_within_the segtal nuclei_of_morghine-
After intraseptal injection of the DAe agonist apomorphine (bilaterally, 
5 yg per side, η = 16) there was no change in the performance of stereo­
typed behaviour. The drug-induced change in number of locomotor patterns 
measured by Δ , and Δ , did not differ significantly from the corre-3
 abs rel ь J 
sponding values measured in distilled water-treated control animals 
(bilaterally, 0.5 ul per side, η = 15; Table 4.5). The same applied to 
the intraseptal injection of the DAe antagonist haloperidol (bilaterally, 
5 pg per side, η = 11; due to solubility problems this agent was admin­
istered in a volume of 1 μΐ; Table 4.5). When administered in a higher 
dose (bilaterally, 10 yg/ul per side, η = 10), however, haloperidol re­
sulted in a slight, but significant, increase in the number of locomotor 
patterns as measured by Δ , (Table 4.5). 
Alteration_of_DAi_activit2_within_the se¡)tal_nuclei of niorghine-
E£Ë£r5Ë£eÉ_£§ï2 
Intraseptal injection of the DAi agonist DPI (bilaterally, 10.0 yg per 
side, η = 15; bilaterally, 4.3 yg per side, η = 7; unilaterally, 5 yg, 
η = 12) greatly affected the performance of stereotyped behaviour. As 
indicated by the values of Δ ., the various doses of DPI produced sig­
nificant decreases in the number of locomotor patterns (Table 4.5). 
Locomotion was totally, or almost totally, absent within a few min 
after an effective injection of DPI; the drug-induced attenuation was 
most pronounced in animals displaying higher pre-injection levels of 
locomotor activity (Fig. 4.8). Although the method chosen does not 
offer hard information about changes in the duration of the drug-in­
duced phenomena, DPI also appeared to shorten the total time spent in 
locomotor activity. The mean latencies +_ S.E.M. of the effects elicited 
by the various doses of DPI were: 0.2 + 0.2 min (2 χ 10 yg) , 0 +^  0 min 
(2 χ 4.3 yg) and 1.5 +^  I .0 min ( 1 x 5 yg) ; additional characteristics 
are illustrated in Fig. 4.7. Even a unilateral injection of 5 yg DPI 
was effective (Table 4.5: Δ .; Fig. 4.7b). With respect to the dose-
dependency of the DPI effect it must be stated that there was no dif­
ference in the magnitude of the effect elicited by bilaterally given 
doses of 10 yg and of 4.3 yg during the first 10 min post-injection 
period (Table 4.5: Δ . ) ; however, the effect caused by 2 χ 4.3 yg DPI 
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Fig, 4.7 Time-dependent development of drug—induced ahanges in fre­
quencies of morphine-induaed locomotor patterns elicited by 
intraseptal administration of: a) distilled water (0. S \il, 
bilaterally, n=9); b) DPI (S yg, unilaterally, n=5i; c) DPT 
(4.3 vg, bilaterally, n=6); d) DPI (10 \ig, bilaterally, n=9) 
40-41 min after morphine injection. The number of locomotor 
patterns scored per animal per min is expressed as percentage 
of the total number of locomotor patterns scored for each 
individual animal during 10 min immediately preceding and 
19 min immediately following the local injection. Presented 
are mean values of these percentages averaged over the whole 
test group (with exception of animals shawing less than 10 
locomotor patterns during the pre-injection period). This 
method takes into account the inter-individual differences 
in locomotor activity. 
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scores of locomotor activity 
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animals(n=15) ordered according to their pre-injection level 
Fig. 4.8 Behavioural effects elicited by intraseptal adninistration 
of: a) distilled water (O.S \il, bilaterally, n=15); b) DPI 
(10 vg, bilaterally, n=15) on morphine-induced locomotor 
activity. Animals were ranked in order of increasing scores 
of locomotor activity displayed during the pre—injection 
period of 10 min. These pre-injection scores per animal are 
represented in the figure as successive columns of increas­
ing height. For each individual animal the scores for loco­
motor activity displayed during the post-injection period 
of 10 min are also given in the appropriate columns. Drug-
induced differences between post- and. pre-injection levels 
are illustrated as follows: Ώ increase, Я decrease. 
Note the dependence of the DPI-induced effect on the pre-
injection level. 
had a shorter duration than the effect caused by 2 χ IO pg DPI (cf. 
Figs. 4.7c and 4.7d). 
From a qualitative point of view, the behaviour following the DPI 
injection was not different from that before the injection: the move­
ments themselves remained staccato and poorly co-ordinated, and the 
behavioural patterns were still stereotyped. In some animals, however, 
DPI produced a remarkable effect, i.e. the cats adopted a posture quite 
similar to the species-specific genital grooming posture for shorter or 
longer periods during which they did not start to groom. Occasionally, 
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this posture changed into lying, or almost lying, with extended fore­
legs. These particular postures were observed for a mean period of 
about 80 sec in 40% of the animals receiving the lowest dose of DPI 
(unilaterally 5 yg) and for a mean period of about 200 sec in 90% of 
the animals receiving the highest dose of DPI (bilaterally, 10 pg per 
side). 
A number of animals in which DPI turned out to be effective were 
also given intraseptal dopamine (bilaterally, 10 yg per side, η = 8) 
or the a-NA agonist oxymetazoline (bilaterally, 10 ug per side, η = 7): 
dopamine, but not oxymetazoline, mimicked the DPI-induced effect (Table 
4.6: Δ , ) . 
rel 
TABLE 4.6 
Behavioural effects elicited by drugs applied intra-
septally 40-41 min after systemic morphine in ЭРІ-
sensitive animals. Frequencies of stereotyped loco­
motor patterns are used as dependent variables 
d r U e
 a.b treatment * 
distilled water 
dopamine 
oxymetazoline 
DPI 
DPI 
ergometrine 
2 
2 
2 
1 
1 
1 
χ 
X 
X 
X 
X 
X 
0.5 μΐ 
10.0 ug 
10.0 ug 
10.0 ug 
10.0 ugi 
10.0 ug/ 
η 
15 
8 
7 
10 
10 
Δ , 
ab s 
(mean+SEM) 
6 i 3 f 
-21 + 10е 
13 и- 5 n s 
-39 + 10f 
-18+ 7 f' 8 
с 
η 
9 
8 
7 
10 
10 
Л
ге1 (%> 
(mean+SEM) 
13 + 8 f 
-9 + 4 e 
9 + 4 n S 
-36 + 10f 
-19 + 6 f · 8 
For each drug treatment mean values +_ S.E.4. averaged over the whole 
test group are given for both Δ , (defined as X _,_ - X ) and Λ -, J д J
 abs J post pre rei 
(defined as (X .-X )/(X ^+Х ) χ 100%) : for more 'details see J
 pooi pre post pre J 
section Behavioural analysis in morphine-pretreated animals. 
a = all drugs were administered in a volume of 0.5 \xl. 
b - the agents were given bilaterally (2x) apart from DPI and ergo­
metrine, which were injected unilaterally (lx). 
с = only animals with Х
 г е
 (number of locomotor patterns displayed 
during the pre-injection period) 5 10. 
d - given 10 min prior to DPI 
e - ρ < O.O.S, ns = not significant, f - not tested (drugs vs. distilled 
water), g = ρ < 0.05 (DPI vs. DPI/ergometrine). 
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The DAi antagonist ergometrine (bilaterally, 10 ug per side, η = 10) 
alone did not modify the behavioural effects of morphine when adminis­
tered intraseptally. However, intraseptal injection of ergometrine 
(unilaterally, 10 Vig, η = 10) did antagonize the effect of DPI (uni­
laterally, 10 pg, η = 10): animals selected on basis of their apparent 
DPI effectiveness and treated unilaterally with both 10 vig DPI and 
10 ug ergometrine, given 10 min earlier, showed a significantly re­
duced DPI effect (Table A.6: Δ , ) . 
rel 
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The intraseptal injection of the a-NA agonists oxymetazoline (bi-
laterally, 10 pg per side, η = 8) and noradrenaline (bilaterally, 10 ug 
per side, η = 9) did not affect the stereotyped locomotor patterns (Table 
4.6). After bilateral injection of the a-NA antagonist phentolamine (bi­
laterally, 10 ug per side, η = 19) there was a slight, but significant, 
enhancement of locomotor activity (Table 4.6: Δ , ). This enhancement 
ab s 
was not present in animals receiving a combined solution of phentolamine 
and oxymetazoline (n » 8; Table 4.6: Δ , ). 
ab s 
Alteration_of DAe¿ DAi_and_a-NA_activitjr within_the_se2tal_nuclei_of 
non-morghinized_cats 
The drugs affecting morphine-induced behaviour were also tested in non-
pretreated animals. Neither haloperidol (bilaterally, 10 yg per side, 
η = 5) nor phentolamine (bilaterally, 10 yg per side, η = 5) was ef­
fective. Intraseptal injection of DPI (bilaterally, 10 pg per side, 
η = 13; unilaterally,10 yg, a = 10; bilaterally, 4.3 vg per side, 
η = 8; unilaterally, 5 ug, η = 12), however, elicited one or more of 
the following elimination effects, viz. vomiting, urination and de­
fecation (Table 4.7). Defecation was always followed by vomiting. 
Similar effects were also observed after intraseptal injection of 
the a-NA agonist oxymetazoline (bilaterally, 10 pg per side, η = 8) 
in a small number of cats: vomiting after a latency of 13-16 min 
(η = 2) and defecation after a latency of 20-60 min (η = 2). Animals 
displaying DPI-induced vomiting (n = 3), defecation (n = 1) and urina­
tion (n = 3) did not show these effects when pretreated with the a-NA 
antagonist yohimbine (0.5 mg/kg, i.p.) given 30 min prior to DPI (bi­
laterally, 10 yg per side). 
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TABLE 4.7 
Charaoterízabion of the DPI-induaed elimination 
effects eliaited in non-morphinized aato 
DPI DPI DPI DPI 
10 pg 
bil. 
n=13 
10 vg 
unii. 
n=10 
4.3 м% 
bil. 
n=8 
5 ug 
unii. 
n=12 
5 (38%) 
7.4+0.5 
6-9 
5 (50%) 
9.0+1.3 
6-12 
0 (0%) 
-
-
1 (8%) 
7 
7 
Vomiting 
number of effective animals 
latency (mean +_ SEM, min) 
latency (range, min) 
Défécation 
number of effective animals 2 (15%) 0 (0%) 0 (0%) 0 (0%) 
latency (mean + SEM, min) 4 - - -
latency (range, min) 4 
Urination 
number of effective animals 2 (15%) 1 (10%) 0 (0%) 1 (8%) 
latency (mean + SEM, min) 7.5+3.5 12 - 7 
latency (range, min) 4-11 12 - 7 
Finally, none of the 44 morphine-treated cats receiving DPI displayed 
elimination effects with the exception of 2 animals showing defecation 
after injection of the highest dose of DPI (bilaterally, 10 ug per side) 
with latencies of 4 and 20 min. 
Relation_between_the effect of DPI_u2on_elimination and_that_UE>2D_the 
morphine-indueed_behaviour 
No correlation was found between the occurrence of both DPI-induced ef-
fects as indicated by 2 sets of data: 1) data derived from animals re-
ceiving a single dose of DPI with and without morphine pretreatment 
(η = 34). During the 10 min period immediately after DPI injection, 17 
out of the 34 animals when pretreated with morphine had frequencies of 
locomotor patterns significantly lower than those present during the 
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10 min pre-injection period (ρ < 0.05, two-tailed Mann-Whitney U-test). 
Only 5 out of these 17 animals showed elimination when only DPI treatment 
was given. Such a single DPI treatment given to cats in which DPI was un­
able to affect morphine-induced behaviour (n = 17) produced elimination 
in A animals. In other words, the occurrence of elimination in animals 
that showed the DPI effect on morphine-induced behaviour (viz. in 29% of 
the animals) was not different from that in cats not showing the DPI ef­
fect on morphine-induced behaviour (viz. in 24% of the animals). 
2) data derived from the animals showing a significant DPI effect upon 
morphine-induced behaviour (n = 17). As mentioned above, only 5 animals 
showed elimination. These 5 animals showed a DPI-induced decrease in the 
morphine-induced locomotor activity (Δ
 1 = -43+9%) that was not signi­
ficantly different from that elicited by DPI in the remaining 12 animals 
(A
rel = - 5 1± 8 %>· 
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All injection sites were localized within the septal nuclei; the majority 
of these sites were concentrated in the anterior part of the septal nuclei 
(i.e. stereotaxic co-ordinates A15-A19; cf. Snider and Niemer, 1964). It 
might be useful to note that all DPI sites effective in attenuating loco-
motor activity in morphine-treated animals were, in addition, restricted 
to the nucleus septalis medialis pars anterior +_ 1 mm (cf. Andy and 
Stephan, 1964). 
5 Discussion 
The intraseptal injection of DPI suppressed locomotor activity in 
morphine-pretreated cats. This effect of DPI was mimicked by that of 
intraseptal injection of dopamine and antagonized by intraseptal injec-
tion of ergometrine; neither apomorphine nor haloperidol in a low dosage 
was effective in this respect. These observations suggest that the septal 
nuclei contain DA receptors with pharmacological properties identical to 
those of the so-called inhibition-mediating dopamine (DAi) receptor (Cools 
and Van Rossum, 1976, 1980). To substantiate this statement the specific-
ity of the effects elicited by the various agents has to be discussed. 
The small injection volume (0.5 μΐ) together with the rather short 
latency for the DPI effect (ca. 1 min), even after unilateral injections 
into medially localized sites within the septal nuclei, argues for in-
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volvement of septal receptors in the mediation of the DPI effect on 
stereotyped behaviour. This argument is strenghtened by the fact that 
the effective sites are found within a restricted area of the septal 
nuclei, viz. the nucleus septalis medialis pars anterior. It is when 
injected in this part of the septal nuclei that cholinergic and opiate 
agents likewise affected the behaviour of morphine-pretreated cats 
(Megens and Cools, 1979 and unpublished data). As there were no animals 
with both the left and right cannula implanted into purely medial or 
lateral structures, no definite conclusion could be drawn in this re­
spect. To emphasize the locus specificity of the DPI-induced effect on 
morphine-induced behaviour it is worth mentioning that injections of 
DPI into regions adjacent to the septum, i.e. neostriatal structures 
potentiate but do not inhibit the morphine-induced behaviour (Cools et 
al., 1978). 
The present results attest to the specific dopaminergic character 
of the DPI-induced suppression. The effect elicited by the DAi agonist 
was mimicked by dopamine, but not by a-NA agents, and antagonized by 
the DAi antagonist ergometrine. Although the dopamine-induced decrease 
was relatively small (Δ , = -8+4% (DA) vs. Δ . = -36+10% (DPI)), the 
rel — rel — 
effectiveness of higher doses was not assessed as increasing doses 
would have resulted in a higher spread of the injected drug (cf. Bonda-
reff et al., 1970) and, accordingly, would have affected septal struc­
tures as well as regions adjacent to them. Anyhow, taken together, all 
the data clearly indicate that the DPI effect has a dopaminergic charac­
ter. This dopaminergic character of the DPI effect is consistent with 
the high affinity of DPI for limbic dopamine receptors (cf. Blackburn 
et al., 1978). In this context, it is worth mentioning that the DPI ef­
fect mimicked to a certain degree the effect elicited by manipulation 
of the mesencephalic A9-A10 area (the origin of dopaminergic afférents 
to the septal nuclei) of morphine-treated cats. On the other hand, the 
DPI effect differed greatly from that elicited by manipulation of the 
locus coeruleus region (the origin of noradrenergic afférents to the 
septal nuclei) of morphine-treated cats (Van Dongen et al., 1979). 
Again, both sets of data emphasize the dopaminergic rather than the 
noradrenergic nature of the DPI-induced effect. 
The DPI-induced elimination effects seem to have been mediated via 
a different neuronal system. First, the latency for the DPI effect on 
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morphine-induced behaviour ranged from 0 to 4 min in contrast to that 
for the elimination effects, which varied from 4 to 12 min. Secondly, 
the DPI effect on morphine-induced behaviour had a dopaminergic charac-
ter (see above), whereas the elimination effects were most probably me-
diated via NA receptors (see below). And, finally, no correlation was 
found between the occurrence of both effects. 
As mentioned, intraseptal injection of the DAi antagonist ergometrine 
antagonized the DPI effect on morphine-induced behaviour. This effect 
was not due to a simple summation of DPI-induced and ergometrine-induced 
behavioural changes since ergometrine injection pev se did not affect 
the performance of stereotyped behaviour. Accordingly, the conclusion 
seems justified that the DPI antagonizing effect of ergometrine was 
specific. Whether or not the absence of an effect of ergometrine alone 
on morphine-induced behaviour implies a minimal firing rate of the sys-
tem affected at the time of ergometrine injection (ca. 40 min after 
morphine administration) remains open for discussion. 
The ability of a relatively high dose of haloperidol to potentiate 
the morphine-induced locomotor activity can be ascribed to its potency 
to antagonize a-NA receptors (Cools, 1978a; Peroutka et al., 1977). 
First, the septal nuclei contain a-NA receptors (Brownstein et al., 
1974b; Lindvall and Stenevi, 1978; Moore, 1978; Segal, 1974; U'Prichard 
et al., 1980). Secondly, the a-NA antagonist phentolamine produced an 
effect that could be counteracted by the a-NA agonist oxymetazoline. 
And, las but not least, haloperidol mimicked phentolamine when applied 
intraseptally. This non-dopaminergic character of the effects elicited 
by a relatively high dose of haloperidol together with the ineffective-
ness of the DAe agonist apomorphine excludes the involvement of the so-
called DAe receptors in the dopaminergic DPI effect described above. 
Apart from this, the latter data show that not only dopamine receptors, 
but also a-NA receptors, are functionally active within the septal nuclei. 
In the present study the postulated existence of the DAi type of re-
ceptor within the septal nuclei is based purely on pharmacological evid-
ence. Considering the electrophysiological properties of DAi receptors 
found in the snail Helix aspersa (Struyker Boudier, 1975), one might 
expect that the above-mentioned DA receptors within the septal nuclei 
are also inhibitory at the electrophysiological level. Still, it has 
been reported that dopaminergic, septal afférents arising from the mes-
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encephalic AIO region are excitatory in nature (Assaf and Miller, 1977). 
As the excitatory responses could be inhibited by haloperidol, these 
electrophysiological responses are apparently mediated by a type of DA 
receptors different from the receptors found in the present study. 
As mentioned in the section 4.3.4, intraseptally applied DPI also 
produced vomiting, urination and defecation. In this case, the involve-
ment of DAi receptors can be excluded on the basis of the following 
arguments. First, the DPI-induced vomiting, defecation and urination 
did not occur following pretreatment with the systemically administered 
a-NA antagonist yohimbine. This together with the fact that the intra-
septally applied a-NA agonist oxymetazoline also elicited vomiting and 
defecation indicates that a-NA rather than DAi receptors appear to be 
involved in the DPI-induced autonomic responses; indeed, DPI has some 
a-NA agonistic activity (Bevan et al., 1979; Struyker Boudier et al., 
1975). Secondly, the DPI-induced suppression of locomotor activity in 
morphine-treated cats appeared nearly immediately following the intra-
septal injection, whereas the DPI-induced vomiting, urination and de-
fecation required a latency of several minutes. And, finally, there was 
no relationship between the DPI-induced effect upon locomotor activity 
on the one hand and that upon vomiting, urination and defecation on the 
other. 
In conclusion, the septal nuclei contain a particular subclass of DA 
receptors marked by pharmacological properties identical to those of the 
so-called DAi receptors, which are known to be present in structures such 
as the nucleus accumbens that are innervated by the dopaminergic, meso-
limbic tract (Cools and Van Rossum, 1976, 1980). 
As a final remark, the present results reinforce the earlier reported 
evidence for an important role of the septal nuclei in mediating the be-
havioural responses of cats to morphine (Megens and Cools, 1979); as de-
monstrated, stimulation of septal DA receptors attenuated the performance 
of stereotyped, morphine-induced behaviour. As it has been reported that 
stimulation of septal, cholinergic receptors potentiated stereotyped be-
haviour (Megens and Cools, 1979), it is evident that the septal nuclei 
contain dopaminergic and cholinergic systems that mediate mutually op-
posite effects. 
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4.4 .INTRASEPTALLY INJECTED OPIATE AGENTS: EFFECTS ON MORPHINE-INDUCED 
BEHAVIOUR OF CATS 
4.4.1 Summary 
Behavioural effects of intraseptally administered (i.s.) opiate 
agents were analyzed in cats pretreated with intraperitoneally given 
(i.p.) morphine to characterize septal opiate receptors, and to in­
vestigate their involvement in the behavioural effects of morphine. 
The intraseptal injections affected only the frequencies of behaviour 
patterns; the nature of the behaviour patterns remained unchanged. The 
following results were obtained by injections (i.s.) 15-16 min after 
morphine (i.p.): 1) naloxone decreased frequencies of head and limb 
movements, 2) morphine was ineffective. The following results were 
obtained by injections (i.s.) 40-41 min after morphine (i.p.): 
1) 8-endorphin and, to a lesser extent, fentanyl increased frequencies 
of locomotor patterns, 2) morphine and Met-enkephalin were ineffective, 
3) naloxone and naltrexone decreased frequencies of locomotor patterns 
in a dose-dependent way, 4) naloxone and naltrexone antagonized the 
effects of g-endorphin and fentanyl, 5) morphine did not attenuate the 
effect of naloxone. Injections (i.s.) of morphine and naloxone in non-
morphinized animals were ineffective. It is concluded that 1) morphine 
(i.p.) does not affect behaviour via a direct action on septal opiate 
receptors, and 2) the receptors mediating the effects mentioned are. 
most probably ε-type opiate receptors. The hypothesis is put forward 
that morphine (i.p.) increases the release of ß-endorphin from hypo-
thalamic-septal neurons. 
4.4.2 Introduction 
Since opiate receptors and neurons containing opioid peptides are 
distributed over various regions of the central nervous system (for 
reviews see: Adler, 1980; Miller and Cuatrecasas, 1978), the broad 
range of distinct effects, elicited by morphine and related opiate 
agonists might result from discrete actions of the opiates at specific 
regions of the central nervous system. The septal nuclei receive af-
férents, originating from the hypothalamus, that secrete the opioid 
peptide S-endorphin (Bloom et al., 1978; Rossier et al., 1977; Watson 
et al., 1977b). In addition, high densities of opiate receptors and 
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opioid peptides are present within the septal nuclei themselves (Bloom 
et al., 1978; Hong et al., 1977; Law et al., 1979; Rossier et al., 
1977; Simantov et al., 1977), and opiate agents are functionally active 
in this brain region (Botticelli and Wurtman, 1981; Moroni et al., 1977, 
1978a). Consequently, some of the opiate-induced effects may be mediated 
via septal opiate receptors. Septal opiate receptors are not involved in 
the analgesic effect of opiates: although septal lesions have been re-
ported to antagonize morphine-induced analgesia (Castellano et al., 1975; 
Oliverio, 1974), intraseptal injections of morphine or ß-endorphin do 
not evoke analgesia (Herz et al., 1970; Herz and Teschemacher, 1971; 
Moroni et al., 1977, 1978a). On the other hand, there is indirect evid-
ence that septal opiate receptors are involved in the behavioural effects 
of opiates: 1) the septal nuclei have been implicated in a wide variety 
of behaviours (for reviews: Fried, 1972; Grossman, 1976), and 2) septal 
neuronal systems play an important role in the behavioural response of 
cats to morphine administration (Megens and Cools, 1979, 1981; Robinson 
and Wang, 1979). In the present study, an investigation was carried out 
into whether septal opiate receptors are indeed a site of action for 
opiates to produce their behavioural effects. Therefore, an analysis was 
carried out on the effects of intraseptally injected opiate agents on 
the behavioural phenomena elicited by systemic administration of morphine 
in cats. 
The existence of multiple opiate receptors has recently been reported 
(Chang et al., 1980; Kachur et al., 1980; Lord et al., 1977; Martin et 
al., 1976; Wüster et al., 1979). In order to characterize septal opiate 
receptors in the present study, we determined the relative effectiveness 
of intraseptally injected opiate agonists (morphine, fentanyl, Met-enke-
phalin and 8-endorphin) that have differential potencies on 3 distinct 
types of opiate receptors (Chang et al., 1979a, b; Law et al., 1979; 
Wüster et al., 1979): 1) the opiate alkaloid receptor or y-receptor 
(fentanyl > g-endorphin > morphine > Met-enkephalin), 2) the enkephalin 
receptor or б-receptor (Met-enkephalin > fentanyl > ß-endorphin > mor-
phine) and 3) the endorphin receptor or ε-receptor (ß-endorphin > fen-
tanyl >> Met-enkephalin, morphine). The opiate antagonists used, 
naloxone and naltrexone, have affinity for all 3 types of opiate recep-
tors, although somewhat more for the μ-receptor (Chang et al., 1979a, b; 
Lemaire et al., 1978; Schulz et al., 1979). 
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• The behavioural effects elicited by systemically administered mor­
phine in cats have been extensively described elsewhere (Cools et al., 
1974, 1977, 1978). Administration of a moderate dose of morphine 
(5 mg/kg, i.p.) causes the development of 3 behavioural phases which 
appear in succession: depression, re-organization and ritualization. 
Depression is characterized by hypoactivity, re-organization by increas­
ing activity, and ritualization by stabilized hyperactivity. Furthermore, 
during re-organization the movements are staccato-like and uncoordinated; 
during ritualization stereotyped behaviour patterns, which develop during 
the re-organization, are regularly repeated. In the present study, the 
effects of intraseptally injected opiate agents were investigated both 
during the re-organization and ritualization phases in cats pretreated 
with morphine (5 mg/kg, i.p.). 
4.4.3 Materials and methods 
For a detailed description of the experimental conditions and proce­
dures the reader is referred to a previous report (Megens and Cools, 
1981); a general outline of the procedure is given below. 
Stereotaxic operations were carried out in adult cats (2.0-4.0 kg) 
R R 
under pentobarbital anaesthesia (Nembutal or Narcovet , 50 mg/kg, 
i.p.): cannulas aimed at the septal nuclei were implanted bilaterally 
(Cools and Van Rossum, 1970; Megens and Cools, 1981). Intracerebral in­
jections, either bilateral (2x) or unilateral (lx), were carried out 
manually with Hamilton syringes. The following agents were used: 
morphine hydrochloride (De Onderlinge Pharmaceutische Groothandel), 
fentanyl citrate (gift from Janssen Pharmaceutica), human 0-endorphin 
and Met-enkephalin (gifts from Organon), naloxone hydrochloride and 
naltrexone hydrochloride (gifts from Endo Laboratories). The intra-
cerebrally administered drugs were dissolved in distilled water (with 
the exception of the opioid peptides, which were dissolved in 0.01 η 
HCl); the intraperitoneally injected morphine was dissolved in saline 
(0.9% NaCl). All doses refer to the salts. 
All the intraseptally applied drugs were tested in cats pretreated 
with intraperitoneal morphine (5 mg/kg) either during the re-organiza­
tion phase (15-16 min after i.p. morphine) or during the ritualization 
phase (40-41 min after i.p. morphine). Morphine and naloxone were also 
tested in non-pretreated cats. When animals were tested more than once, 
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an intertrial interval of at least 2 weeks was used. Using this time-
interval, no signs of tolerance or abstinence were seen, apart from 
increasing salivation. 
After the experiments, the animals were sacrificed with an overdose 
R R 
of pentobarbital (Nembutal or Narcovet ) and perfused intracardially 
with a formaldehyde solution (4-10%) containing the anti-coagulant 
heparin (50 mg/1)• The brains were removed and sectioned along the 
tracks of the guide cannulae. The injection sites were localized with 
reference to Snider and Niemer's atlas (1964). The various parts of the 
septal nuclei in which the injection sites were localized were subdivided 
and named according to Andy and Stephan (1964). 
^
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The animals received an intraperitoneal injection of morphine (5 mg/kg) 
and were observed for a period of 60 min immediately following the mor-
phine injection. Drugs were injected intraseptally 15-16 min after i.p. 
morphine. Drug-induced changes were measured both qualitatively (changes 
in the nature of stereotyped behaviour patterns) and quantitatively 
(changes in frequencies of head and limb movements). For analysis of 
the quantitative effects, the period of 44 min immediately following 
the intraseptal injections was subdivided into 11 periods of 4 min each. 
For each of these 4 min-periods, the scores of head and limb movements 
per animal were determined and expressed as percentages of the total 
number of head and limb movements displayed during the whole post-injec-
tion period of 44 min. In this way, the ongoing development of the 
morphine syndrome following the intraseptal injections was represented 
independently of inter-individual differences in activity. For statis-
tical analysis the percentages determined for all animals in each test 
group were compared per 4 min-period with the corresponding percentages 
measured in control animals treated with distilled water (2-tailed Mann-
Whitney U-test). 
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The animals received an intraperitoneal injection of morphine (5 mg/kg) 
and were observed for a period of 60 min immediately following the mor­
phine injection. Drugs were injected intraseptally 40-41 min after i.p. 
morphine. Drug-induced changes were measured both qualitatively (changes 
in the nature of stereotyped behaviour patterns) and quantitatively 
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(changes in frequencies of locomotor patterns). The definition of loco­
motor patterns is given in a previous report (Megens and Cools, 1981). 
Both the total score of locomotor patterns over the 10 min immediately 
preceding the intraseptal injections (X ) and the total score of 
locomotor patterns over the 10 min immediately following the intraseptal 
injections (X ) were determined per animal. Behaviour was not ana-J
 post r 
lyzed during the 2 min injection period. Further analysis of the effects 
was performed in a different way for the opiate agonists and antagonists, 
for reasons to be mentioned below. 
Opiate agonists. The absolute difference in the number of locomotor 
patterns scored during the pre- and post-injection period per animal 
was determined by: 
Δ , = X - X 
abs post pre 
This variable was calculated for all the animals. The values obtained 
in this way per test group were compared with the corresponding values 
determined for the appropriate control group (Mann-Whitney U-test). 
Opiate antagonists. As might be expected, injection of opiate antag­
onists resulted in decreased frequencies of the morphine-induced loco­
motor patterns. Therefore, statistical analysis of these effects had to 
be performed differently from the procedure outlined above for opiate 
agonists. First, decreases in locomotor activity can only be determined 
in animals showing at least some locomotor activity during the pre-in-
jection period. Hence, only animals with a minimum number of 10 locomotor 
patterns were used to analyze the behavioural effects elicited by the 
opiate antagonists. Furthermore, the magnitude of decreases in locomotor 
activity is dependent on the pre-injection X values, which differed 
considerably between animals. Accordingly, the relative change in the 
number of locomotor patterns was determined per animal, i.e. the differ­
ence between pre- and post-injection values expressed as a percentage of 
the summated pre- and post-injection values: 
Δ = Vst " fere x 100% (X > 10) rel Χ + X pre 
post pre 
The values thus obtained per test group were compared with the corre­
sponding values for the appropriate control group (Mann-Whitney U-test). 
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The difference should be noted between this definition of a relative 
change and the more conventional definition of a relative change, 
Xpost - Xpre
 χ 1 0 0 Z i 
pre 
The time-pattern of the behavioural effects elicited by the 2 opiate 
antagonists naloxone and naltrexone on locomotor activity differed con­
siderably from each other. To show this difference, the time-dependent 
development of these effects is illustrated in Fig. 4.10. Because of 
inter-individual differences in locomotor activity, a particular pro­
cedure was followed to realize this figure: 
1. Use was made of frequencies of locomotor patterns scored per min 
during the 10 min immediately preceding the intraseptal injection and 
during the 19 min immediately following the intraseptal injection. 
2. For each individual animal these frequencies were normalized, i.e. 
the scores per min were divided by the total score over the 10 min pre­
ceding and the 19 min following the intraseptal injection. 
3. Next, the values obtained in this manner were averaged over the test 
group. 
4. The post-injection values expressed as percentages relative to the 
pre-injection level are presented. 
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After a habituation period of a quarter of an hour the inner cannulae 
were unscrewed and a 10 min observation period started. The injections 
were given immediately after this reference period and the animals sub-
sequently observed for a period of 20 min. Since these experiments 
served as controls for drug effects in morphine-pretreated cats, parti-
cular attention was paid to the elements used in the analysis of mor-
phine-induced behaviour. 
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4.A.k Results 
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Intraseptal injections of naloxone ( 2 x 5 yg; 2 x 1 5 nmol; η = 8) caused 
a decrease in the frequencies of head and limb movements, when compared 
with control injections of distilled water (2 χ 0.5 μΐ; η = 7) as indi­
cated in Fig. 4.9. The remaining movements were still staccato-like and 
poorly co-ordinated. Naloxone did not affect the nature of the stereo­
typed behaviour patterns. The decrease in frequencies of head and limb 
movements reached its maximum level about 4 min after the injections. 
0 θ 16 24 32 АО 
îmjection 
0 θ 16 2А 3 2 АО 
ι i n j 
minafter the mtraseplal injection 
Δ — Δ disti l led water ( 2 χ 0 5μΙ , n = 7 ) *p<005 
о о morphine ( 2 x 1 0 ^ 9 , η = θ ) **ρ<001 
•—· naloxone (2 χ 5 ,jug, η = β )***ρ<0001 
Fig. 4.9 Behavioural effects caused by intraseptal administration of 
distilled water, morphine, and naloxone 15-16 min after i.p. 
administration of morphine. The number of head and limb move­
ments scored per animal per 4 min-period is expressed as a 
percentage of the total number of movements scored for each 
individual animal during the whole observation period of 44 
min immediately following the intraseptal injection. Presented 
are mean values averaged over each test group. The values ob­
tained for each test group were compared per 4 min-period with 
those obtained for the control animals (2-tailed Уапп-Whitney 
U-test). For more details see section Behavioural analysis. 
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About 16-20 min after the administration of naloxone the frequencies of 
head and limb movements increased again whereas these frequencies in the 
control animals had already reached their maximum level at this time (Fig. 
it.9). Intraseptal injections of morphine (2 χ 10 yg; 2 χ 31 nmol; η = 8) 
did not affect the behaviour: the frequencies of head and limb movements 
after the intraseptal injections were similar to those of the controls 
(Fig. 4.9). 
Opiate agoniats. Intraseptal injections of the opioid peptide g-endorphin 
(2 χ 10 pg; 2 x 3 nmol; η = 14) caused an increase in the frequencies of 
locomotor patterns when compared with control injections of distilled 
water (2 χ 0.5 μΐ; η = 15) as indicated in Table 4.8. ß-Endorphin did 
not affect the nature of the stereotyped behaviour patterns: patterns 
already present before the injections remained present after the injec-
tions. The overall effect reached its maximum level about 3 min after 
the injections and was still present 16 min later. The ß-endorphin-
induced increase was suppressed by intraseptal injections of naltrexone 
(2 χ 5 yg; 2 χ 15 nmol; η = 8) given immediately before the B-endorphin 
injections (Table 4.8). In an additional experiment, in which 4 animals 
received the naltrexone/ß-endorphin combination 24 hours after ß-endor-
phin alone, a similar result was obtained (Table 4.8). It may be worth 
mentioning, however, that these 4 animals showed a remarkably reduced 
sensitivity for the second intraperitoneal administration of morphine, 
i.e. the values for the number of locomotor patterns displayed during 
the 10 min before the intraseptal injections (X ) were only 24+^14% 
(mean +_ S.E.M.) of those obtained in the first trial. 
Intraseptal injections of fentanyl ( 2 x 5 yg; 2 x 9 nmol; η •» 10) also 
caused a statistically significant increase in the frequencies of loco­
motor patterns (Table 4.8). Although the dose of fentanyl was higher than 
that of g-endorphin, the magnitude of the fentanyl effect was smaller than 
that of g-endorphin. Fentanyl did not affect the nature of the stereotyped 
behaviour patterns. The fentanyl effect appeared immediately after the in­
jections and gradually decreased in the course of the 19 min following the 
intraseptal injections. The fentanyl effect was suppressed by simultaneous 
intraseptal injection of naloxone ( 2 x 5 ug; 2 χ 15 nmol; η = 8). 
Neither intraseptal injections of morphine itself (2 χ 10 yg; 2 χ 31 
nmol; η = 11) nor intraseptal injections of the opioid peptide Met-enke-
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phalin (2 χ 10 yg; 2 x 1 7 nmol; η = 10) did affect the behaviour; the 
drug-induced changes in the frequencies of locomotor patterns were 
similar to those following control injections (Table 4.8). 
TABLE 4.8 
Behaüioural effects elia-ited by intraseptal ad-
ministration of opiate agonists 40-41 min after 
intraperitoneal morphine. Frequencies of loco-
motor patterns are used as dependent variables 
drug treatment 
1 distilled water 
2 morphine 
3 fentanyl 
4 Met-enkephalin 
5 6-endorphin 
6 fentanyl 
naloxone 
7 ö-endorphin 
naltrexone 
8 6-endorphin 
naltrexone 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
0, 
10 
5 
10 
10 
5 
5 
10 
5 
10 
5 
.5 μΐ 
Ug 
yg 
yg 
yg 
Hg4! 
yg/ 
Ug\ 
yg/ 
y g i f 
yg/ 
η 
15 
11 
10 
10 
14 
8 
8 
4 
A
abs 
(mean+SEM) 
6 
14 
21 
21 
31 
-1 
11 
14 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
3C 
7ns 
7 a 
1 2ns 
8b 
jns.d 
7ns,e 
1 7ns 
Mean values + S.E.M. averaged over the whole testgroup for 
Δ , (defined as X . - X ) are given for each drug treat­
ment; for details see section Behavioural analysis. 
a = ρ < 0.05 Ί 
b = ρ < 0.02 К (drug vs. distilled water, 2-tailed 
ns - not significant Mann-Whitney U-test) 
a = not tested s 
d = ρ < 0.01 (fentanyl/naloxone vs. fentanyl, 1-tailed 
Mann-Whitney U-test) 
e = ρ < O.OS (Q-endorphin/naltrexone vs. ^-endorphin, 
1-tailed Mann-Whitney U-test) 
f = same drug treatment as for group 7 with the difference 
that these animals were tested with an intertrial inter­
val of 24 hours instead of the usual interval of 14 days 
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Opiate antagonists. Intraseptal injections of naloxone ( 2 x 5 yg; 2 χ 
15 rnnol; η = 5) produced a decrease in the frequencies of locomotor 
patterns when compared with control injections of distilled water (2 χ 
0.5 μΐ; η = 9) as indicated in Table 4.9. The remaining behaviour was 
still stereotyped. Intraseptal injections of naloxone did not affect 
the nature of the stereotyped behaviour patterns. The overall effect 
TABLE 4.9 
Behavioural effects elicited by intraseptal 
administration of opiate antagonists 40-41 min 
after intraperitoneal morphine. Frequencies of 
locomotor patterns are used as dependent variables 
drug treatment 
1 distilled water 
2 naloxone 
3 naloxone 
4 naltrexone 
5 naltrexone 
6 naloxone 
morphine 
2 
1 
2 
2 
2 
2 
2 
X 
X 
X 
X 
X 
X 
X 
o. 
5 
5 
1 
5 
5 
10 
.5 μΐ 
PS 
ug 
yg 
yg 
Mg\ 
Mg/ 
η 
9 
9 
5 
5 
8 
7 
rel m 
(mean+SEM) 
13 
-1 
-38 
-15 
-29 
-16 
+ 
+ 
+ 
+ 
+ 
+ 
8 C 
9ns 
.5 b' d 
13 n S 
10 b' e 
8a,f 
Mean values +_ S.E.M, averaged over the whole test group for 
Δ
 7 (defined as (Χ .-Χ )/(Χ ,+Χ ) χ 100%) are given rel ·' post pre post pre ΰ 
for each drug treatment; for details see section Behavioural 
Analysis. 
T.05 "] 
(drug vs. distilled water, 2-tailed 
Mann-Whitney U-test) 
not significant (unilateral naloxone vs. bilateral 
naloxone, 1-tailed Mann-Whitney U-test) 
not significant (S vg naltrexone vs. 1 \ig naltrexone, 
1-tailed Mann-Whitney U-test) 
not significant (naloxone/morphine vs. naloxone, 
1-tailed Mann-Whitney U-test) 
a = ρ < 
Ъ = ρ < 
ns - not 
a = not 
0.05 
0.02 
significant 
tested 
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of naloxone reached its maximum level (about 73% inhibition relative to 
the pre-injection level) about 3 min following the intraseptal injec­
tions and was still present 16 min later (Fig. 4.10A). Unilateral in­
jections of naloxone ( 1 x 5 \ig; 1 χ 15 nmol; η = 9) elicited a less 
pronounced effect being just not significantly different from that 
following the control injections (Table 4.9; Fig. 4.10A). Intraseptal 
injections of morphine (2 χ 10 vig; 2 χ 31 nmol; η = 7) did not signi­
ficantly affect the naloxone-induced decrease when administered imme­
diately before naloxone ( 2 x 5 yg; 2 χ 15 nmol) (Table 4.9). 
Intraseptal injections of naltrexone (2 χ 5 yg; 2 χ 15 nmol; η = 8) 
caused an effect similar to that of naloxone, viz. a decrease in the 
frequencies of locomotor patterns (Table 4.9). The drug affected the 
behaviour of the majority of the animals within 3 min; the effect 
reached its maximum level (about 84% inhibition relative to the pre-
injection level) about 11 min following the injections (Fig. 4.10B). 
A lower dose of naltrexone (2 χ 1 yg; 2 x 3 nmol; η = 5) caused a 
smaller decrease, which also reached its maximum level (about 67% 
inhibition relative to the pre-injection level) about II min follow­
ing the injections (Fig. 4.10B). 
Intrase2tal_in|ections_in non-mor2hinized_cats 
Neither intraseptal injections of morphine (2 χ 10 yg; 2 χ 31 nmol; 
η » 6) nor intraseptal injections of naloxone ( 2 x 5 yg; 2 χ 15 nmol; 
η = 5) affected the behaviour of non-morphinized cats. 
Localization_of_the_in¿ection sites 
All injection sites were localized within the anterior part of the 
septal nuclei (i.e. between the stereotaxic co-ordinates A 15.0 and 
A 18.5; cf. Snider and Niemer (1964)). Table 4.10 shows in which parts 
of the septal nuclei the injection sites for the effective agents, i.e. 
for naloxone, naltrexone, fentanyl and ß-endorphin, were localized: 
66% of the injection sites were localized within the nucleus septalis 
medialis pars anterior (MA), and a further 26% with 1 mm of it. Further-
more, the ratio effective/ineffective sites was the highest for this 
part of the septal nuclei. 
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locomotor patterns 
( percentage relative to the pre-mjection level ) 
0 A 
tmject ion 
- · naloxone 1x Spgln iQ) 
-o naloxone 2x5>jg(n=5) 
- • nal trexone 2 « 1 ¿jg ( η = 5 
-o nal trexone 2 xS^jg ( n= θ 
mm after mtraseptal injection 
i distilled water 2x05pl ( n = 9 ) 
.-pre-mjection level 
Fig. 4.10 Behavioural effects caused by intraseptil injeation of dis­
tilled water, naloxone, and naltrexone at 40-41 min after 
intraperitoneal administration of morphine: tine-aourse of 
the drug-induaed effects. The scores per min of locomotor 
patterns were normalized for each individual animal and 
averaged over each test group. Presented are the mean 
post-injection values expressed as percentages relative 
to a pre—injection level of 10 min. For more details see 
section Behavioural Analysis. 
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TABLE 4.10 
Distribution throughout the septal nuclei of in­
jection sites into which naloxone, naltrexone, 
fentanyl or ^-endorphin were injected. The 
ratio between the number of effective sites 
and ineffective sites is given per nucleus. 
brain 
region 
BD 
DA 
DM 
H 
1С 
LI 
MA 
(MA + 1 mm; 
MP 
number of 
effective 
sites (a) 
16 
2 
2 
2 
0 
1 
69 
) (94) 
8 
number of 
ineffective 
sites (b) 
6 
1 
0 
1 
1 
0 
12 
(19) 
2 
ratio 
(a/b) 
2.67 
2.00 
-
2.00 
0.00 
-
5.75 
(4.95) 
4.00 
Total 100 23 
Abbreviations: 
BD = nucleus of the diagonal band of Broca pars dorsalis; 
DA - nucleus septalis dorsalis pars anterior; 
DM = nucleus septalis dorsalis pars intermedius; 
H = anterior continuation of the hippocampus ; 
1С = islands of Calleja; LI = nucleus septalis lateralis 
pars interna; MA - nucleus septalis medialis pars anterior; 
MP = nucleus septalis medialis pars posterior. 
(nomenclature according to Andy and Stephan (1964)) 
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4.4.5 Discussion 
Opiate agents injected into the septal nuclei can affect the behav-
iour of cats: behavioural effects of intraperitoneal administration of 
morphine are diminished by intraseptal injections of opiate antagonists 
(naloxone and naltrexone) and potentiated by intraseptal injections of 
some opiate agonists (ß-endorphin and fentanyl). The behavioural effects 
reported here are most probably due to interactions of the drugs with 
opiate receptors since 1) opiate agonists and antagonists elicited 
mutually opposite effects, i.e. agonists increased and antagonists de-
creased the intensity of the behaviour, and 2) the effects elicited by 
the opiate agonists could be suppressed by opiate antagonists. 
The effects under discussion are most probably mediated via septal 
structures : 
1. In contrast to manipulation of structures adjacent to the septal 
nuclei such as the caudate nucleus, manipulation of the septal nuclei 
themselves only causes changes in the frequency of behavioural pat-
terns induced by intraperitoneal morphine, without affecting the 
nature of the stereotyped behaviour patterns (Cools et al., 1978; 
Megens and Cools, 1979, 1981; Cools and Van Beek, unpublished 
results). Again, in the present study, only changes in the frequency 
of morphine-induced behaviour patterns have been found after manipu-
lation of the septal nuclei. 
2. At least the effect of ß-endorphin is not mediated via diffusion into 
the adjacent ventricular system: in the present study, excitatory be-
havioural effects were seen within 3 min following intraseptal ad-
ministration of ß-endorphin whereas similar effects have been reported 
to occur after a latency of 15-30 min following intraventricular in-
jection of a similar dose of the peptide (Feldberg and Smyth, 1977; 
Meglio et al., 1977) . 
3. The majority of the injection sites were localized within or near a 
restricted part of the septal nuclei, viz. the nucleus septalis 
medialis pars anterior. As the ratio effective/ineffective sites 
was highest for this part of the septal nuclei, a foremost conclusion 
is that, especially, receptors within this particular part, rather 
than septal structures adjacent to it, are essential for the display 
of the observed phenomena. It is just this anterior part of the septal 
nuclei which has been implicated earlier in the behavioural effects of 
morphine in rats (Kerr and Pozuelo, 1971). 
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A noticeable observation was that naltrexone produced its greatest 
effect about 11 rain after intraseptal injection; the particular time-
course of this effect may be related to the relatively low lipophilicity 
of this agent (cf. Herz and Teschemacher, 1971; Kaufman et al., 1975). 
A further point of discussion is the differential effectiveness of 
the intraseptally injected opiate agonists. Although factors such as 
differences between drugs in dosage, pharmacokinetics, or localiza-
tion of the injection sites cannot be excluded, a major factor appears 
to be the ability of the opiate agonists to interact differentially 
with various types of opiate receptors (see 4.4.1) as will be explained 
below. 
The most effective opiate agonist in the present study was ß-endorphin, 
although this agent was injected in the lowest dose (on a molar base). 
This argues for the involvement of the e-type opiate receptor (cf. Schulz 
et al., 1979; Wüster et al., 1979, 1980). Although the presence of &-
receptors and enkephalins within the septal nuclei has been demonstrated 
before (Duka et al., 1981; Hong et al., 1977; Rossier et al., 1977; Sar 
et al., 1978; Simantov et al., 1977; Watson et al., 1977a), intraseptal 
injection of the δ-agonist Met-enkephalin was ineffective in the present 
study. Accordingly, the effects of the other opiate agents are probably 
not due to (5-receptors. Intraseptal injection of the y-agonist morphine 
was also ineffective, although it was injected at a maximum dose (on a 
molar base). The effectiveness of higher doses was not assessed as in-· 
creasing doses would have resulted in a higher spread of the drugs in­
jected (cf. Bondareff et al., 1970). On the other hand, the potent 
μ-agonist fentanyl was effective in the present study. Although the 
dose used for fentanyl was 3 times as high as that for 8-endorphin, 
the effect of fentanyl was however smaller than that of ß-endorphin. 
Moreover, as fentanyl also has some potency on e-type opiate receptors 
in contrast to morphine and Met-enkephalin, which were ineffective in 
the present study, these data argue for the involvement of ε-type re­
ceptors rather than μ-type receptors (cf. Wüster et al., 1979). 
Accordingly, it may be concluded that the present effects are 
mediated via e-like type of opiate receptors. This is corroborated 
by the findings of other authors: the high levels of ß-endorphin in 
the septal nuclei (Bloom et al., 1978; Law et al., 1979; Rossier et 
al., 1977), the only moderate level of enkephalins (Hong et al., 1977; 
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Rossier et al., 1977; Sar et al., 1978; Simantov et al., 1977; Watson 
et al., 1977a) and the small density of μ-receptors (Atweh and Kuhar, 
1977; Pert et al., 1976). In addition, it has been reported that intra-
septal injection of p-endorphin is far more effective than intraseptal 
injection of morphine in decreasing the hippocampal turnover rate of 
acetylcholine (Moroni et al., 1977, 1978a). 
The conclusion that the present effects are mediated via morphine-
insensitive, ε-like types of opiate receptors has the following implica­
tions: 1) systemically administered morphine does not act directly on 
the opiate receptors involved in the present effects, and 2) the effects 
elicited by the intraseptally applied opiate antagonists are due to their 
ability to antagonize the action of endogenous ß-endorphin on ε-like re­
ceptors and not to their ability to antagonize the action of systemically 
administered morphine on ц-receptors. 
In order to explain the finding that intraseptally administered 
naloxone was effective only in morphinized cats but not in non-morphin-
ized animals, the following is of relevance. Hypothalamic neurons con­
taining both S-endorphin and adrenocorticotrophic hormone (ACTH) course 
to the septal nuclei (Bloom et al., 1978; Rossier et al., 1977; Watson 
et al., 1977b, 1978b). g-Endorphin can be released concomitantly with 
ACTH (Allen et al., 1978; Guillemin et al., 1977; Vale et al., 1978). 
Morphine administration results in an increased release of ACTH from 
the pituitary via an action on the hypothalamus (French et al., 1979; 
Guaza et al., 1979; Meites et al., 1979; Sloan, 1971). Accordingly, the 
hypothesis is put forward that systemic administration of morphine causes 
an increase in the release of ß-endorphin from the hypothalamic-septal 
neurons, which, in turn, activates septal, ε-like opiate receptors. In­
deed, it has been demonstrated that chronic morphineadministration af­
fects the level of ß-endorphin within the septal nuclei (Przewlocki et 
al., 1979). This hypothesis offers a simple explanation of 1) the dif-
ferential effectiveness of the intraseptally administered opiate agonists, 
and 2) the observation that intraseptally injected opiate agonists and 
antagonists respectively potentiate and diminish the effects of system-
ically administered morphine, although they do not act on morphine's 
receptors. 
As a final remark, which already has been mentioned in section 4.4.4, 
intraseptal ß-endorphin apparently reduced the sensitivity of the animals 
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to a second intraperitoneal injection of morphine 24 hours later, 
suggesting that septal opiate receptors of the e-type are not devoid 
of a possible role in the development of tolerance (cf. Kerr and Pozuelo, 
1971; Przewlocki et al., 1979). 
It is concluded that 1) systemically administered morphine does not 
affect behaviour via a direct action on septal opiate receptors, and 
2) the receptors mediating the effects of the intraseptal injections 
are most probably ε-type, opiate receptor's. The hypothesis is put for­
ward that systemically administered morphine causes an increase in the 
release of 3-endorphin from hypothalamic-septal neurons. 
4.5 GENERAL COMMENTS 
Analysis of the effects of intraseptally injected drugs on the be­
haviour of morphine-treated cats was used in the present study as a 
method to get more insight into the pharmacological and functional 
properties of septal neurotransmission processes. This approach is 
only valid when the intracerebrally-evoked effects are mediated via 
septal structures. Indeed, the reported effects are most probably 
mediated via septal structures since: 
1. Manipulation of structures adjacent to the septum, such as the 
caudate nucleus, causes changes in the nature of morphine-induced 
behaviour patterns (Cools et al., 1974; Cools and Van Beek, un­
published results; section 3.2). In contrast, the drugs injected 
into the septum caused only changes in the frequency and not in 
the nature of the morphine-induced behaviour patterns. Hence, it 
can be stated that the effects observed in this study are charac­
teristic for septal structures. 
2. The latencies for the intraseptally-evoked effects were, in general, 
rather small. These short latencies and the small injection volume 
(0.5 μΐ) argue against the possibility that the observed effects 
might have been mediated via a spread of the intraseptally injected 
drugs to extraseptal regions of the brain. 
3. The injection sites were localized within a restricted part of the 
septum, i.e. mainly within the nucleus septalis medialis pars 
anterior (Fig. 4.1). Although mediation of the present effects via 
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more lateral parts of the septum cannot be excluded, this restricted 
localization of the injection sites, together with the short laten­
cies and the small injection volume, indicates that the effects are 
most probably mediated via this nucleus septalis medialis pars 
anterior and not via caudal or ventral parts of the septum or via 
the lateral ventricles. In this context, it is worth mentioning that 
this rostral part of the septum has already previously been impli­
cated in the behaviour effects of morphine and vasopressin in rats 
(Kerr and Pozuelo, 1971; Wimersma Greidanus et al., 1972). 
The specificity of the effects seems established: 1) the effects are 
dose-dependent, 2) the effects are mimicked by those of other agents 
of the same drug-class, and 3) the effects are sensitive for agonist/ 
antagonist interactions. The effects are certainly not due to the 
local anaesthetic properties of the drugs, since intraseptal injections 
of the local anaesthetic lidocaine ( 2 x 5 pg) did not affect the fre­
quencies of morphine-induced locomotor patterns: Δ, = 1 0 + ^ 7 ( n » 9 ) 
and Δ , = 14 + 13% (η = 5) for lidocaine vs. Δ , = 6 + 3 (η = 15) 
rel — abs — 
and Δ . = 13 ^  8% (η • 9) for distilled water (unpublished results). 
The present method appeared to be suitable for the study of septal 
neurotransmission processes since it enabled us to get more insight 
into several aspects of these processes, e.g. 
1 . Tl}e_functional activit2_of se£tal_neurotransmission_2rocesses_at 
Ïiïê_k£tï§Yi2ü£_-'-eve^ 
The present study shows that septal cholinergic, dopaminergic, nor-
adrenergic and endorphinergic processes are functionally active at 
the behaviour level. This study is the first report indicating a 
definite role for septal dopaminergic and endorphinergic systems 
in behaviour. Septal cholinergic processes have already previously 
been implicated in avoidance behaviour, anti-nociception, food- and 
water-intake, emotionality and urinary excretion (see section 4.1.4). 
Septal noradrenergic processes have been reported previously to play 
a role in avoidance behaviour, food- and water-intake, and urinary 
excretion (see section 4.1.4). The present study shows that these 
neuronal systems are also involved in morphine-induced behaviour of 
cats. Septal glutamatergic processes may also be functionally active 
at the behaviour level since intraseptal injections of glutamate (2 χ 
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5 yg) caused a tendency towards decreased frequencies of morphine-
induced locomotor patterns: Δ . = -21 +^15% (η = 6) for glutamate 
vs. Δ . = 13 +_ 8% (η = 9) for distilled water. The present results 
are considered as insufficient for determining the nature of septal 
function in behaviour although it is noticeable that the intraseptal 
injections affected only the frequencies, and not the nature of the 
morphine-induced behaviour patterns. More sophisticated test situa­
tions are required to investigate septal function in behaviour in 
more detail. 
2. The gharmacological character_of septal rece2tor_sites 
Taking advantage of the specificity of the intraseptally injected 
drugs, it has been possible in the present study to determine the 
pharmacological character of those receptor sites, within the septum, 
that were involved in the intracerebrally-evoked effects: the acetyl­
choline receptors are of the muscarinic type, the dopamine receptors 
of the DAi type, the noradrenaline receptors of the α-type, and the 
opiate receptors of the e-type. 
3· ïiië_£!iS££i2Sal_intërâc£i2D2_'3Stï£ËS_SÊE£2l_SSuE2£EaS2!2Îa5Î22 
grocesses 
The intraseptally injected drugs produced a common effect, i.e. 
changes in frequencies of morphine-induced locomotor patterns, which 
implicates that the various effects are mediated via a common neuro.nal 
pathway. In other words, it is quite probable that the present ef-
fects are mediated via a direct or indirect action on a common output 
system of the septum. Intraseptal injections of cholinergic agonists, 
endorphinergic agonists or noradrenergic antagonists produced in-
creased frequencies of morphine-induced locomotor patterns, whereas 
intraseptal. injections of dopaminergic agonists, endorphinergic antag-
onists or, presumably, glutamatergic agonists produced decreased 
frequencies of morphine-induced locomotor patterns. This data indi-
cates that septal cholinergic and endorphinergic systems on the one 
hand and septal dopaminergic, noradrenergic and, presumably, gluta-
matergic systems on the other hand exert opposite actions on a common 
output system of the septum. Several arguments are available to con-
sider the cholinergic, septo-hippocampal pathway as the most probable 
candidate for this common output system: a) the injection sites were 
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located in the nucleus septalis medialis, which is the origin of the 
septo-hippocampal neurons (section 4.1.3), b) the intraseptal injec­
tion of opiate agonists or noradrenaline antagonists, which produced 
increased frequencies of morphine-induced locomotor patterns, have 
been reported to decrease the activity of the septo-hippocampal 
neurons (Moroni et al., 1977, 1978a; Robinson et al., 1978), с) the 
intraseptal injection of cholinergic agonists, which also produced 
increased frequencies of morphine-induced locomotor patterns, may 
also decrease the activity of the septo-hippocampal neurons since 
intraseptal injection of acetylcholine has been reported to decrease 
the activity of medial septal cells (Segal, 1974). On the basis of 
the present data, however, the (additional) involvement of other 
septal projections cannot be excluded. The functional interactions 
between septal dopaminergic and cholinergic processes are investi­
gated in more detail in Chapter 5. 
4. The action_of_morghine_on_segtal_neurotransmission_£rocesses 
The present results show that the morphine-induced behaviour is 
affected by changes in septal neuronal activity. Moreover, as septal 
cells respond to systemically administered morphine (Robinson and 
Wang, 1979), it is demonstrated that septal neuronal systems are 
intermediates between target sites of morphine and the behaviour 
consequences of morphine administration. 
5. The §çtion_of morphine on se2tal_ogiate_recegtors 
The present results show that morphine does not act directly on 
septal opiate receptors but that it may act indirectly via an in-
creased release of 0-endorphin from hypothalamic-septal neurons. 
Frequencies of morphine-induced locomotor patterns were used in this 
study as experimental variable for the drug-induced effects. No dif-
ference was observed between male and female cats in the degree of the 
morphine-induced locomotor activity as indicated by the number (mean ^ 
S.E.M.) of locomotor patterns displayed in the period of 30-39 min 
after administration of morphine to naive cats, i.e. 25 +_ 6 locomotor 
patterns for male cats (n = 87) vs. 2 7 + 5 locomotor patterns for 
female cats (n = 99). Table 4.11 gives values for the number of loco-
motor patterns (displayed 30-39 min after morphine injection), ordered 
according to the time of injection during the year. This data - which 
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TABLE 4.11 
Possible seasonal rhythm in the loco-
motor response of oats to morphine 
administration CS mg/kg, i.p.) 
, number number of 
month _ , 
of cats locomotor patterns 
2 4 + 8 
1 2 + 6 
67 + 21 
4 + 1 
7 + 4 
4 4 + 1 7 
17 + 10 
21 + 10 
14 + 12 
31 + 15 
26 + 11 
1 8 + 5 
Given are values (mean +_ SEM) for the number of 
locomotor patterns displayed in the period 30-39 
min after morphine administration (5 mg/kg, i.p.) 
to naive animals. 
(The values are averaged over 4 years) 
January 
February 
March 
April 
May 
June 
July 
August 
September 
October 
November 
December 
19 
14 
14 
9 
3 
23 
7 
26 
8 
16 
19 
28 
is averaged over a period of 4 years - is not sufficient to prove the 
existence of a seasonable rhythm in the locomotor response of cats to 
morphine administration. Nevertheless, it may be a warning for investi-
gators working in this field. An important observation considering the 
relationship between septal damage and the occurrence of hyperreactivity 
(Fried, 1973) is that no relation was found between the anatomical lo-
calization of the cannula-placement and the degree of morphine-induced 
locomotor activity (not shown). 
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In general, the cats were used in more than one experiment in the 
present study. An intertrial interval of 2 weeks was used in those 
cases. Using this schedule of morphine administration, no signs of 
tolerance or abstinence were observed, apart from an increasing 
salivation. As all drug-induced effects reported in this chapter were 
also observed in naive animals, it can be stated that these were not 
secondary effects, due to previous drug-treatment. Apart from carba-
chol, the intraseptally injected drugs produced no long-term effects. 
Intraseptal injections of carbachol (2 χ 1 yg) at 40-41 min after 
morphine administration resulted in an enhanced locomotor response 
of the cats to morphine, not only immediately following the intra­
septal injection of carbachol but also when morphine was injected 
once more 2 weeks later. This is illustrated by the following sets 
of data: 1) When comparing the number of locomotor patterns displayed 
during the 10 min immediately before the carbachol injection, i.e. 30-
39 min after morphine injection, with that displayed by the cats during 
the corresponding period after the morphine injection 2 weeks later, 
there is an increase of 25 + 11 locomotor patterns (n = 16; ρ < 0.05, 
two-tailed Wilcoxon matched-pairs signed ranks test). 2) When distilled 
water (2 χ 0.5 ul, η = 11) was injected instead of carbachol the cor­
responding value was only 0+^5 locomotor patterns. 
In conclusion, it can be stated that the analysis of the effects 
of intraseptally injected drugs on the morphine-induced behaviour of 
cats appeared to be a suitable method for the study of pharmacological 
and functional properties of neurotransmission processes in the septum. 
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CHAPTER 5 
MORPHINE-INDUCED BEHAVIOUR OF CATS: A TOOL TO STUDY FUNCTIONAL 
INTERACTIONS BETWEEN NEUROTRANSMISSION PROCESSES WITHIN SEPTAL 
AND STRIATAL NUCLEI 
THE SEPTAL NUCLEI AND INVOLVEMENT IN CENTRAL DOPAMINE-ACETYLCHOLINE 
BALANCE: A BEHAVIOURAL STUDY ON CATS 
1 Summary 
An imbalance between dopaminergic and cholinergic interactions with-
in the basal ganglia, particularly the caudate nucleus, is generally 
thought to be one of the etiological factors in Parkinson's disease. 
In the present study, we call attention to a definite role of the septal 
nuclei in the central dopamine-acetylcholine balance. Functional inter-
actions between the septal nuclei and the caudate nucleus were studied 
by analysis of the behavioural effects elicited by intracerebrally in-
jected drugs in cats pretreated with intraperitoneal morphine (5 mg/kg). 
Changes in frequencies of morphine-induced locomotor patterns were used 
as experimental variables. Simultaneous activation of the so-called 
inhibition-mediating dopamine (DAi) receptors within the septal nuclei 
and those within the caudate nucleus by means of the DAi-agonist (3,4-
dihydroxyphenylamino)-2-imidazoline (DPI) resulted simply in an effect 
characteristic of activation of the septal DAi receptors. This effect 
is a significant decrease in the frequencies of morphine-induced loco-
motor patterns; the effect characteristic of activation of the caudate 
DAi receptors, i.e. a significant potentiation of the morphine-induced 
behaviour, was fully suppressed. Analogous results were obtained in ex-
periments in which the activity at the level of the DAi receptors within 
the septal nuclei and that within the caudate nucleus were simultaneously 
inhibited by the DAi-antagonist ergometrine. Finally, it was found that 
the behavioural effect elicited by intraseptal injections of the cholin-
ergic agonist carbachol, i.e. a significant increase in the frequencies 
of morphine-induced locomotor patterns, was suppressed either by activa-
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tion of the DAi receptors within the septal nuclei or by inhibition of 
the DAi receptors within the caudate nucleus. In the latter case, the 
behavioural effect characteristic of inhibition of caudate DAi recep-
tors, i.e. the replacement of stereotyped behaviour patterns by normal 
ones, remained absent. The present study shows a functional relation-
ship between dopaminergic activity within the caudate nucleus and a 
dopamine-acetylcholine balance within the septal nuclei. The hypothesis 
is put forward that changes in DAi activity within the caudate nucleus 
trigger the activity of a feed-forward system coursing from the caudate 
nucleus to the septal nuclei. The significance of the present findings 
is discussed in the context of the central dopamine-acetylcholine 
balance. 
5.1.2 Introduction 
Studies on the functional interaction between cholinergic and dopa-
minergic mechanisms have demonstrated that there exists a so-called 
dopamine-acetylcholine (DA-ACh) balance within the brain (Arnfred and 
Randrup, 1968; ColpaerL et al., 1975; Corrodi et al., 1972; Costali and 
Olley, 1971; Gianutsos and Lai, 1977; Mennear, 1965; Scheel-Kriiger, 
1970). Effects elicited by activation of the dopaminergic system are 
respectively attenuated or potentiated by activation or inhibition of 
the cholinergic system, and vice versa. In other words, the overall 
interactions between cholinergic and dopaminergic neuronal systems are 
mutually antagonistic. 
A disturbance of this DA-^Ch balance is thought to be one of the 
etiological factors in Parkinson's disease; indeed, degeneration of 
dopaminergic, neostriatal neurons has been demonstrated in Parkinson 
patients (Bernheimer et al., 1973; Calne, 1970; Hornykiewicz, 1975; 
Spehlmann and Stahl, 1976). Biochemical and electrophysiological studies 
provide evidence in favour of the hypothesis that the DA-ACh balance has 
its origin within the basal ganglia, in particular the caudate nucleus 
(Agid et al., 1975; Connor, 1968; Consolo et al., 1974; Ladinski et al., 
1975; McLennan and York, 1966; Sethy and Van Woert, 1974; Stadler et 
al., 1973; Stoof et al., 1979; Trabucchi et al., 1975). Behavioural 
studies however point in the opposite direction: dopamine and acetyl-
choline appear to co-operate with rather than counteract each other 
within this brain region (Cools, 1974; Cools et al., 1975; Costali 
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and Naylor, 1972; Poirier et al., 1974; Wolfarth and Kolasiewicz, 1977). 
Accordingly, the DA-ACh balance has to be considered as a result of a 
functional interaction between dopaminergic activity within the caudate 
nucleus and cholinergic systems outside the caudate nucleus. 
To make a first move in that direction, we investigated whether the 
septal nuclei are important in this respect. Besides the fact that the 
septal nuclei are vulnerable links in various central, cholinergic sys-
tems (Bajgar et al., 1977; Dudar, 1975; Gottesfeld and Jacobowitz, 1978, 
1979; Kataoka et al., 1977; Mellgren and Srebro,,1973; Sethy et al., 
1973; Smith, 1974), there is in any case already some indirect evidence 
that the caudate nucleus is functionally connected with the cholinergic, 
septo-hippocampal system (Baker and Kratky, 1975; Baker et al., 1979; 
Fish, 1976 (referred in Colbern et al., 1977); Click et al., 1974, 
1980). 
In the present study, functional relationships were investigated 
between cholinergic and dopaminergic activity within the septal nuclei 
and dopaminergic activity within the caudate nucleus. The intracerebral 
injection technique was used for changing the activity of these neuro-
transmitter processes. The resulting behavioural effects were investi-
gated in cats pretreated with morphine (5 mg/kg, i.p.), since the 
morphine-induced behaviour of cats has been shown to be a reliable and 
valid model for assessing the efficacy of experimentally induced changes 
in the neurotransmission activity within either the septal nuclei or the 
caudate nucleus (Cools et al., 1978; Megens and Cools, 1979, 1981). As 
both the septal nuclei and the anterodorsal part of the caudate nucleus 
contain so-called inhibition-mediating dopamine (DAi) receptors (Cools 
and Van Rossum, 1976, 1980; Cools et al., 1976; Megens and Cools, 1981), 
we chose the DAi-agonist (3,4-dihydroxyphenylamino)-2-imidazoline (DPI) 
and the DAi-antagonist ergometrine as tools to modify dopaminergic ac-
tivity within the brain structures mentioned; the cholinergic agonist 
carbachol was chosen as a tool to change cholinergic activity within 
the septal nuclei. 
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.3 Materials and methods 
For a detailed description of the experimental conditions and proce-
dures, the reader is referred to previous reports (Megens and Cools, 
1979, 1981); only details of the experimental conditions and procedures 
relevant to the present experiments will be described below. Adult cats 
(2.0-3.5 kg) of both sexes were used. Each animal was bilaterally 
equipped with a cannula directed to the septal nuclei and/or one aimed 
at the anterodorsal part of the caudate nucleus (r-CRM region; cf. Cools 
et al., 1978). 
Drugs were administered intracerebrally by means of Hamilton injec-
tion syringes. The volume injected was 0.5 vl for target sites within 
the septal nuclei and 5.0 ul for target sites within the caudate nucleus 
(Cools et al., 1978; Megens and Cools, 1979, 1981). All the drugs were 
administered bilaterally. The following agents were used: carbamyl-
choline hydrochloride (carbachol; Sigma), (3,A-dihydroxyphenylamino)-2-
imidazoline hydrochloride (DPI; Wander), ergometrine maléate (Haiewood 
Chemicals), and morphine hydrochloride (De Onderlinge Pharmaceutische 
Groothandel). All the drugs were dissolved in distilled water apart 
from morphine, which was dissolved in saline (0.9% NaCl). The doses 
mentioned in the text refer to the salts. 
When animals were tested more than once, an intertrial interval of 
2 weeks was used. Furthermore, the experiments were performed under 
comparable experimental conditions. After the experiments the animals 
were sacrificed by means of an overdose of pentobarbital (Nembutal or 
ρ 
Narcovet ) and intracardially perfused with a formaldehyde solution 
(4-10%) containing the anticoagulant heparin (50 mg/1). The brains were 
cut open along the tracks of the guide cannulae. The injection sites 
were localized with the help of Snider and Niemer's atlas (1964). 
Behaviour al_analj;s is 
All the cats were pretreated with morphine (5 mg/kg, i.p.) 40 min before 
the intracerebral injections and were observed for a period of 60 min 
immediately following the morphine administration. The morphine-induced 
behaviour of cats has been extensively described elsewhere (Cools et al., 
1974, 1977, 1978). In this study, frequencies of morphine-induced loco­
motor patterns (for definition, see Megens and Cools, 1981) were used 
for the statistical evaluation of the drug-induced effects. Both the 
totals of locomotor patterns over the 10 min immediately preceding the 
intracerebral injections (X ) and those over the 10 min immediately 
following the intracerebral injections (X ) were determined per ani-
post 
mal. The behaviour was not analyzed during the 2 min injection period. 
Drug-induced increases were assessed by measuring the absolute dif­
ference per animal in the number of locomotor patterns during the pre-
and post-injection periods: 
Д . = X - X 
abs post pre 
The values obtained in this manner per test group were compared with 
the corresponding values for the appropriate control group. 
As drug-induced decreases can only occur in animals showing at least 
some locomotor patterns during the pre-injection period, only animals 
with at least 10 locomotor patterns during the pre-injection period were 
used in the assessment of drug-induced decreases. Furthermore, the dif­
ferences between pre- and post-injection values were expressed as per­
centages of the pre- and post-injection values summed, since a decrease 
in the number of locomotor patterns measured by the variable Δ would 
be limited by the pre-iniection value X : J r J
 pre 
ή = Vst " V e
 x 1oo% (X > 10) rel X ^ + X pre 
post pre r 
The resulting values were compared with the corresponding values for the 
appropriate control group. Note the difference between this definition 
of relative changes and the more conventional definition 
Xpost " Xpre
 χ I 0 0 % > 
л pre 
For assessing intra-individual differences, the Wilcoxon matched 
pairs signed rank test was used in contrast to the assessment of inter-
individual differences, for which the Mann-Whitney U-test was used. All 
statistical tests were two-tailed. 
Experimental_set-up 
Five experiments were conducted. In the first experiment, animals re­
ceived simultaneous injections of the DAi-agonist DPI into the septal 
nuclei and the caudate nucleus; cats receiving single injections of DPI 
into the septal nuclei served as controls. In the second experiment, the 
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DAi-antagonist ergometrine was simultaneously injected into the septal 
nuclei and the caudate nucleus; controls in this case were animals re­
ceiving single injections of ergometrine into the septal nuclei. In the 
third experiment, single intraseptal injections of the cholinergic ago­
nist carbachol were given in 2 separate trials, 2 weeks apart. In the 
fourth experiment, animals were also treated with intraseptal carbachol 
in 2 trials, 2 weeks apart; in the second trial, however, these animals 
received simultaneous intraseptal injections of DPI. In the fifth ex­
periment, the animals were tested with intraseptal injections of car­
bachol in combination with intracaudate injections of distilled water; 
2 weeks later, these animals received intraseptal injections of car­
bachol in combination with intracaudate injections of ergometrine. 
5.1.4 Results 
In the first experiment, the cats received simultaneous injections 
of DPI (2 χ 10 )jg) into the septal nuclei and the caudate nucleus; 
animals receiving single intraseptal injections of DPI served as con­
trols. The intracaudate injections of DPI did not affect the decrease 
in frequencies of morphine-induced locomotor patterns elicited by the 
intraseptal injections of DPI (cf. Megens and Cools, 1981). No differ­
ence between the groups was found in the values for Δ , (mean +_ SEM) : 
Δ = -29+9% (n=8) for the experimental group vs. Δ = -36+15% (n=9) 
for the control group. Fig. 5.1 illustrates the time course of the drug-
induced effects for both groups. On the other hand, the intraseptal 
injection of DPI fully suppressed the effect commonly observed after 
single intracaudate injections of DPI, as extensively described else­
where (Cools et al., 1978), i.e. no potentiation of the morphine-induced 
behaviour occurred. 
In the second experiment, the animals were simultaneously treated 
with injections of ergometrine (2 χ 10 μ$) into the septal nuclei and 
the caudate nucleus; animals receiving single injections of ergometrine 
into the septal nuclei served as controls. The injections of ergometrine 
into the caudate nucleus did not affect the failure of intraseptal ergo­
metrine to change the frequencies of morphine-induced locomotor patterns, 
which has been previously reported in detail (cf. Megens and Cools, 1981). 
Neither the values for Δ , nor the values for Δ . differed between the 
abs rel 
groups: Δ , = -1+20 (n=ll) and Δ . = 6+15% (n=8) for the experimental 
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l o c o m o t o r patterns 
(percentage relative 
to the pre in ject ion level ) 
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A0-
intraseptal DPI 
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+ intracaudate DPI 
pre-mjection level 
njection m m after mtraseptal injection 
Fig. 5.1 Time-dependent development of changes in frequencies of 
morphine-induoed loaonotov patterns elicited by intra­
cerebral injections of 1) DPI (2 χ 10 уд, n=9) into the 
septal nuclei, and 2) DPI (2 χ 10 vg3 n=8) into the septal 
nuclei in combination with DPI (2 χ 10 vg) invo the caudate 
nucleus. The number of locomotor patterns scored per animal 
per minute is expressed as a percentage of the total number 
of locomotor patterns scored for each individual animal 
during the 10 min immediately preceding and the 19 min im­
mediately following the local injection. Presented are the' 
mean values of these percentages averaged over the test 
group and expressed as a percentage of the pre-injeotion 
level. 
group vs. Δ . = 14+6 (n=10) and Δ . = 6+9% (n=4) for the control & r
 abs — rel — 
group. On the other hand, the intraseptal injection of ergometrine 
suppressed the behavioural effect that was commonly observed following 
single injections of ergometrine into the caudate nucleus as described 
elsewhere in detail (Cools et al., 1978), i.e. the stereotyped behav­
iour patterns were not replaced by normal behaviour patterns. 
The results of the last 3 experiments are illustrated in Fig. 5.2. 
In all 3 experiments, the animals received intraseptal injections of 
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carbachol (2 χ ! yg) in 2 separate trials, 2 weeks apart. In the first 
trial, the magnitude of the carbachol effect, i.e. an increase in the 
frequencies of morphine-induced locomotor patterns (cf. Megens and 
Cools, 1979) was comparable for the 3 groups of animals as indicated 
by the values for Δ
 t in Fig. 5.2A; simultaneous injection of dis-J
 abs 
tilled water ( 2 x 5 ul) into the caudate nucleus does not apparently 
affect the effect of intraseptal carbachol. Furthermore, the carbachol 
effect was consistent in magnitude when single intraseptal injections 
of carbachol were given in the second trial (Fig. 5.2B). However, when 
locomotor pat terns/10 m m · 
180 τ A tnall 
• p<005 
η s not significant 
1 0 0
 С Э group1(n = 7) 
Γ~1 groupSO-irll ) 
group3(n = θ ) 
IAO 
120-
100 
80-
60 
ДО 
20 
.-. ; : 
t nal 2 
.•:••"· 1 
•.m 
CARB.S CARB.S CARB.S 
AOUA.C 
CARB.S CARB.S CARB.S 
D P I S ERGO. С 
Fig. 5.2 Behavioural effects eliaited by intraseptal (s) and/or intra-
aaudate (a) injections of aarbaahol (CARB, 2x1 vg), DPI 
(2x5 vg)3 ergometrine (ERGO, 2 χ 10 цд)1 and distilled 
water (AQUA, 2 χ 5 \il) in oats pretreated with morphine 
(6 mg/kg). Drugs were administered in 2 separate trials, 
2 weeks apart. Values for Δ , (mean +_ SEM) are given for 
eaah drug treatment. 
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in the second trial the DAi-agonist DPI ( 2 x 5 ug) was simultaneously 
injected into the septal nuclei, the carbachol effect was significantly 
reduced (Fig. 5.2B). When in the second trial the DAi-antagonist ergo-
metrine (2 χ 10 \¡g) was simultaneously injected into the caudate nucleus, 
the carbachol effect was also significantly reduced (Fig. 5.2B); more-
over, in this latter case no behavioural effects occurred that are 
commonly observed following single injections of ergometrine into the 
caudate nucleus as previously reported (Cools et al., 1978), that is 
to say the stereotyped behaviour patterns were not replaced by normal 
ones. As a final remark, no differences were observed in the results 
obtained for male and female animals. 
Localization of_the_inj.eçtion §i£e5 
The septal injection sites were localized within the anterior part of 
the septal nuclei (stereotaxic co-ordinates: A 15.0 - A 19.0, L 0.0 -
L 2.0, H 1.0 - H 5.5; cf. Snider and Niemer, 1964); the caudate injec-
tion sites were localized within the anterodorsal part of the caudate 
nucleus (stereotaxic co-ordinates: A 17.5 - A 19.5, L 2.8 - L 4.5, 
H 3.0 - H 7.0; cf. Snider and Niemer, 1964). It might be useful to 
note that for the behavioural effects elicited both by intraseptal 
injection of carbachol and by intraseptal injection of DPI the ef-
fective sites were localized within or near (= within 1 mm of) the 
nucleus septalis medialis pars anterior (cf. Andy and Stephan, 1964). 
5.1.5 Discussion 
The present results indicate the existence of a functional relation-
ship between the septal nuclei and the caudate nucleus: 1) simultaneous 
activation of DAi receptors within the septal nuclei and those within 
the caudate nucleus results in an effect characteristic of activation 
of septal DAi receptors and suppresses the effect characteristic of 
activation of caudate DAi receptors; 2) simultaneous inhibition of DAi 
receptors within the septal nuclei and those within the caudate nucleus 
results in an effect characteristic of inhibition of septal DAi recep-
tors and suppresses the effect characteristic of inhibition of caudate 
DAi receptors; 3) simultaneous activation of acetylcholine receptors 
within the septal nuclei and inhibition of DAi receptors within the 
caudate nucleus inhibits both the effect characteristic of inhibition 
of caudate DAi receptors and the effect characteristic of activation of 
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septal acetylcholine receptors. Such interactions between the septal 
nuclei and the caudate nucleus are remarkable since no direct connec-
tions between these two brain regions have yet been demonstrated. 
Before discussing these interactions in more detail, the interactions 
between dopamine and acetylcholine within the septal nuclei themselves 
will be discussed in detail. 
The finding that the behavioural effect elicited by intraseptal in-
jection of the cholinergic agonist carbachol is inhibited by intrasep-
tal injection of the DAi-agonist DPI indicates the existence of a 
functional antagonism between cholinergic and dopaminergic neuronal 
systems within the septal nuclei themselves. This is not surprising, 
as it has been previously reported that intraseptal injection of DAi 
agonists results in behavioural effects opposite to those elicited by 
intraseptal injection of cholinergic agonists (Megens and Cools, 1979, 
1981). This antagonism between septal cholinergic activity and septal 
DAi activity cannot be due to a cholinergic-induced inhibition of sep-
tal DAi activity since the behavioural effect of the cholinergic agonist 
carbachol is not mimicked by that of the DAi antagonist ergometrine 
(Megens and Cools, 1979, 1981). Nor can it be due to a dopaminergic-
induced inhibition of septal cholinergic activity since the behavioural 
effect of the DAi agonist DPI is not mimicked by that of the cholinergic 
antagonists atropine or scopolamine (Megens and Cools, 1979, 1981). Con-
sequently, it is argued that the septal DAi system and the septal acetyl-
choline system are not serially connected, but that both neuronal systems 
converge on a common output system upon where they exert mutually oppo-
site actions. 
The mechanism for the interactions observed between the septal nuclei 
and the caudate nucleus is less evident. The finding that intraseptal 
injection of the DAi-antagonist ergometrine, which is ineffective per se 
(Megens and Cools, 1981), suppresses the effect caused by intracaudate 
injection of ergometrine indicates that the latter effect is, at least 
partly, mediated via an enhanced DAi activity within the septal nuclei. 
This indication is further strengthened by the ability of intracaudate 
ergometrine to inhibit, just as intraseptal injection of the DAi-agonist 
DPI, the effect of intraseptal carbachol. Septal DAi activity is appar-
ently inversely related to caudate DAi activity. Both the septal nuclei 
and the anterodorsal part of the caudate nucleus, in which the caudate 
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DAi receptors are concentrated (Cools et al., 1976; Cools and Van Rossum, 
1976, 1980), receive their dopaminergic afférents from a common origin, 
the A-10 cell group in the mesencephalic area ventralis tegmenti (Deniau 
et al., 1980; Fallon and Moore, 1978; Simon et al., 1979). Consequently, 
it is quite possible that changes to caudate DAi activity trigger "feed-
back" mechanisms coupling the caudate nucleus with the septal nuclei via 
the area ventralis tegmenti. Evidence for the existence of an analogous 
feed-back loop mechanism between two central dopaminergic pathways has 
been previously presented by Yehuda (1979). Indeed, such a mechanism, 
being in fact a "feed-forward" mechanism, offers a reasonable explana-
tion of the observation that effects caused by alteration of DAi activ-
ity within the caudate nucleus are suppressed by manipulation at the 
level of the septal nuclei. 
The existence of the interactions mentioned above suggests an im-
portant role for the septal nuclei in the central DA-ACh balance. The 
septal nuclei are the origin of several cholinergic projections, par-
ticularly to the hippocampal formation, but also to the habenula, the 
nucleus interpeduncularis, and the amygdala (Bajgar et al., 1977; Dudar, 
1975; Gottesfeld and Jacobowitz, 1978, 1979; Kataoka et al., 1977; Mell-
gren and Srebro, 1973; Sethy et al., 1973; Smith, 1974). Based on the 
present results, septal neuronal activity and, presumably, the release 
of acetylcholine from septal, cholinergic projections are related to 
dopaminergic activity within the caudate nucleus. In other words, 
caudate dopamine controls the cholinergic output of the septal nuclei. 
This line of reasoning can be easily extended to include all mutual 
interactions between dopaminergic input of the caudate nucleus and 
cholinergic output of the septal nuclei. Furthermore, the output 
stations of the septal, cholinergic projections and the area ventralis 
tegmenti may also co-operate via mechanisms that are analogous to the 
above-mentioned feed-forward mechanism. Indeed, the existence of a 
hippocampo-septal pathway has been demonstrated (Chronister and De 
France, 1979; Meibach and Siegel, 1977b; Siegel and Edinger, 1976; 
Swanson and Cowan, 1977); moreover, there is evidence for a septal 
projection to the area ventralis tegmenti, which controls the dopa-
minergic output of this region of the brain (Krayniak et al., 1980; 
Maeda and Mogenson, 1981; Meibach and Siegel, 1977a; Phillipson, 1979; 
Swanson and Cowan, 1979). 
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In any case, the involvement of the septal nuclei in the central 
DA-ACh balance suggests a role for the septal nuclei in the etiology 
of Parkinson's disease. Indeed, two sets of data point in that direc-
tion: 1) The generation of hippocampal theta thythm critically depends 
upon the functioning of the cholinergic, septo-hippocampal neurons 
(Apostel and Creutzfeldt, 1974; Green and Arduini, 1954; Kramis and 
Vanderwolf, 1980; Petsche et al., 1962; Rawlins et al., 1979). This 
hippocampal theta rhythm has been correlated with the occurrence of 
voluntary movements or with transitions from one behavioural state to 
another (Arnolds et al., 1979; Vanderwolf, 1971). Such aspects of be-
haviour are disturbed in patients suffering from Parkinson's disease. 
2) Behavioural effects caused by peripherally administered anti-
cholinergics can be mimicked by manipulation at the level of the sep-
tal nuclei (Hamilton et al., 1968; Hamilton and Grossman, 1969). These 
peripherally administered anticholinergics are beneficial in the treat-
ment of Parkinson's disease (Bernheimer et al., 1973; Calne, 1970; 
Hornykiewicz, 1975; Spehlmann and Stahl, 1976). 
The existence of a DA-ACh balance within the brain is chiefly based 
on studies investigating the interactions between peripherally adminis-
tered dopaminergic and cholinergic drugs (see 5.1.2). Such peripherally 
administered drugs spread throughout the brain and act on all drug-
sensitive, neuronal systems. Most studies have focussed attention on 
the presence of DA-ACh interactions within the caudate nucleus (see 
5.1.2). The present study suggests a functional relationship between 
dopaminergic activity within the caudate nucleus and a dopamine-acetyl-
choline balance within the septal nuclei. Moreover, the present findings 
indicate the existence of a feed-forward mechanism operating between the 
caudate nucleus and the septal nuclei. Consequently, dopaminergic activ-
ity within the caudate nucleus is related to septal neuronal activity 
and, presumably, to the release of acetylcholine from the various septal 
cholinergic projections. These data indicate a definite role for the 
septal nuclei in the central DA-ACh balance. This notion may stimulate 
further studies in this direction in order to elucidate the true nature 
of the central DA-ACh balance and to increase our basic insight into the 
etiology of Parkinson's disease. 
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SUMMARY 
The work described in this thesis analyzes the effects of intracere-
brally injected drugs on the morphine-induced behaviour of the cat. 
The aim of this work was to investigate whether this analysis would 
enable us to study the pharmacological and functional properties of 
neurotransmission processes within anatomically circumscribed regions 
of the brain. Attention is paid to several aspects of neurotransmission 
processes, e.g. 1) the functional activity of neurotransmission processes 
at the behaviour level, 2) the pharmacological character of receptor 
sites, 3) the flexibility of neurotransmission processes, A) functional 
interactions between neurotransmission processes, 5) the action of mor-
phine on neurotransmission processes, and 6) the action of morphine on 
opiate receptors. 
The Preface deals with some introductory comments on the scope, 
general method and the purpose of the investigations. It states the 
research problems and explains the reasons for investigating them. 
Chapter 1 is a general introduction to the use of morphine in the 
present experiments. In the first section, the history of the opiate 
agonist is briefly summarized. The remaining of the chapter is devoted 
to a survey of the various effects of morphine in man and cats. After 
giving a survey of the overt effects of morphine, the more specific 
effects are discussed in detail. A separate section deals with the 
central effects of morphine in the cat. Attention is paid to such 
subjects as specificity, dose-dependency, development of tolerance 
and dependence, effects of drugs, intracerebral injections, and ef-
fects of opioid peptides. It is concluded that the cat is a suitable 
experimental animal for the study of morphine's central action. 
Chapter 2 deals with the experimental method used in the present 
investigations, i.e. the analysis of effects of intracerebrally in-
jected drugs on the morphine-induced behaviour of cats. First, the 
rationale is given for using this method: it might enable us to study, 
in acute experiments, the pharmacological and functional properties of 
neurotransmission processes within anatomically circumscribed regions 
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of the brain, including the action of morphine on these processes. Next, 
after giving a general outline of the experimental procedure, both qua-
litative and quantitative aspects of the morphine-induced behaviour of 
the cat are discussed. Three behaviour phases are distinguished, i.e. 
depression, re-organization and ritualization, which appear in success-
ion. It is argued that, on the basis of its highly structured organiza-
tion and characteristic behaviour patterns, the morphine-induced behav-
iour of the cat is a suitable tool for the disclosure of experimentally 
evoked changes in behaviour. 
Chapters 3, 4 and 5 deal with the experimental studies of the present 
thesis. For a detailed survey of the results obtained in these studies, 
the reader is referred to the summary presented at the beginning of each 
section. A general survey is given below. 
Chapter 3 is devoted to two studies dealing with the action of mor-
phine on central neurotransmission processes. In the first section, the 
analysis is described of both the acute- and the after-effects of nor-
adrenergic agents intracerebrally injected into the nucleus raphe 
linearis. It is demonstrated that noradrenergic processes in this raphe 
nucleus adjust their properties to changed neurotransmission activity, 
and that this flexibility might play a critical role in the development 
of tolerance to morphine. The second section deals with a study concern-
ing the effect of morphine on two pharmacologically distinct dopaminergic 
systems in the caudate nucleus. It is demonstrated that this effect is 
biphasic and that it depends on which dopaminergic system is studied. 
The data is discussed in the context of two diametrically opposite hypo-
theses concerning morphine's effect on central dopaminergic activity. 
Some general comments on the results obtained are given in the final 
section. 
Chapter 4 deals with studies on neurotransmission processes within 
the septum. The first section is a general introduction to this subject 
and gives a survey of the morphology, the anatomical connections and the 
neurochemistry of the septum. It is argued that it is nearly impossible, 
because of the heterogeneity of the septum, to analyze the function of 
this brain structure by classic methods, such as electrical stimulation 
and lesions. The second section - dealing with the effects of intra-
septally injected cholinergic agents - shows that the morphine-induced 
behaviour of the cat can be used as an variable for experimentally-evoked 
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changes in septal neuronal activity. It is suggested that intraseptally 
injected cholinergics and systemically administered morphine exert a 
synergistic action on a common output system of the septum, presumably 
the septo-hippocampal system. The third section deals with the effects 
of intraseptal injections of dopaminergic and noradrenergic agents. The 
results show that a subpopulation of dopamine receptors, i.e. the so-
called DAi receptors, are present within the septum, and that septal 
dopaminergic and noradrenergic processes are involved in behaviour. 
The fourth section deals with the effects of intraseptally injected 
opiate agents. It is demonstrated that septal opiate receptors are 
most probably of the ε-type, and that these, although involved in be­
haviour, are not a site of action for systemically administered morphine 
to produce behaviour effects. It is suggested that morphine enhances the 
release of ¡3-endorphin in the septum via an action on hypothalamic-septal, 
endorphinergic neurons. At the end of this chapter, some general comments 
on the results obtained are given. It is demonstrated that no difference 
exists between male and female cats in the effect of morphine on loco-
motor activity. Furthermore, data is presented which might indicate the 
existence of a seasonal rhythm in this morphine-induced locomotor 
response. 
Chapter 5 deals with the effects of single and combined injections 
of dopaminergic and cholinergic agents into the septum and the caudate 
nucleus. The study demonstrates the existence of a functional relation-
ship between I) dopaminergic and cholinergic activity in the septum, 
and 2) dopaminergic activity in the caudate nucleus and dopaminergic 
and cholinergic activity in the septum. A possible mechanism for the 
observed interactions is proposed. Moreover, a possible role of septal 
structures in central dopamine-acetylcholine interactions and in the 
etiology of Parkinson's disease is discussed. 
It is concluded that the analysis of the effects of intracerebrally 
injected drugs on the morphine-induced behaviour of the cat is a suit-
able method for the study of pharmacological and functional properties 
of central neurotransmission processes. 
2A0 

SAMENVATTING 
In de experimenten, die in dit proefschrift beschreven worden, worden 
de effecten geanalyseerd van intracerebraal toegediende farmaca op het 
morfine-geïnduceerde gedrag van de kat. Het doel van dit onderzoek was 
na te gaan of deze analyse ons in staat zou stellen de farmacologische 
en functionele eigenschappen te bestuderen van neurotransmissie pro-
cessen in anatomisch omschreven hersengebieden. Aandacht wordt besteed 
aan verschillende aspecten van neurotransmissie processen, bijv. 
1) de functionele activiteit van neurotransmissie processen op gedrags-
niveau, 2) het farmacologische karakter van receptoren, 3) de flexibi-
liteit van neurotransmissie processen, 4) functionele interacties tus-
sen neurotransmissie processen, 5) het effect van morfine op neuro-
transmissie processen, en 6) het effect van morfine op opiate receptoren. 
In het Voorwoord worden enkele inleidende opmerkingen gemaakt over 
het onderzoeksgebied, de gebruikte methode en het doel van het onder-
zoek. Verder wordt een uiteenzetting gegeven van de onderzoeksproblemen 
en van de redenen om deze problemen te onderzoeken. 
Hoofdstuk 1 is een algemene inleiding op het gebruik van morfine in 
de experimenten. In de eerste sectie wordt in het kort de geschiedenis 
van de opiate agonist samengevat. De volgende secties worden besteed 
aan een overzicht van de verschillende effecten van morfine in mens en 
kat. Nadat een overzicht is gegeven van de direct zichtbare effecten 
van morfine, worden de meer specifieke effecten in detail beschreven. 
Een afzonderlijke sectie behandelt de centrale effecten van morfine in 
de kat. Aandacht wordt besteed aan onderwerpen als specificiteit, dosis-
afhankelijkheid, ontwikkeling van tolerantie en afhankelijkheid, effecten 
van farmaca, intracerebrale injecties, en effecten van opioid peptiden. 
Als conclusie wordt betoogd dat de kat een geschikt proefdier is voor 
de bestudering van de centrale werking van morfine. 
Hoofdstuk 2 handelt over de methode die gebruikt wordt in de experi-
menten, i.e. de analyse van de effecten van intracerebraal toegediende 
farmaca op het morfine-geïnduceerde gedrag van de kat. Op de eerste 
plaats wordt de rationale gegeven voor het gebruik van deze methode: 
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het zou ons in staat kunnen stellen om, in acute experimenten, meer in-
zicht te verkrijgen in de farmacologische en functionele eigenschappen 
van neurotransmissie processen binnen anatomisch omschreven hersen-
gebieden, als ook in het effect van morfine op deze neurotransmissie 
processen. Nadat vervolgens in grote lijnen de experimentele methode 
is aangegeven, worden kwalitatieve en kwantitatieve aspecten van het 
morfine-geïnduceerde gedrag van de kat besproken. Drie opeenvolgende 
gedragsfasen worden onderscheiden, i.e. depressie, reorganisatie en 
ritualisatie. Het wordt betoogd dat, op basis van zijn zeer gestruc-
tureerde opbouw en karakteristieke gedragspatronen, het morfine-geïndu-
ceerde gedrag van de kat een geschikt middel is om experimenteel opge-
roepen veranderingen in gedrag te ontdekken. 
Hoofdstukken 3, 4 en 5 beschrijven de experimentele studies van dit 
proefschrift. Voor een gedetailleerd overzicht van de resultaten, die 
in deze studies verkregen werden, wordt de lezer verwezen naar de 
samenvatting aan het begin van iedere sectie. Een algemeen overzicht 
wordt hieronder gegeven. 
Hoofdstuk 3 beschrijft 2 studies naar het effect van morfine op 
centrale neurotransmissie processen. In de eerste sectie wordt de 
analyse beschreven van zowel de acute werking als de nawerking van 
noradrenerge farmaca die intracerebraal werden toegediend in de 
nucleus raphe linearis. Aangetoond wordt dat noradrenerge processen 
in deze raphe kern hun eigenschappen aanpassen aan veranderde neuro-
transmissie activiteit, en dat deze flexibiliteit een belangrijke rol 
zou kunnen spelen in de ontwikkeling van tolerantie voor morfine. De 
tweede sectie beschrijft een studie betreffende het effect van morfine 
op twee farmacologisch verschillende dopaminerge systemen in de nucleus 
caudatus. Aangetoond wordt dat dit effect bifasisch is en dat het af-
hangt van welk dopaminerg systeem bestudeerd wordt. De data worden 
bediscussieerd in de kontekst van twee lijnrecht tegenover elkaar 
staande hypothesen over het effect van morfine op centrale dopaminerge 
activiteit. In de laatste sectie worden enkele, algemene opmerkingen 
gemaakt over de verkregen resultaten. 
Hoofdstuk 4 is gewijd aan studies betreffende neurotransmissie 
processen in het septum. De eerste sectie is een algemene inleiding 
tot dit onderwerp en geeft een overzicht van de morfologie, de anato-
mische verbindingen en de neurochemie van het septum. Het wordt betoogd 
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dat het, vanwege de heterogeniteit van het septum, bijna onmogelijk is 
de functie van deze hersenstructuur te analyseren met behulp van klas-
sieke methoden zoals electrische stimulatie of lesies. De tweede sectie 
- die de effecten van intraseptaal toegediende cholinerge farmaca 
beschrijft - laat zien dat het morfine-geïnduceerde gedrag van de kat 
gebruikt kan worden als variabele voor experimenteel opgeroepen ver-
anderingen in septale neuronale activiteit. De suggestie wordt gedaan 
dat intraseptaal geïnjecteerde cholinergica en systemisch toegediend 
morfine een synergistisch effect uitoefenen op een gemeenschappelijk 
output systeem van het septum, vermoedelijk het septo-hippocampale 
systeem. De derde sectie behandelt de effecten van intraseptale injec-
ties van dopaminerge en noradrenerge farmaca. De resultaten laten zien 
dat een subpopulatie van dopamine receptoren, i.e. de zo genoemde DAi 
receptoren, aanwezig zijn in het septum, en dat septale dopaminerge en 
noradrenerge processen betrokken zijn bij gedrag. De vierde sectie be-
treft de effecten van intraseptaal toegediende opiaten. Aangetoond wordt 
dat septale opiate receptoren het meest waarschijnlijk van het ε-type 
zijn en dat deze, ofschoon betrokken bij gedrag, geen aangrijpingspunt 
zijn voor systemisch toegediend morfine om gedragseffecten te produceren. 
De suggestie wordt gedaan dat morfine de afgifte van ß-endorfine in het 
septum verhoogt via een effect op hypothalamische-septale, endorfinerge 
neuronen. Ter afsluiting van het hoofdstuk worden enkele algemene op-
merkingen gemaakt over de verkregen resultaten. Aangetoond wordt dat 
geen verschil bestaat tussen mannelijke en vrouwelijke katten in het 
effect van morfine op locomotorische activiteit. Verder worden data 
gepresenteerd, die erop zouden kunnen wijzen dat een seizoensritme 
bestaat in deze morfine-geïnduceerde locomotorische activiteit. 
Hoofdstuk 5 behandelt de effecten van enkelvoudige en gecombineerde 
injecties van dopaminerge en cholinerge farmaca in het septum en de 
nucleus caudatus. De studie toont aan dat een functionele relatie 
bestaat tussen 1) dopaminerge en cholinerge activiteit in het septum, 
en 2) dopaminerge activiteit in de nucleus caudatus en dopaminerge en 
cholinerge activiteit in het septum. Een mogelijk mechanisme voor de 
waargenomen interacties wordt voorgesteld. Bovendien wordt een moge-
lijke rol van septale structuren in centrale dopamine-acetylcholine 
interacties en in de etiologie van de Ziekte van Parkinson bediscus-
sieerd. 
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Als conclusie wordt gesteld dat de analyse van de effecten van intra-
cerebraal toegediende farmaca op het morfine-geïnduceerde gedrag van 
de kat een geschikte methode is voor de bestudering van farmacologische 
en functionele eigenschappen van centrale neurotransmissie processen. 
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STELLINGEN 
1 
Analyse van gedragsveranderingen welke middels intracerebrale toediening 
van specifiek werkende fannaca in morfine behandelde katten worden opge-
roepen is een geschikte methode om inzicht te verkrijgen in gedragsregu-
lerende, neurochemische processen in het brein die anderszins niet of 
nauwelijks bestudeerd kunnen worden. 
dit proefschrift 
2 
Antagonisme door intracerebraal toegediend naloxon of naltrexon van 
effecten die worden opgeroepen door systemisch toegediend morfine is 
een noodzakelijke, maar niet voldoende voorwaarde om de directe be-
trokkenheid van centrale morfine receptoren bij het tot stand komen 
van deze effecten aan te tonen. 
dit proefschrift 
3 
Een mogelijke rol van septale, cholinerge projecties in het tot stand 
komen van het therapeutisch effect van anticholinergica bij de behan-
deling van de ziekte van Parkinson verdient aandacht. 
dit proefschrift 
4 
De rol van centrale noradrenerge processen in de ontwikkeling van 
tolerantie voor morfine opent perspectieven voor een mogelijk ef-
fectief gebruik van noradrenerge farmaca ter preventie van ver-
schijnselen als tolerantie en afhankelijkheid. 
dit proefschrift 
5 
Bij de bestudering van raorfine-geïnduceerde effecten dient ruime aandacht 
besteed te worden aan het tijdsverloop van deze effecten. 
dit proefschrift 
6 
De stelling van Woodruff et al. (1976, 1978) dat ergometrine een agonist 
is van dopamine receptoren in de nucleus caudatus en de nucleus accumbens 
van de rat wordt onvoldoende gestaafd door hun electrofysiologische be-
vindingen. 
Woodruff, G.N. et al., Brain Res. lib, 23Z-242 (1976) 
Woodruff, G.N., Adv. Bioahem. Psychopharmaool. 19, 
89-119 (1978) 
7 
Ten onrechte concluderen Kilbey en Ellinwood (1980) dat katten weinig of 
geen fysiologische afhankelijkheid van morfine ontwikkelen. 
Kilbey, M.M. en E.H. Ellinwood, Int. J. Addict. 15, 
447-460 (1980) 
8 
De biochemische veranderingen door Moroni et al. (1978) gemeten op meer 
dan 20 min na intracerebrale toediening van farmaca zijn niet zonder 
meer te beschouwen als directe effecten van deze farmaca, aangezien het 
optreden van "rebound" verschijnselen niet kan worden uitgesloten. 
Moroni, F. et al.. Neuropharmacology 17_, 191-196 
(1978) 
9 
Bij het vaststellen van de mate waarin de metabolieten van paracetamol 
worden uitgescheiden door middel van actieve transport processen houden 
Duggin en Mudge (1975) onvoldoende rekening met metabolisme van para-
cetamol in de nier. 
Duggin, G.G. en G.H. Mudge, Br. J. Pharmac. 54_, 
359-366 (1975) 
Hart, S. et al., Clin. Sci. 58_, 379-384 (1980) 
IO 
Bij het interpreteren van de kinetiek van farmaca dient meer aandacht 
besteed te worden aan de centrale werking van deze farmaca aangezien 
deze een belangrijke bepalende factor in de kinetiek van farmaca kan zijn. 
11 
Het leggen van een causaal verband tussen plasmaconcentratie en thera­
peutisch effect van chlorpromazine is weinig zinvol. 
Rivera-C'аЫтЪгп, L. et al.. Commun. Psycho-
phamaool. 2, 215-222 (1978) 
Kolakowska, T. et al., Psyahopharmacology 49, 
101-107 (1976) 
12 
In de stelling van Alderson en Baum (1981) dat - indien steroid deprivatie 
leidt tot degeneratie van mesolimbische dopamine neuronen - acute toedie­
ning van haloperidol minder gemakkelijk zou leiden tot verhoogde DOPAC en 
HVA concentraties in gecastreerde ratten zonder steroid implantatie dan 
in gecastreerde ratten met Steroid implantatie dienen de woorden zonder 
en met vervangen te worden door resp. met en zonder. 
Anderson, L.M. en M.J. Baum, Brain Res. 219, 
189-206 (1981) 
13 
Aangezien het niet goed functioneren van neurochemisch verschillende 
processen in het brein kan leiden tot één en hetzelfde ziektebeeld, 
dient men er zich terdege van bewust te zijn dat patiënten met één 
en hetzelfde ziektebeeld mogelijk farmacotherapeutisch verschillend 
behandeld dienen te worden. 
14 
Overwogen dient te worden het gebruik van de LD5Q, i.e. de dosis van 
een farmacon waarbij 50% van de proefdieren sterft binnen 24 uur na 
toediening van dat farmacon, als maat voor de toxiciteit van farmaca 
te vervangen door het gebruik van bijvoorbeeld de TDCQ, i.e. de dosis 
waarbij 50% van de proefdieren de eerste toxische verschijnselen ver­
toont . 
15 
Speciaal schrijvers van boeken met de titel "Hoe schrijf ik een weten­
schappelijke tekst?" dienen op de omslag van hun eigen publicatie de 
door hen gegeven voorschriften na te volgen. 
Lamers, H.A.J.M., "Hoe schrijf ik een wetenschappelijke 
tekst?", ed. Ό. Coutinho, Muiderberg (1979) 
16 
Het op de markt brengen van zelfklevende postzegels zou de noodzaak van 
het bekende oro-linguale ritueel bij het verzenden van post wegnemen. 
17 
In het kader van de problemen rond de exploitatie van de ons ter beschik­
king staande energiebronnen, kunnen onze automobielen niet langer als 
"zelf voortbewegend" worden beschouwd en dient, derhalve, een andere 
naamgeving overwogen te worden. 
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